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Behaviour Change Update: 
Stage 3 
BCT analysis of behaviour change interventions 
reported in studies of cost effectiveness 
1. Executive Summary 
Using a search strategy of studies with economic analyses by Bazian, 251 
interventions targeting smoking cessation, diet, physical activity, sexual 
health, alcohol and multiple health-related behaviours were identified. Of 
these, 102 provided cost-utility (CUA) estimates and 85.3% were 
considered to be cost-effective based on a conservative NICE threshold. 
Overall, smoking cessation interventions provided lower CUA values and 
were more likely to be cost-effective than interventions for multiple 
health-related behaviours. Across all interventions, those targeting the 
general population had lower CUA results and were more likely to be cost-
effective than those aimed at vulnerable populations. In addition, 
interventions featuring behaviour change techniques (BCTs) related to 
“Reduce negative emotions” had higher CUA values and those featuring 
the BCT “Monitoring outcome(s) of behaviour by others without feedback” 
were less likely to be cost-effective. 
When looking at health-related behaviours separately, diet interventions 
that provided medication only had higher CUA outcomes than other types 
of diet interventions. Moreover, diet interventions including BCTs related 
to “Comparison of outcomes” and interventions for multiple health-related 
behaviours that used electronic supporting material were less likely to be 
cost-effective than interventions that did not. 
Cost-effective interventions included in this report had CUA estimates 
broadly similar to interventions already appraised as cost-effective by NICE 
(reported in Stage 1). However, a higher proportion of interventions in this 
report focused on multiple health-related behaviours, were set in primary 
care, aimed at vulnerable populations, involved training and included BCTs 
pertaining to practical and social support and to discussing body changes. 
By contrast, fewer interventions than in Stage 1 focused on alcohol, were 
set in the work place, delivered at population level, used self-help material 
or incentives, and featured ‘choice architecture’ (CA). In general, 
interventions in this report served fewer functions, covered fewer BCT 
clusters and included fewer individual BCTs compared with Stage 1 
interventions. Based on the present analysis, there is no consistent and 
little association between the presence of an individual BCT or BCT cluster 
and an intervention being considered cost-effective. 
These findings need to be interpreted cautiously given 1) different search 
strategies for this and the Stage 1 report, 2) reliance on incomplete 
information in published papers, 3) heterogeneity in economic analyses, 4) 
lack of consensus for a definition of CA and 5) bias in reporting of study 
findings.  
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3. Background 
NICE has received a referral to update its guidance on behaviour change. The update will 
focus on evidence-based, individual-level behaviour-change techniques and interventions 
based on modifying the decision environment (or ‘choice architecture’) specifically in 
relation to smoking, alcohol, diet, physical activity and sexual health. It will include 
interventions for different population groups aged 16 years and older. There will be a 
particular emphasis on the techniques and skills practitioners require to help people sustain 
their new behaviour. 
NICE uses economic analyses to compare the costs and benefits of an intervention to 
determine whether it provides value for money. The overall aim is to maximise the benefits 
relative to the resources available. The main method used by NICE is cost utility analysis 
which considers the length of life someone will gain, adjusted for quality of life experienced, 
as a result of intervening in a particular way (i.e. the ‘quality-adjusted life year’; QALY). Other 
methods such as cost consequence analysis or cost benefit analysis may be used as 
appropriate. 
Three reviews have been commissioned to inform the development of an update of the 
guidance on behaviour change (undertaken by Bazian). It is anticipated that a number of the 
interventions and behaviour change techniques (BCTs) that are likely to be identified in these 
reviews will be covered by NICE’s existing economic analyses. However, it is also recognised 
that the three reviews might identify interventions and BCTs not already considered by NICE.  
For the updated guidance a four-step approach to the economic analysis is proposed which 
seeks to maximise the use of existing evidence whilst ensuring there are no significant gaps. 
Should any significant gaps be identified, it may be possible to use NICE’s existing models to 
fill those gaps. Should existing economic analyses and models be insufficient, a bespoke 
analysis will be commissioned to supplement existing analyses. 
Stage 1 
The first stage entails an analysis of interventions already assessed by NICE as cost effective 
with the aim of identifying and classifying the behaviour change techniques therein, 
including whether they are based on choice architecture. This analysis together with stage 2 
will be used to determine whether there are any significant gaps that need to be addressed 
with a commissioned piece of work. 
Stage 2 
In stage 2, which will run contemporaneously with stage 1, the searches developed by Bazian 
and the NICE team for the effectiveness reviews will be adapted and run by NICE information 
services in the economic databases ECONLIT, NHS EED and HEED. The aim of this stage is to 
determine whether there are any studies of cost effectiveness that address the areas 
covered by the effectiveness reviews for the guidance update. 
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Stage 3 
The outputs from stage 1 and 2 will be used to determine whether there are any significant 
gaps in the interventions and behaviour change techniques in NICE’s existing economic 
evidence base which need to be addressed to support the development of the guidance. If 
timelines allow, information from the effectiveness searches will also inform this stage.  
Stage 4 
The last stage will synthesize relevant existing NICE economic analyses and, if necessary, 
supplement these with a bespoke (commissioned) analysis to fill any significant gaps  
The current report presents findings that contribute to Stage 3 of this process. Specifically, 
this report aims to: 
1) Describe the content and classify BCTs of interventions identified in Stage 2, 
including whether interventions are based on choice architecture1 
2) Compare BCTs of interventions appraised as cost-effective and cost-ineffective 
according to NICE threshold2 
3) Compare BCTs of cost-effective interventions identified in Stage 1 with cost-
effective interventions identified in Stage 2 
  
                                                             
1 Please note that the search strategy in stage 2 was not designed to specifically identify choice architecture studies (but 
would not have explicitly excluded such studies as relevant if meeting other inclusion criteria detailed in Table 1). 
2 Interventions above £20.000-30.000 per quality adjusted life year (QALY) saved are usually considered cost-ineffective 
(cf. Footnote 5). Studies that did not provide information in £/QALY were included if they provided some other data on 
cost-effectiveness (see 4.1 Review of papers identified by Bazian search strategy for further information) 
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Obtained either as electronic copy online or directly 
from authors or as hard copy from library
Literature reviews 
Individual 
interventions
1.) Retrieval of source material(N=186)a
2.) Inclusion/exclusion determinedb
3.) Description of interventionsc and identification of BCTsd
Data extraction / 
Coding
4.) Analysis
Descriptive /inferential statistics of intervention 
characteristics ; comparison with Stage 1
6.) Final report Incorporation of feedback, data synthesis and 
interpretation
5.) Draft report Tabulation of results
4. Methodology 
The sequence of steps taken in the production of this report is provided in Figure 1. 
FIGURE 1: REPORT PROCEDURE 
aBased on Bazian search strategy of economic databases and Medline carried out by NICE information services; material 
that could not be obtained in the ways described was not included. 
bInclusion/exclusion criteria: see section 4.1 for details 
cInterventions were characterised according to the same categories as in Stage 1 [1] to maintain consistency across 
reports. Interventions reported in reviews were coded directly from reviews. 
dBCTs were classified according to latest BCT taxonomy [2]. In line with previous analyses, at least 25% of source material 
was double coded to establish good agreement. 
 
4.1 Review of papers identified by Bazian search strategy 
The scoping of this report produced several inclusion and exclusion criteria. The initial sift 
through of papers identified with the Bazian search strategy was carried out by NICE. Only 
papers that reported an economic analysis of interventions3 designed to change behaviour in 
                                                             
3 Econometric analyses generally compare the impact of two or more alternative courses of action with regards to their 
costs and outcomes. Depending on the outcome and techniques used, different terminology is applied [3]. Cost-benefit 
analysis (CBA) expresses all direct and indirect costs and benefits in a common unit, usually in monetary terms, and 
enables calculation of net benefit (unit difference of benefits minus costs). Thus the alternative with the greatest net 
benefit (which of course can be negative) would be chosen. A problem of CBA is the need to put monetary value on 
sometimes intangible outcomes and the assumption that benefits and costs are quantitatively but not qualitatively 
different. Cost-consequence analysis (CCA) is a special form of CBA which does not attempt to express all costs and 
benefits in the same unit of measurement and therefore to aggregate findings into single indicator. Thus different 
benefits and different costs may be measured using different units and a decision as to which alternative course of action 
to take is dependent on weights or importance placed on different benefits and costs. Cost-effectiveness analysis (CEA) 
differs from both CBA and CCA, expressing outcomes in natural units. It therefore does not take into account all possible 
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6 
one of the following six domains were included: Smoking, Diet, Physical Activity, Alcohol, 
Sexual Health and Multiple Health-related Behaviours. The exclusion criteria applied by NICE 
are provided in Table 1. Following the screening of papers, a total of 186 were included on a 
preliminary basis. All papers that could be retrieved were reviewed again on the basis of full-
texts and further papers excluded as outlined in Figure 2. 
TABLE 1: NICE EXCLUSION CRITERIA 
Reason for 
exclusion  
Explanation Additional comments 
Wrong 
question 
Study does not assess the cost 
effectiveness of a behaviour change 
intervention in the areas of diet, 
physical activity, smoking, alcohol, or 
sexual health 
 
Wrong study 
design 
Not a CUA, CCA, CBA or CEA
a
  
Wrong level of 
intervention 
Not an individual level behaviour 
change intervention 
This includes studies which are community 
or population level, including those that do 
not select participants based on their 
behaviour or health status  
Wrong type of 
intervention 
Not an intervention targeting a health 
behaviour/health behaviour change 
This includes studies not targeting health 
behaviour/health behaviour change, e.g. 
those targeting unrelated 
behaviours/outcomes  
Wrong 
population 
Not in adults aged 16 and over Do not tag non-individual level intervention 
studies with this tag, use WLI 
Wrong 
comparator 
Studies comparing two clearly non-
standard behaviour change 
interventions and no “No 
intervention/Waiting 
list/usual/standard care” or similar 
control 
(note: studies must compare the 
intervention with no intervention, or with 
usual practice, or compare two or more 
intervention types) 
Wrong 
outcome 
Studies not reporting a CUA, CBA, CCA 
or CEA on the behavioural outcome 
targeted by the intervention 
This includes: 
- studies which describe a behavioural 
outcome which is not the target of the 
intervention 
- studies reporting non-behavioural 
outcomes only 
- studies not reporting any outcomes (e.g. 
RCT rationale and methods descriptions 
only) 
aCBA: cost-benefit analysis; CCA: cost-consequence analysis; CEA: cost-effectiveness analysis; CUA: cost-utility analysis 
(see Footnote 3 for details). 
                                                                                                                                                                       
benefits (e.g. indirect ones), using a single unit of measure for benefits. Within the health care setting such cost-
effectiveness analysis usually focuses on the additional cost per additional unit of health gain (e.g. life saved, case 
averted) created by one compared with another intervention: the incremental cost-effectiveness ratio (ICER). Cost-utility 
analysis (CUA) is a special form of CEA which adjusts health benefits for quality of life (see Footnote 4). 
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Bazian
search
186
Wrong 
designa
29
Duplicateb
18
No EAc
17
Conference 
Abstractd
14
Not founde
4
Wrong 
targetf
2
Papers
69
Cost utility 
analysis
42
Other EAh
27
Reviews
33
Cost utility 
analysis
12
Insufficient 
infog
18
Other EAh
3
FIGURE 2: SELECTION TREE 
a Papers excluded if: 
• costs and effects of individual interventions are inseparable (cannot be linked to intervention components) 
• analysis not based on direct health behaviour-related outcome but on indirect consequences (e.g. on insurance 
claims) as confounding effects of other variables cannot be excluded 
• outcome of analysis is unclear, i.e. in the absence of standard criteria (see Footnote 5), authors do not provide 
judgement on cost-effectiveness of intervention 
• control condition to which intervention condition is compared to evaluate cost-effectiveness is not specified 
• analysis is purely hypothetical, i.e. no actual effectiveness data exist 
b Papers that were included in Stage 1 or which were duplicate in the Bazian search were excluded 
c No economic analysis (EA): papers reporting only intervention costs (but not its effectiveness) or papers that simply 
stated that an intervention is cost-effective without providing actual data were excluded 
d Conference abstracts were excluded due to insufficient details on intervention content 
e Papers that could not be obtained and thus only abstract was available were excluded due to insufficient details on 
intervention content 
f Papers that reported interventions aimed at changing provider behaviour rather than health-related behaviour of 
recipient 
g Reviews that provided insufficient information to code interventions included with any detail were excluded 
h This refers to economic analysis other than cost-utility analyses, reporting costs per unit change or on cost saving 
interventions etc. (e.g. CBA, CCA, CEA) 
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8 
The majority of papers after review of the abstract or full text were excluded because the 
design used did not fit with inclusion criteria (see Table 1), because papers had already been 
included in Stage 1 [1] or were duplicates in this search or because papers and reviews that 
were retrieved either provided no explicit information on cost-effectiveness or too little 
information for interventions to be coded. A total of 84 papers were included and 108 were 
excluded (for details see Appendix 9 and Appendix 10, respectively). Of 84 included papers, 
15 were reviews that covered 198 individual interventions. Of these, 78 interventions were 
not analysed, mostly because they did not include an economic analysis (N=36) or because 
the design was wrong (e.g. economic analysis was amalgamated and could not be linked to 
intervention components or control condition was unspecified, N=36). The remainder were 
excluded as they had the wrong target, or focused on participants below 16 years of age. In 
addition to the review papers, the 69 non-review papers covered 136 interventions of which 
five were excluded because they did not include an economic analysis, duplicated an 
intervention or because the intervention focused on children. Thus this report included 84 
papers covering 251 eligible interventions. Details of both are provided in Appendix 1. 
4.2 Review of economic analyses 
Papers in this report were identified with a search strategy developed by Bazian that focused 
on cost-effectiveness analyses. A total of 84 papers reporting some form of economic 
analysis were identified. Cost-effectiveness information was extracted where available, 
mostly in the form of incremental cost-effectiveness ratios (ICER, see Footnote 3), measured 
in cost per adjusted life years gained4. Data were derived directly from figures in reports 
(Appendix 1 reports original data), representing costs for the average intervention user and, 
where necessary, converted into GBP at time of original analysis or, when this information 
was not available, at the time of the paper publication. As some of the economic analyses 
carried out sensitivity analysis, varying cost-effectiveness estimates based on various factors 
such as user characteristics and time horizons, both lower (most optimistic) and upper (most 
pessimistic) limits of CEA estimates were recorded where available and cost-effectiveness 
determined according to NICE guidelines5. In cases where no such sensitivity analysis was 
carried out, the single CEA estimate was included as both the lower and upper limit.6  
                                                             
4 CEA/CUA uses either life-years (LY) or quality/disability adjusted life years (QALY/DALY) gained [4]. The former simply 
counts the additional years added to a person’s life due to an intervention while the latter weights these years according 
to the perceived life quality in terms of a number of factors such as pain/discomfort, mobility and mental well-being [5]. 
Each QALY/DALY is assigned a value between 1.0 (perfect health) and 0.0 (death). The fact that the worth of extended life 
in the future is considered to be less than if immediately realised due to the uncertainties we associate with future events 
is also considered in CEA/CUA [6]. Each LY or QALY/DALY is therefore discounted by a fixed amount per year, typically 
between 1.5%-3.5% [7]. 
5 NICE evaluates the effectiveness as well as cost-effectiveness of treatments so as to make recommendations about the 
implementation in the UK National Health Service [8]. NICE has adopted a cost-effectiveness threshold of £20,000-
£30,000 per QALY above which interventions are unlikely to be recommended. However, there is debate about the 
correct level of this threshold which is considered implicit rather than explicit [9] and varies enormously between 
countries [10]. In fact, in NHS settings the cost-effectiveness threshold for circulatory diseases and cancers is below 
£20,000 [11] whilst NICE recommendations in practice have a much higher threshold [12]. 
6 Where ICER are reported, interventions can be recorded as dominant (i.e. both less costly and more effective than the 
comparison condition) or dominated (i.e. both more costly and less effective than the comparison condition). For this 
reason, dominant interventions were recorded as £0 per QALY gained and CUA estimates for dominated interventions 
derived from comparison with other control condition, if provided, or no estimate was recorded. 
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However, not all papers reported information in the required form (i.e. conducted cost-
utility or cost-effectiveness analyses). Of all interventions included (N=251), 167 used CEA 
that expressed outcomes in (adjusted) life-years saved, with 60% gaving a single CEA 
estimate and 40% providing multiple estimates. Of these 167 interventions, 25 used life-
years saved, 40 used disability-adjusted life-years saved and the remainder (N=102) used 
cost-utility analysis (i.e. expressed outcomes in QALY). The rest of the 251 interventions 
(N=84) used some form of economic analysis (e.g. CCA/CBA) that yielded data not expressed 
in (adjusted) life-years saved. In all cases it was possible to establish whether an intervention 
was cost-effective or not, either based on CUA following NICE guidelines or, in the absence 
of CUA, based on authors’ conclusions resulting from the evaluation of some other economic 
analysis (CEA/CBA/CCC) presented in their paper. However, in order to meaningfully 
interpret data and maintain consistency with NICE guidelines, the 149 interventions7 where 
cost-effectiveness status was based on analyses not expressed in cost per QALY gained were 
not included in analyses relating to report aim 2), i.e. the comparison of BCTs of 
interventions appraised as cost-effective and cost-ineffective according to NICE threshold, 
and to report aim 3), i.e. the comparison of BCTs of cost-effective interventions identified in 
Stage 1 with cost-effective interventions identified in Stage 2. 
Based on descriptions in included papers, interventions were characterised in a number of 
broad categories derived by consensus among the authors of this report, outlined below: 
Intervention intensity (low; medium; high): Low: one face-to-face contact or other direct 
contact lasting up to 5 minutes or any non-specific (impersonal, e.g. through media) contact; 
Medium: one face-to-face contact or other direct contact lasting more than 5 minutes, or 
one face-to-face contact or other direct contact lasting up to 5 minutes on more than one 
occasion; High: any face-to-face contact or other direct contact lasting more than 5 minutes 
on more than one occasion. 
Setting (primary or secondary care; community, workplace or other): Interventions were 
classified according to the main location/physical environment in which interventions took 
place. 
Mode of delivery (physician; health professional; media; combination; other/not specified): 
The main route that was used to deliver the intervention was recorded. Note that health 
professionals included nurses, pharmacists, psychologists, dieticians and other qualified 
personnel. 
Target level (individual; group; population): Interventions were characterised according to 
the target recipient of delivery. 
Supporting material (none; self-help; electronic; mixture): The use of supporting material 
was recorded including written (self-help) or electronic (e.g. telephone, mobile phone, 
computer) material. 
Other categories: Interventions were also characterised according to whether they used 
pharmacological support, incentives or social marketing and whether they targeted the 
general population or vulnerable populations (e.g. pregnant women, individuals at risk of 
disease, those from low socio-economic groups). 
                                                             
7 This figure is derived by adding interventions presenting cost-effectiveness in LY or DALY saved (N=25+40=65) to 
interventions reporting other economic analyses, not expressed in (adjusted) life-years saved (N=84). 
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10 
Given the large number of individual interventions considered, the extracted information 
was used to group all interventions into six exhaustive categories determined by consensus: 
1) Medication 
2) Brief intervention 
3) Brief intervention and medication 
4) Comprehensive intervention 
5) Comprehensive intervention and medication 
6) Mass media intervention 
In addition to interventions, information on control conditions was also obtained and 
content categorised in relation to the active intervention condition as follows: 
1) Nothing/Usual Care (e.g. waitlist control, normal treatment) 
2) Lower impact control (either non-matched or placebo control condition) 
3) Matched control (control condition of comparable intensity) 
Finally, interventions as described in papers were characterised with regards to their main 
functions according to the behaviour change wheel (BCW) framework [13]. Interventions 
could have several of the functions shown in Table 2. 
TABLE 2: INTERVENTION FUNCTIONS 
Intervention 
type 
Definition Examples 
Education Increasing knowledge or understanding 
Providing information to promote 
healthy eating 
Persuasion 
Using communication to induce positive 
or negative feelings or stimulate action 
Using imagery to motivate increases in 
physical activity 
Incentivisation Creating expectation of reward 
Using prize draws to induce attempts to 
stop smoking 
Coercion 
Creating expectation of punishment or 
cost 
Raising the financial cost to reduce 
excessive alcohol consumption 
Training Imparting skills 
Advanced driver training to increase 
safe driving 
Restriction 
Using rules to reduce the opportunity to 
engage in the target behaviour (or to 
increase the target behaviour by reducing 
the opportunity to engage in competing 
behaviours) 
Prohibiting sales of solvents to people 
under 18 to reduce use for intoxication 
Environmental 
restructuring 
Changing the physical or social context 
Providing on-screen prompts for GPs to 
ask about smoking behaviour 
Modelling 
Providing an example for people to aspire 
to or imitate 
Using TV drama scenes involving safe-
sex practices to increase condom use 
Enablement 
Increasing means/reducing barriers to 
increase capability or opportunity
1
 
Behavioural support for smoking 
cessation, medication for cognitive 
deficits, surgery to reduce obesity, 
prostheses to promote physical activity 
Adapted from [13] 
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4.3 Retrieval of source material 
As detailed in 4.1, information from abstracts were used to determine inclusion or exclusion 
of papers. In cases where the abstract did not provide sufficient information, the full text 
was obtained to come to a decision. Information extracted about interventions content or 
characteristics could either be from publications reporting primary data pertaining to the 
interventions, or secondary summaries located in systematic reviews/meta-analyses. A total 
of 251 relevant interventions were identified (see Appendix 1). In cases where insufficient 
detail was provided on intervention content in systematic reviews/meta-analyses, such 
reviews were excluded as limited resources did not allow retrieval of all primary data and the 
limited information provided would have biased results. A list of included individual papers 
and reviews is provided in Appendix 9. 
Retrieval of source material followed a specific schedule. Material was primarily retrieved 
online. Where electronic versions of the articles of interest were unavailable, corresponding 
authors, co-authors and educational institutions within London were contacted and hard 
full-text copies obtained if possible. When hard copies were unavailable, it was decided not 
to code interventions based on limited information provided in online abstracts so as to 
avoid biasing results. A list of excluded papers and reviews is provided in Appendix 10. 
4.4 Identification of BCTs 
Interventions were coded using a taxonomy of 93 BCTs (BCT taxonomy v1) developed by 
Michie and colleagues [2], presented in Appendix 11. The taxonomy was developed through 
a process of consensus among a large expert panel of international academics and behaviour 
change practitioners, and aims to provide a comprehensive list of discrete generic 
techniques that may be used in behaviour change interventions. Techniques are included 
within the taxonomy if they (a) are used with the aim of changing behaviour, (b) are the 
proposed ‘active ingredient’ of an intervention, (c) are the smallest component compatible 
with retaining the proposed active ingredient, (d) can be used alone or in combination with 
other BCTs, (e) are observable and replicable, (f) can have a measurable effect on a specified 
behaviour, and (g) are the smallest unit that has the potential to bring about behaviour 
change [2]. 
The taxonomy remains under development, and an earlier 89-item BCT taxonomy (May 
2012)8 is being used by Bazian as part of the evidence reviews for the present NICE public 
health guidance update. Techniques within the taxonomy are organised hierarchically into 
16 theoretical clusters: 1) social support, 2) regulation, 3) feedback and monitoring, 4) 
associations, 5) repetition and substitution, 6) antecedents, 7) shaping knowledge, 8) self-
belief, 9) scheduled consequences, 10) reward and threat, 11) goals and planning; 12) 
                                                             
8 Specifically, BCT taxonomy v1 differs from the 89-item BCT taxonomy (May 2012) in that one item from the 89-item 
taxonomy (‘incentive’, defined as ‘inform that future rewards or removal of punishment will be contingent on 
performance of behaviour’) has been partitioned into five discrete BCTs in BCT taxonomy v1. These are: material incentive 
for behaviour (BCT60); material incentive for outcome (BCT61); social incentives (BCT62); non-specific incentives (BCT63); 
and self-incentives (BCT64; these are defined in Appendix 11). As Appendices 2-11 show, three of these BCTs (61, 62, 64) 
were not present in any of the coded papers. BCT60 was coded in 9 papers and BCT63 in 4 papers. Aside from adding 
specificity to our coding, the distinction between types of incentives thus had minimal impact on our findings. 
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12 
comparison of outcomes; 13) identity, 14) natural consequences, 15) comparison of 
behaviour and 16) covert learning. The taxonomy includes a standard definition of and 
detailed coding instructions for each BCT, including examples of instances in which each BCT 
should or should not be coded.  
Coding followed standard guidelines [14]: BCTs were coded only where coders believed that 
there was unequivocal evidence for their inclusion in a given intervention. In total 96 papers 
were coded detailing 329 separate interventions for six types of health-related behaviours 
(smoking, diet, exercise, alcohol use, sexual health, and multiple behaviours). A subset of 28 
papers (29.2%) was coded in batches by a second coder with disagreements resolved 
through discussion after each batch. Agreement was 99.2%, with a mean Cohen’s Kappa of 
0.89, indicating good inter-rater reliability. Details of BCTs identified in each intervention 
according to the health-related behaviour targeted are provided in Appendix 2 - Appendix 7. 
4.5 Identification of ‘choice architecture’ 
The term ‘choice architecture’ as described in the popular text Nudge [15] has no precise, 
operational definition, but is generally used to refer to elements of a decisional context, 
and/or the configuration of those elements, that influence the behavioural decisions taken 
by an individual, and the modification of these which may thereby have the potential to 
change people’s behaviours [16]. It may be defined as a collection of environmental tools 
that “alters people’s behaviour in a predictable way without forbidding any options or 
significantly changing their economic incentives” [15]. This involves several principles 
including defaults, expecting error, understanding mapping, structuring complex choices and 
creating incentives through which decisions are influenced based on how choices are 
presented. 
As the Bazian search did not explicitly seek out to identify interventions using ‘choice 
architecture’, interventions considered in this report did not generally make explicit 
references to ‘choice architecture’. The current report therefore operationalized this 
construct on the basis of particular BCTs that were identified by consensus among the 
authors of the Stage 1 report [1] so as to maintain consistency. In particular, evidence of 
‘choice architecture’ is provided if interventions included any of the BCTs presented in Table 
3. 
TABLE 3: OPERATIONALISATION OF CHOICE ARCHITECTURE ACCORDING TO BCTS 
BCT 
Number 
Description Definition Examples 
15 Prompts/Cues 
Introduce or define environmental or 
social stimulus with the purpose of 
prompting or cueing the behaviour. 
The prompt or cue would normally 
occur at the time or place of 
performance 
Put a sticker on the bathroom 
mirror to remind people to 
brush their teeth  
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BCT 
Number 
Description Definition Examples 
16 
Reduce 
prompts/cues 
Withdraw gradually prompts to 
perform the behaviour (includes 
‘Fading’)  
Reduce gradually the number 
of reminders used to take 
medication  
30 
Restructuring 
the physical 
environment 
Change, or advise to change the 
environment in order to facilitate 
performance of the wanted behaviour 
or create barriers to the unwanted 
behaviour (other than prompts/cues, 
rewards and punishments) 
Advise to keep biscuits and 
snacks in a cupboard that is 
inconvenient to get to  
Arrange to move vending 
machine out of the school  
31 
Restructuring 
the social 
environment
9
 
Change, or advise to change the social 
environment in order to facilitate 
performance of the wanted behaviour 
or create barriers to the unwanted 
behaviour (other than prompts/cues, 
rewards and punishments) 
Advise to minimise time spent 
with friends who drink heavily 
to reduce alcohol 
consumption  
32 
Avoidance/ 
reducing 
exposure to 
cues for the 
behaviour 
Advise on how to avoid exposure to 
specific social and contextual/physical 
cues for the behaviour, including 
changing daily or weekly routines  
Suggest to a person who 
wants to quit smoking that 
their social life focus on 
activities other than pubs and 
bars which have been 
associated with smoking  
34 
Adding objects 
to the 
environment  
Add objects to the environment in 
order to facilitate performance of the 
behaviour  
Provide free condoms to 
facilitate safe sex  
Provide attractive toothbrush 
to improve tooth brushing 
technique  
79 
Framing/ 
reframing  
Suggest the deliberate adoption of a 
perspective or new perspective on 
behaviour (e.g. its purpose) in order to 
change cognitions or emotions about 
performing the behaviour (includes 
‘Cognitive restructuring’)  
Suggest that the person might 
think of the tasks as reducing 
sedentary behaviour (rather 
than increasing activity)  
Adapted from [2] 
As an example, the ‘nudging’ commonly seen in commercial contexts such as placing sweets 
at the end of checkouts in supermarkets in the line of sight of children would involve 
‘prompts/cues’ (BCT 15), in that the sweets act as a prompt to ask parents to buy them. It 
would also involve ‘restructuring the physical environment’ (BCT 30), in so far as the sweets 
are placed within easy reach of children, as well ‘adding objects to the environment’ (BCT 
34). Similarly, the lack of mirrors in casinos to maintain the illusion of a glamorous lifestyle 
[17] may be seen as an example of reducing prompts and cues (BCT 15) or 
avoidance/reducing exposure to cues (BCT 32) to nudge people into a behaviour (i.e. 
continuing to gamble). Likewise, increasing the visual (if not actual) presence of police 
                                                             
9 Note that ‘restructuring the social environment’ (BCT 31) does not include provision of normative information to change 
behaviour as this is captured by ‘social comparison’ (BCT 89) and/or ‘information about others’ approval (BCT 90) which 
was judged not to form part of choice architecture (but see [16] regarding the inherent problem arising from the vague 
definition of a ‘nudge’). 
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14 
officers to reduce criminal behaviour provides an example of restructuring the social 
environment (BCT 31). Lastly, putting the emphasis on the percentage of fat-free (as 
opposed to fat-containing) content in various foods to persuade people to purchase items 
would be an example of framing/re-framing (BCT 79; see Table 3 for further examples). 
However, given the lack of a clear definition of ‘choice architecture’ and nudging, in 
sensitivity analysis ‘choice architecture’ was restricted to those BCTs in Table 3 that were 
significantly correlated across all interventions, suggesting that they relate to the same 
underlying construct, in agreement with procedures from the Stage 1 report. 
4.6 Analysis of findings 
Data from economic reports were recorded in a MS Word file and individual papers were 
analysed and BCT recorded in a standardised coding form before being transferred into a MS 
Word file. All data were then entered into IBM SPSS v.20. Descriptive statistics were used to 
describe interventions and associated BCTs. Where appropriate, differences according to 
intervention characteristics were analysed using t-tests or one-way ANOVAs and χ2- or Fisher 
Exact tests for continuous and categorical variables, respectively. Given that univariate 
associations may overestimate the importance of individual variables, multivariate logistic 
and multiple linear regression analyses were carried out to evaluate the independent 
association of intervention characteristics and the presence of BCTs with cost-effectiveness 
estimates and to compare cost-effective interventions identified in this with the Stage 1 
report. The Bonferroni correction was applied in post hoc analyses. 
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5. Results 
5.1 Descriptive analysis of BCTs included in interventions 
5.1.1 General characteristics of interventions 
Overall, 251 interventions were identified from 84 papers and reviews. Over a third of these 
(92), reported in 27 papers (including five reviews)10 were smoking cessation interventions. 
This was followed by interventions with multiple health-related behaviour targets (48 
interventions from 26 papers, including four reviews), interventions to improve sexual health 
(44 interventions from 11 papers, including four reviews) or for diet (39 interventions from 
11 papers, including three reviews), interventions for physical activity (28 interventions from 
eight papers, including one review) and, lastly, alcohol interventions (eight interventions 
from six papers, no reviews). Table 4 provides broad characteristics of these interventions 
(see Appendix 1 for further details of individual interventions). There was a fairly equal split 
between different intervention categories with the exception of mass media interventions 
which featured only five times and which may be a by-product of the search strategy. 
Control conditions mostly consisted of nothing or usual care11 and less than one in ten 
intervention studies used a matched control condition. Over a third of interventions were 
classified as being of low intensity (i.e. mostly brief or pharmacological interventions), mainly 
set in primary care and delivered by health professionals. Interventions mostly targeted 
individuals from both general and vulnerable populations. 
TABLE 4: INTERVENTION CHARACTERISTICS BY HEALTH-RELATED BEHAVIOUR 
 
All 
(N=251) 
Smoking 
(N=92) 
Diet 
(N=39) 
Physical 
Activity 
(N=20) 
Alcohol 
(N=8) 
Sexual 
Health 
(N=44) 
Multiple 
targets 
(N=48) 
P* 
 % (N) 
Category 
 Med 
 BI 
 Med+BI 
 Comp 
 Med+Comp 
 Mass Media 
 
14.7 (37) 
22.3 (56) 
13.9 (35) 
34.7 (87) 
12.4 (31) 
2.0  (5) 
a
 
29.3 (27) 
13.0 (12) 
26.1 (24) 
10.9 (10) 
20.7 (19) 
0.0 (0) 
b
 
20.5 (8) 
30.8 (12) 
2.6 (1) 
38.5 (15) 
2.6 (1) 
5.1 (2) 
b,c
 
0.0 (0) 
55.0 (10) 
0.0 (0) 
45.0 (9) 
0.0 (0) 
5.0 (1) 
b,c
 
0.0 (0) 
75.0 (6) 
0.0 (0) 
25.0 (2) 
0.0 (0) 
0.0 (0) 
c
 
2.3 (1) 
15.9 (7) 
18.2 (8) 
43.2 (19) 
15.9 (7) 
4.5 (2) 
b,c
 
2.1 (1) 
18.8 (9) 
4.2 (2) 
66.7 (32) 
8.3 (4) 
0.0 (0) 
<0.001 
Control condition 
 Nothing/UC 
 Lower Impact 
 Matched Impact 
 
66.9 (168) 
25.1 (63) 
8.0 (20) 
a
 
55.4 (51) 
34.8 (32) 
9.8 (9) 
a,b
 
61.5 (24) 
33.3 (13) 
5.1 (2) 
a,b 
75.0 (15) 
20.0 (4) 
5.0 (1) 
a,b
 
50.0 (4) 
37.5 (3) 
12.5 (1) 
b
 
88.6 (39) 
6.8 (3) 
4.5 (2) 
a,b 
72.9 (35) 
16.7 (8) 
10.4 (5) 
<0.001 
                                                             
10 Please note some reviews reported on several health-related behaviours 
11 Usual care is likely to vary considerably, depending on the country/region in which interventions were delivered and for 
this reason, where information was available, a more detailed description of control conditions was extracted (see 
Appendix 1). 
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All 
(N=251) 
Smoking 
(N=92) 
Diet 
(N=39) 
Physical 
Activity 
(N=20) 
Alcohol 
(N=8) 
Sexual 
Health 
(N=44) 
Multiple 
targets 
(N=48) 
P* 
Intervention 
Intensity 
 Unclear 
 Low 
 Medium 
 High 
 
 
4.8 (12) 
38.2 (96) 
24.3 (61) 
32.7 (82) 
 
a
 
0.0 (0) 
57.6 (53) 
20.7 (19) 
21.7 (20) 
 
b
 
12.8 (5) 
43.6 (17) 
10.3 (4) 
33.3 (13) 
 
a,b 
5.0 (1) 
40.0 (8) 
30.0 (6) 
25.0 (5) 
 
a,b,c
 
0.0 (0) 
25.0 (2) 
25.0 (2) 
50.0 (4) 
 
a
 
2.3 (1) 
29.5 (13) 
40.9 (18) 
27.3 (12) 
 
c 
10.4 (5) 
6.2 (3) 
25.0 (12) 
58.3 (28) 
<0.001 
Setting 
 Primary Care 
 Secondary Care 
 Community 
 Workplace 
 Unclear/other
≠
 
 
65.3 (164) 
6.4 (16) 
17.1 (43) 
1.6 (4) 
9.6 (24) 
a 
85.9 (79) 
2.2 (2) 
7.6 (7) 
3.3 (3) 
1.1 (1) 
b,c
 
53.8 (21) 
15.4 (6) 
15.4 (6) 
2.6 (1) 
12.8 (5) 
c
 
40.0 (8) 
0.0 (0) 
35.0 (7) 
0.0 (0) 
25.0 (5) 
a,b
 
75.0 (6) 
25.0(2) 
0.0 (0) 
0.0 (0) 
0.0 (0) 
b,c
 
65.9 (29) 
0.0 (0) 
20.5 (9) 
0.0 (0) 
13.6 (6) 
b,c
 
43.1 (21) 
12.5 (6) 
29.2 (14) 
0.0 (0) 
14.6 (7) 
<0.001 
Delivery Mode 
 Physician 
 HP 
 Media 
 Mix 
 Unclear/other
±
 
 
9.2 (23) 
66.4 (166) 
4.0 (10) 
4.4 (11) 
16.0 (40) 
a 
15.4 (14) 
65.9 (60) 
0.0 (0) 
4.4 (4) 
14.3 (13) 
a,b 
17.9 (7) 
43.6 (17) 
7.7 (3) 
7.7 (3) 
23.1 (9) 
b 
0.0 (0) 
65.0 (13) 
15.0 (3) 
5.0 (1) 
15.0 (3) 
a,b 
0.0 (0) 
100.0 (15) 
0.0 (0) 
0.0 (0) 
0.0 (0) 
a,b 
2.3 (1) 
77.3 (34) 
4.5 (2) 
2.3 (1) 
13.6 (6) 
a,b 
2.1 (1) 
70.8 (34) 
4.2 (2) 
4.2 (2) 
18.8 (9) 
0.015 
Target Level 
 Individual 
 Groups 
 Population 
 Mix 
 
84.1 (211) 
8.4 (21) 
2.4 (6) 
5.2 (13) 
 
94.6 (87) 
3.3 (3) 
0.0 (0) 
2.2 (2) 
 
74.4 (29) 
10.3 (4) 
5.1 (2) 
10.3 (4) 
 
85.0 (17) 
10.0 (2) 
5.0 (1) 
0.0 (0) 
 
62.5 (5) 
37.5 (3) 
0.0 (0) 
0.0 (0) 
 
79.5 (35) 
6.8 (3) 
4.5 (2) 
9.1 (4) 
 
79.2 (38) 
12.5 (6) 
2.1 (1) 
6.2 (3) 
0.037 
Population 
 General 
 Vulnerable 
 
49.0 (123) 
51.0 (128) 
a 
14.1 (13) 
85.9 (79) 
b,c 
64.1 (25 
35.9 (14) 
b,c 
55.0 (11) 
45.0 (9) 
b,c 
87.5 (7) 
12.5 (1) 
b 
56.8 (25) 
43.2 (19) 
c 
87.5 (42) 
12.5 (6) 
<0.001 
Supporting 
Material 
 None 
 Self-help 
 Electronic 
 Mix 
 
 
70.5 (177) 
9.2 (23) 
10.4 (26) 
10.0 (25) 
 
 
69.6 (64) 
14.1 (13) 
8.7 (8) 
7.6 (7) 
 
 
76.9 (30) 
7.7 (3) 
5.1 (2) 
10.3 (4) 
 
 
55.0 (11) 
15.0 (3) 
15.0 (3) 
15.0 (3) 
 
 
87.5 (7) 
12.5 (1) 
0.0 (0) 
0.0 (0) 
 
 
79.5 (35) 
2.3 (1) 
9.1 (4) 
9.1 (4) 
 
 
62.5 (30) 
4.2 (2) 
18.8 (9) 
14.6 (7) 
0.178 
Pharmacological 
support 
43.8 (110) 78.3 (72)
a
 33.3 (13)
b
 0 (0)
c
 0.0 (0)
b,c
 36.4 (16)
b
 18.8(9)
b,c
 <0.001 
Social marketing 4.0 (10) 0 (0) 5.1 (2) 15.0 (3) 0 (0) 6.8 (3) 4.2 (2) 0.025 
Incentives 4.4 (11) 4.3 (4) 2.6 (1) 20.0 (4) 0 (0) 2.3 (1) 2.1 (1) 0.116 
Cost-effective^ 87.6 (220) 93.5 (86)
a
 84.6 (35)
a,b
 95.0 (21)
a,b
 100.0 (8)
a,b
 88.6 (44)
a,b
 72.9 (36)
b
 0.012 
*Significant overall differences are in italics; ≠Refers to state/policy level interventions (e.g. changes in legislation/physical infrastructure) 
or interventions in non-specific settings (e.g. online/phone interventions), ±This refers to delivery by peers, teachers, researchers or the 
state; ^ Based on CUA (N=102) and non-CUA (N=149) cost-effectiveness studies; a,b,cComparison of interventions targeting different 
health-related behaviours, different letters indicate significant difference at p<0.05 (Bonferroni-corrected); BI – Brief intervention; Med – 
Medication; Comp – Comprehensive; UC – Usual care; HP – Health professional (nurse, pharmacist, psychologist etc.). 
Nearly half of all interventions included involved testing of some medication or included 
pharmacological support but generally most interventions used little supporting material, 
incentives or social marketing strategies. Based on conclusions based on a variety of 
economic analyses, including CCA, CBA and CUA, over four fifths of interventions were 
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considered cost-effective. More detailed analysis of cost-effectiveness based on cost-utility 
analyses according to NICE criteria is presented in Section 5.2 Factors associated with cost-
effectiveness. 
There were some differences between health-related behaviour interventions. Compared 
with all others, smoking cessation interventions had the largest proportion categorised as 
involving medication (i.e. medication alone and/or in conjunction with brief or 
comprehensive interventions) and interventions with multiple health-related behavioural 
targets were most likely to be comprehensive. In terms of control conditions, smoking 
cessation and alcohol interventions were tested most rigorously with almost half being 
tested against fully or partially matched control treatment, whilst sexual health interventions 
were nearly exclusively compared with usual care or no control intervention (Table 4). 
Perhaps unsurprisingly, half of interventions targeting multiple behaviours were classified as 
high in intensity compared with around a quarter of smoking cessation, diet or sexual health 
interventions. The majority of smoking cessation and alcohol interventions but less than half 
of physical activity interventions were set in primary care and the rest more equally spread 
across other settings. Consequently, the former was significantly more likely to be delivered 
by a physician than the latter. 
There were no individual disparities between health-related behaviour interventions as a 
function of the target level, use of supporting material, social marketing (despite overall 
differences) or incentives (Table 4). However, smoking cessation interventions were more 
likely than any other type of intervention to involve pharmacological support. While the 
majority of smoking cessation and sexual health intervention was aimed at vulnerable 
populations (possibly reflecting particularly strong socio-economic gradients in these 
behavioural outcomes), other heath behaviour interventions  tended to target the general 
population, in particular those aimed at changing multiple behaviours. These interventions 
were also judged to be less cost-effective than smoking cessation interventions (see Table 4). 
5.1.2 Main functions of interventions 
Overall, the most common functions, identified in three quarters of interventions, were to 
increase knowledge and/or understanding as well as the imparting of skills through training 
(Table 5). Nearly half of interventions aimed to increase capability and/or opportunity and a 
quarter of interventions used communication persuasively to stimulate action. Restructuring 
the environment by changing physical or social contexts or using incentives to create an 
expectation of reward was relatively uncommon, and the use of restriction and modelling 
virtually, and coercion completely, non-existent. 
Intervention functions differed significantly according to the health-related behaviour 
targeted. The use of training was significantly more prevalent in diet interventions and 
interventions aimed at changing multiple behaviours than in physical activity and sexual 
health interventions with smoking cessation interventions falling in between these two 
groups. The use of education was lowest in smoking cessation interventions – significantly so 
compared with multiple behaviour interventions as shown in post-hoc analysis. 
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TABLE 5: INTERVENTION FUNCTIONS BY HEALTH-RELATED BEHAVIOUR 
 All (N=251) 
Smoking 
(N=92) 
Diet 
(N=39) 
Physical 
Activity 
(N=20) 
Alcohol 
(N=8) 
Sexual 
Health 
(N=44) 
Multiple 
targets 
(N=48) 
P* 
 % (N) 
Training 74.9 (188) 78.2 (72)
a,c
 92.3 (36)
c
 35.0 (7)
b
 50.0 (4)
a,b,c
 56.8 (25)
a,b
 91.7 (42)
c
 <0.001 
Education 72.1 (181) 62.0 (57)
a
 66.7 (26)
a,b
 65.0 (13)
a,b
 100.0 (8)
a,b
 77.3 (34)
a,b
 89.6 (43)
b
 0.001 
Enablement 45.8 (115) 72.8 (67)
a
 30.8 (12)
b
 10.0 (2)
b
 0 (0)
b
 36.4 (16)
b
 37.5 (18)
b
 <0.001 
Persuasion 24.7 (62) 33.7 (31)
a,c
 2.6 (1)
b
 35.0 (7)
a,c
 62.5 (5)
a
 27.3 (12)
a,c
 12.5 (6)
b,c
 <0.001 
Environmental 
restructuring 
5.2 (13) 6.5 (6) 7.7 (3) 15.0 (3) 0 (0) 0 (0) 2.1 (1) 0.071 
Incentivisation 4.0 (10) 4.3 (4) 2.6 (1) 10.0 (2) 0 (0) 2.3 (1) 4.2 (2) 0.730 
Restriction 2.8 (7) 0 (0)
a
 15.4 (6)
b
 0 (0)
a,b
 0 (0)
a,b
 0 (0)
a,b
 2.1 (1)
a,b
 0.001 
Modelling 1.2 (3) 0 (0) 0 (0) 0 (0) 0 (0) 2.3 (1) 4.2 (2) 0.273 
Coercion 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) NC 
*Significant overall differences are in italics; a,b,c, Comparison of interventions targeting different health-related behaviours, different 
letters indicate significant difference at p<0.05 (Bonferroni-corrected); NC – cannot be computed 
By contrast, smoking cessation interventions were much more likely than interventions 
aimed at changing any other health-related behaviour to employ enablement techniques 
(Table 5). Alcohol and smoking cessation interventions were also more likely than 
interventions targeting multiple health-related behaviours or diet interventions whereas 
restriction was more common in the latter than in smoking cessation interventions. No other 
differences were apparent as a function of the health-related behaviour targeted (see Table 
5). 
5.1.3 BCT clusters in interventions 
BCTs were clustered into superordinate categories as shown in Table 6. Out of a total of 16 
BCT clusters, four (shaping knowledge, antecedents, regulation and social support) were 
particularly prevalent, coded for in about half of the interventions considered. A further five 
BCT clusters (comparison of outcomes, feedback and monitoring, goals and planning, natural 
consequences and self-beliefs) were commonly identified, coded for in between a fifth to a 
third of interventions. The remainder was coded in less than ten percent of interventions 
and the use of BCTs pertaining to identity, scheduled consequences and covert learning was 
particularly sparse or non-existent. On average, BCTs included in interventions came from 
four clusters with a maximum of nine out of 16 possible BCT clusters present in a given 
intervention (Table 6). 
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TABLE 6: BCT CLUSTERS AND TOTAL NUMBER OF BCTS BY HEALTH-RELATED 
BEHAVIOUR 
 All (N=251) 
Smoking 
(N=92) 
Diet 
(N=39) 
Physical 
Activity 
(N=20) 
Alcohol 
(N=8) 
Sexual 
Health 
(N=44) 
Multiple 
targets 
(N=48) 
P* 
 % (N) 
Shaping knowledge 
(BCT36-39) 
86.5 (217) 92.4 (85)
a,c
 89.7 (35)a,b,c 55.0 (11)
b
 50.0 (4)
a,b
 95.5 (42)
c
 83.3 (40)a,b,c <0.001 
Antecedents (BCT30-
35) 
53.0 (133) 76.1 (70)
a
 56.4 (22)
a,b
 35.0 (7)
b,c
 0 (0)
c
 43.2 (19)
b,c
 31.2 (15)
b,c
 <0.001 
Regulation (BCT4-7) 47.7 (119) 78.3 (72)
a
 35.9 (14)
b,d
 0 (0)
c
 0 (0)
b,c
 52.3 (23)
b
 20.8 (10)
c,d
 <0.001 
Social support 
(BCT1-3) 
44.6 (112) 43.5 (40) 33.3 (13) 50.0 (10) 87.5 (7) 38.6 (17) 52.1 (25) 0.062 
Comparison of 
outcomes (BCT74-
BCT76) 
37.1 (93) 44.6 (41)
a,b
 20.5 (8)
a
 25.0 (5)
a,b
 25.0 (2)
a,b
 22.7 (10)
a
 56.3 (27)
b
 0.001 
Feedback and 
monitoring (BCT8-14) 
27.1 (68) 9.8 (9)
a
 38.5 (15)
b
 20.0 (4)
a,b
 75.0 (6)
b
 25.0 (11)
a,b
 47.9 (23)
b
 <0.001 
Goals and planning 
(BCT65-73) 
26.7 (67) 16.3 (15)
a
 20.5 (8)
a
 30.0 (6)
a,b
 50.0 (4)
a,b
 20.5 (9)
a
 52.1 (25)
b
 <0.001 
Natural 
consequences 
(BCT82-87) 
22.7 (57) 8.7 (8)
a
 23.1  (9)
a,b
 15.0 (3)
a,b
 12.5 (1)
a,b
 45.5 (20)
b
 33.3 (16)
b
 <0.001 
Self-beliefs (BCT40-
43) 
22.3 (56) 28.3 (26)
a
 2.6 (1)
b
 40.0 (8)
a
 37.5 (3)
a,b
 27.3 (12)
a
 12.5 (6)
a,b
 <0.001 
Repetition and 
substitution (BCT23-
29) 
10.0 (25) 0 (0)
a
 7.7 (3)
a
 10.0 (2)
a,b
 0 (0)
a,b
 4.5 (2)
a
 37.5 (18)
b
 <0.001 
Comparison of 
behaviour (BCT88-
90) 
9.6 (24) 1.1 (1)
a
 7.7 (3)
a,b
 0 (0)
a,b
 0 (0)
a,b
 13.6 (6)
a,b
 29.2 (14)
b
 <0.001 
Associations (BCT15-
22) 
9.2 (23) 8.7 (8) 7.7 (3)  15.0 (3) 0 (0) 9.1 (4) 10.4 (5) 0.783 
Reward and threat 
(BCT54-64) 
6.8 (17) 6.5 (6) 2.6 (1) 20.0 (4) 0 (0) 2.3 (1) 10.4 (5) 0.107 
Identity 
(BCT77-81) 
0.8(2) 1.1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 2.1 (1) 0.768 
Scheduled 
consequences 
(BCT44-53) 
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) NC 
Covert learning 
(BCT91-93) 
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) NC 
 Mean (Range) 
Number of BCT 
clusters 
4.0 (1-9) 4.2 (1-8)
a,b
 3.5 (1-6)
a
 3.2 (1-7)
a
 3.4 (2-4)
a,b
 4.0 (2-7)
a,b
 4.8 (1-9)
b
 <0.001 
*Significant overall differences are in italics; a,b,c,dComparison of interventions targeting different health-related behaviours, different letters 
indicate significant difference at p<0.05 (Bonferroni-corrected); NC – cannot be computed 
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The prevalence of BCT clusters differed between interventions. Shaping knowledge was most 
common in smoking, diet and sexual health interventions as was the use of antecedents 
(Table 6). Regulatory BCTs were particularly common in smoking cessation interventions but 
not at all present in physical activity or alcohol interventions, possibly reflecting the big 
differential in the use of pharmacological support in these interventions (see Table 4). 
Interventions with multiple behavioural targets often focused on comparison of outcomes 
and goals and planning, the former being less prevalent in diet and sexual health 
interventions and the latter in smoking cessation, diet and sexual health interventions. The 
use of feedback and monitoring was commonest in interventions for diet, alcohol and 
multiple health-related behaviour targets but relatively rare in smoking cessation 
interventions. BCTs concerning self-beliefs were particularly uncommon in diet 
interventions. BCTs that highlighted natural consequences were present in nearly half of 
sexual health interventions and a third of interventions with multiple behavioural targets but 
relatively uncommon in other interventions, particularly smoking cessation interventions. 
Smoking cessation interventions also barely ever included BCTs that involved repetition and 
substitution or which instigated comparison of behaviour, particularly when compared with 
multiple health-related behaviour interventions (see Table 6). The only common cluster 
which was equally present across all health-related behavioural interventions was social 
support. 
Overall, there was a significant difference in the number of BCT clusters used by 
interventions targeting different health-related behaviours (F(5,245)=4.77, p<0.001). In 
agreement with differences in the level of intensity of interventions by health-related 
behaviour target (see Table 4), interventions to change multiple behavioural targets included 
the largest number of BCT clusters, significantly more than diet or physical activity 
interventions (for both p=0.003). 
5.1.4 Prevalence of individual BCTs across all interventions 
Out of the total of 93 possible BCTs, the average intervention contained just over five BCTs. 
There was a wide range across individual interventions with some containing only one 
behaviour change interventions and others evidencing 16 different BCTs. As can be seen in 
Figure 3, multiple behaviour change interventions included the largest number of BCTs on 
average (mean=7.1, median=6.5, mode=4) as would be expected from findings presented in 
Table 6, followed by interventions to improve sexual health (mean=5.9, median=5, mode=3), 
alcohol interventions (mean=5.8, median=6, mode=7), smoking cessation interventions 
(mean=4.9, median=4, mode=4) and diet interventions (mean=4.7, median=4, mode=3), 
while physical activity interventions included the smallest number of BCTs (mean=4.6, 
median=4, mode=4). There was an overall difference as a function of the health-related 
behaviour targeted (F(5, 245)=4.29, p=0.001) and post-hoc comparison revealed that 
interventions with multiple behaviour targets included significantly more BCTs than smoking 
cessation (p=0.001), diet (p=0.005) and physical activity (p=0.042) interventions. 
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FIGURE 3: NUMBER OF RECORDED BCTS BY HEALTH-RELATED BEHAVIOUR 
Dotted line indicates average across all interventions (N=251); Bars are standard error of the mean; Line indicates 
comparator groups (*p<0.05, **p<0.01 in Bonferroni-corrected post-hoc comparison) 
A total of 35 BCTs were coded for in at least one percent (N=3) of all included 251 
interventions (presented in Figure 4). An additional 16 BCTs were coded in at least one 
intervention targeting one of the health-related behaviours: eight BCTs [9, 11, 29, 30, 38, 54, 
55, 61] were mentioned in two interventions and eight BCTs [6, 25, 58, 59, 62, 80, 81, 86] in 
only one intervention. This means that 42 BCTs were not coded for at all: BCTs [7, 16-22, 26, 
27, 31-33, 37, 39, 41-53, 56, 63, 64, 70, 72, 73, 76-79, 87, 91-93]. 
Instructions on how to perform a behaviour (BCT 36) was by far the most prevalent of BCTs, 
being included in nearly nine out of ten interventions. Body changes (BCT 35), 
pharmacological support (BCT 4) and unspecified social support (BCT 3) were also common 
and present in nearly half of all interventions analysed (Figure 4). A third of interventions 
made use of a persuasive source (BCT 74) and a quarter included practical (BCT 1) or 
emotional (BCT 2) social support or used verbal persuasion to increase capability (BCT 40). 
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FIGURE 4: PREVALENCE OF INDIVIDUAL BCTS ACROSS ALL INTERVENTIONS# 
#Only BCTs (N=35) described in at least one percent (N=3) of interventions are shown; *See Appendix 11 for details of 
BCTs 
Around one in five interventions, provided information about health consequences (BCT 82), 
involved setting goals for behaviour change (BCT 66) and offered information about 
emotional (BCT 83) or social and environmental consequences (BCT 84, see Figure 4). In 
around ten percent of interventions, goals for positive outcomes of behaviour change were 
set (BCT 67), feedback on behaviour was provided (BCT 8) in addition to using biomarker 
feedback (BCT 14), problem solving techniques (BCT 65), prompts and cues (BCT 15), and 
action planning (BCT 68). The remaining BCTs were used much more infrequently. 
5.1.5 Prevalence of individual BCTs in smoking cessation interventions 
A total of 30 distinct BCTs, listed in Figure 5, were coded at least once in 92 smoking 
cessation interventions (for further details see Appendix 2). The most prevalent BCT 
(recorded in over 90% of smoking cessation interventions) was the inclusion of instructions 
on how to perform a behaviour (BCT 36). Three quarters of smoking cessation interventions 
also discussed body changes (BCT 35) and provided pharmacological support (BCT 4). Just 
under half of interventions involved the inclusion of a persuasive source (BCT 74) and also 
provided non-specific social support (BCT 3). Related to this, nearly a third of interventions 
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used verbal persuasion about a person’s capability to strengthen their self-beliefs (BCT 40). 
Lastly, in at least ten percent of interventions, practical (BCT 1) or emotional (BCT 2) social 
support was provided, negative emotions reduced (BCT 5), and goal setting for desired 
behaviour encouraged (BCT 66) applied (Figure 5). 
FIGURE 5: OCCURRENCE OF INDIVIDUAL BCTS IN SMOKING CESSATION INTERVENTIONS# 
 
#BCTs (N=30) described in at least one smoking cessation intervention are shown; *See Appendix 11 for details of BCTs  
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5.1.6 Prevalence of individual BCTs in diet interventions 
Altogether 29 BCTs were detailed in 39 diet interventions as shown in Figure 6 (for further 
details see Appendix 3). As for smoking cessation interventions, the most prevalent BCTs 
were instructions on how to perform a behaviour (BCT 36), being present in 90% of 
interventions, and the discussion of body changes (BCT 35) included in over half (N=22) of 
interventions. A third of interventions provided unspecified social support (BCT 3) and 
pharmacological support (BCT 4) and a quarter included practical (BCT 1) and emotional (BCT 
2) social support. Around one in five diet interventions used a persuasive source (BCT 74), 
provided information about health consequences (BCT 82), gave feedback on behaviour (BCT 
8), set behavioural goals (BCT 66), offered information on emotional (BCT 83) and social and 
environmental consequences (BCT 84; Figure 6). 
FIGURE 6: OCCURRENCE OF INDIVIDUAL BCTS IN DIET INTERVENTIONS# 
#BCTs (N=29) described in at least one diet intervention are shown; *See Appendix 11 for details of BCTs 
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5.1.7 Prevalence of individual BCTs in physical activity interventions 
Physical activity interventions included a total of 27 BCTs (Figure 7), comparable to 
interventions targeted other health-related behaviours (for further details see Appendix 4). 
However, whilst instructions on how to perform a behaviour (BCT 36) was again the most 
prevalent BCT, mentioned in nearly six out of ten physical activity interventions, only one 
other BCT, non-specific support (BCT 3), was also commonly coded and present in at least 
half of interventions. In just under half used verbal persuasion about a person’s capability to 
strengthen their self-beliefs (BCT 40). Practical (BCT 1) and emotional (BCT 2) social support 
as well as goal setting for behaviours (BCT 66) were included in around a third of 
interventions. Lastly, one in five interventions included a persuasive source (BCT 74) and set 
goals for a desired outcome (BCT 67; Figure 7). 
FIGURE 7: OCCURRENCE OF INDIVIDUAL BCTS IN PHYSICAL ACTIVITY 
INTERVENTIONS
# 
#BCTs (N=27) described in at least one physical activity intervention are shown; *See Appendix 11 for details of BCTs  
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5.1.8 Prevalence of individual BCTs in alcohol interventions 
Alcohol interventions included the fewest number of BCTs but this was also the behaviour 
related to health with the smallest number of interventions coded (for further details see 
Appendix 5). A total of 13 BCTs were found at least once in eight alcohol interventions 
(Figure 8). Nearly all interventions provided unspecified social support (BCT 3) and three 
quarters also offered practical (BCT 1) and emotional (BCT 2) social support and provided 
biomarker feedback (BCT 14). Unlike for other health-related behaviours, instructions on 
how to perform a behaviour (BCT 36) was only in half of interventions as was the use of 
problem solving techniques (BCT 65). Around a third of alcohol interventions (N=3) used 
verbal persuasion to strengthen self-beliefs and self-efficacy (BCT 40) or included a 
behavioural contract (BCT 71). Lastly, a quarter of interventions provided feedback on 
behaviour (BCT 8) or used a persuasive source (BCT 74; Figure 8). 
FIGURE 8: OCCURRENCE OF INDIVIDUAL BCTS IN ALCOHOL INTERVENTIONS# 
#BCTs (N=13) described in at least one alcohol intervention are shown; *See Appendix 11 for details of BCTs  
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5.1.9 Prevalence of individual BCTs in sexual health interventions 
Thirty BCTs were coded across 44 interventions to improve sexual health as shown in Figure 
9 (for further details see Appendix 6). Nearly all interventions (N=42) included instructions 
on how to perform a desired behaviour (BCT 36) and around half also provided 
pharmacological support (BCT 4) or information about health consequences (BCT 82). Over a 
third of interventions offered non-specific support (BCT 3), discussed body changes (BCT 35), 
included information on emotional (BCT 83) as well as social and environmental 
consequences (BCT 84) and over a quarter used verbal persuasion to increase capability (BCT 
40). Lastly, around a fifth of interventions involved a persuasive source (BCT 74), provided 
biomarker feedback (BCT 14), practical (BCT 1) and emotional (BCT 2) social support and set 
behavioural goals (BCT 66; Figure 9). 
FIGURE 9: OCCURRENCE OF INDIVIDUAL BCTS IN SEXUAL HEALTH 
INTERVENTIONS
# 
#BCTs (N=30) described in at least one sexual health intervention are shown; *See Appendix 11 for details of BCTs  
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5.1.10 Prevalence of individual BCTs in interventions targeting multiple 
behaviours 
The largest number of BCTs (N=40) was coded across the 48 cost-effective interventions 
targeting multiple behaviours (for further details see Appendix 7). As can be see Figure 10, 
instructions on how to perform a behaviour (BCT 36) was the most prevalent BCT included in 
four fifths of interventions. Half of interventions included a persuasive source (BCT 74) and 
provided some social support (BCT 3). Just under half offered practical (BCT 1) and emotional 
(BCT 2) social support and encouraged the setting of behavioural goals (BCT 66). Three in ten 
interventions to change multiple health-related behaviours gave information about health 
consequences (BCT 82), discussed body changes (BCT 35) and demonstrated behaviour (BCT 
88). Around a quarter used behavioural or practical rehearsal (BCT 23), involved goal setting 
for desired outcomes (BCT 67) and action planning (BCT 68) and at least a fifth of 
interventions provided information on emotional (BCT 83) or social and environmental 
consequences (BCT 84) and used problem solving techniques (BCT 65; see Figure 10). 
FIGURE 10: OCCURRENCE OF INDIVIDUAL BCTS IN INTERVENTIONS TO CHANGE 
MULTIPLE BEHAVIOURS
# 
#BCTs (N=39) described in at least one multiple behaviour intervention are shown; *See Appendix 11 for details of BCTs  
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5.1.11 Prevalence of ‘choice architecture’ in interventions 
The use of ‘choice architecture’ as defined in this report was not particularly common among 
interventions. Overall, only 13.9% (95%CI 10.2-18.8) out of the 251 interventions (N=35) 
included a BCT which reflected the use of some environmental tool or element designed to 
alters people’s behaviour “in a predictable way without forbidding any options or 
significantly changing their economic incentives”. As shown in Figure 11, ‘choice 
architecture’ was most prevalent in physical activity interventions, being present in around a 
fifth of these. By contrast, none of the interventions targeting alcohol use included BCTs 
related to ‘choice architecture’. While prevalence differed significantly as a function of the 
health-related behaviour targeted (Likelihood ratio χ2(5)=11.2, p=0.047), none of the post-
hoc comparisons reached corrected statistical significance levels. 
FIGURE 11: PREVALENCE OF CHOICE ARCHITECTURE BY HEALTH-RELATED 
BEHAVIOUR 
Dotted line indicates average across all interventions (N=79); Error bars are 95% confidence intervals 
As shown in Table 7, none of the BCTs included in the definition of ‘choice architecture’ were 
significantly correlated within interventions. Therefore it was impossible to carry out the 
sensitivity analysis as planned. 
TABLE 7: CORRELATIONS# AMONG CHOICE ARCHITECTURE BCTS 
BCT  15 16 30 31$ 32$ 34 
16$       
30 -.028 -     
31$ - - -    
32$ - - - -   
34 .113 - -.021 - -  
79$ - - - - - - 
#Reports Spearman’s rho; $Not coded in any intervention  
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5.2 Factors associated with cost-effectiveness 
In order to meaningfully interpret data in relation to NICE threshold guidelines (cf. footnote 
2), only interventions reporting cost-utility analyses were included in the appraisal of cost-
effectiveness in this section (N=102). As some of the economic analyses carried out 
sensitivity analysis, varying cost-effectiveness estimates based on various factors such as 
user characteristics and time horizons, both lower (most optimistic) and upper (most 
pessimistic) limits of CUA estimates were recorded where available and cost-effectiveness 
determined according to NICE guidelines In cases where no such sensitivity analysis was 
carried out, the single estimate was included as both the lower and upper limit. Of the 
included interventions, 62% (N=63) used a single CUA estimate and 38% (N=39) provided 
multiple CUA estimates. 
TABLE 8: PREVALENCE OF COST-EFFECTIVE INTERVENTIONS AS A FUNCTION OF 
NICE THRESHOLD AND LOWER/UPPER COST-EFFECTIVENESS ESTIMATES 
*Significant overall differences are in italics; a,b,c Comparison of interventions targeting different health-related 
behaviours, different letters indicate significant difference at p<0.05 (Bonferroni-corrected) 
As can be seen in Table 8, when looking at the average lower estimates, there was a 
significant difference between smoking cessation interventions and interventions targeting 
multiple health-related behaviours (F(5, 96)=3.47, p=0.006) but there were no significant 
differences between different health-related behavioural interventions for the higher 
estimate. This finding was also reflected when comparing cost-effective and cost-ineffective 
interventions based on the £20,000 threshold – only with the lower estimate was there a 
significant difference between smoking cessation and multiple health-related behaviour 
interventions but there were no differences when using other thresholds or estimates. 
 
All 
(N=102) 
Smoking 
(N=37) 
Diet 
(N=20) 
Physical 
Activity 
(N=3) 
Alcohol 
(N=2) 
Sexual 
health 
(N=13) 
Multiple 
health 
targets 
(N=27) 
P* 
 Mean (SEM)  
Lower 
estimate 
£8,025 
(1,528) 
£2,382a 
(648) 
£6,098a,b 
(1,265) 
£109a,b 
(109) 
£4,858a,b 
(572) 
£11,012a,b 
(6,360) 
£16,864b 
(4,286) 
0.006 
Higher 
Estimate 
£11,470 
(1,898) 
£7,593 
(2,769) 
£11,812 
(3,714) 
£4,962 
(4,962) 
£4,858 
(572) 
£11,763 
(6,540) 
£17,601 
(4,310) 
0.439 
 % (N) below £20,000 threshold  
Lower 
estimate 
91.2 
(93) 
100.0 
(37)a 
95.0 
(19)a,b 
100.0 
(3)a,b 
100.0 
(2)a,b 
84.6 
(11)a,b 
77.8 
(21)b 
0.022 
Higher 
Estimate 
85.3 
(87) 
91.9 (34) 85.0 (17) 100.0 (3) 100.0 (2) 84.6 (11) 74.1 (20) 0.370 
 % (N) below £30,000 threshold  
Lower 
estimate 
95.1 
(97) 
100.0 
(37) 
100.0 
(20) 
100.0 (3) 100.0 (2) 92.3 (12) 85.2 (23) 0.070 
Higher 
Estimate 
90.2 
(92) 
94.6 (35) 95.0 (19) 100.0 (3) 100.0 (2) 84.6 (11) 81.5 (22) 0.429 
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5.2.1 Cost-utility analyses (continuous outcome) 
5.2.1.1 All interventions 
Given the large number of potential predictor variables and for the sake of simplicity, only 
those variables that were associated with cost-utility estimates in univariate analysis 
(detailed below) were included in the multiple regression analysis. 
- Intervention characteristics (see Table 4): Only the population targeted was 
associated with cost-effectiveness CUA estimates. Interventions for the general 
population produced better (lower) CUA values for both lower (t(100)=3.3, p<0.001) 
and upper (t(100)=3.2, p=0.002) estimates than interventions aimed at vulnerable 
populations. 
FIGURE 12: COST-EFFECTIVENESS BY BCT PREVALENCE# 
#Lines are linear regressions  
- Intervention functions (see Table 5): There was evidence that interventions whose 
function focused on “persuasion” had better cost-utility estimates than those which 
did not (for upper estimate only (t(100)=2.8, p=0.006) and the opposite was true for 
interventions focusing on “education” (for lower estimate only; t(100)=3.0, p=0.004) 
- BCTs / BCT clusters (see Table 6): As shown in Figure 12, there was a positive 
association between the number of BCTs recorded and cost-utility estimates (this 
was significant for the lower estimate r=0.249, p=0.012; indicated by thick 
regression line). Given large differences in the prevalence of individual BCTs, only 
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BCT clusters were included in univariate analysis. This revealed that none of the 
clusters were associated with cost-utility estimates. 
- Choice Architecture (see Table 7): There was no difference in the cost-utility 
estimates of interventions that did or did not include BCTs relevant to ‘choice 
architecture’. 
Multiple linear regression was conducted using both the lower and upper cost-utility 
estimates to determine, which, if any, variables were independently associated with these 
estimates. The linear regression model showed that the target population was the only 
variable reliably and significantly associated with cost-effectiveness: interventions aimed at 
vulnerable populations had worse (i.e. higher) cost-utility values (in £/QALY) (for lower 
estimate: β=0.268, t=2.74, p=0.007; for upper estimate: β=0.313, t=3.34, p=0.001) compared 
with those aimed at the general population. None of the other intervention features were 
associated with either the lower or upper cost-utility estimates. However, for the upper cost-
utility estimate there was also evidence that interventions focusing on “persuasion” had 
better cost-utility estimates than those that did not (β=-0.189, t=2.02, p=0.046). As no BCT 
cluster was associated independently with cost-effectiveness, a second linear two-step 
regression was carried out to establish whether any important associations may have been 
missed. In the first step the only variables with known independent association (target 
population for analysis using the lower estimate and target population and “persuasion” for 
the analysis with the upper estimate) was entered and in the second step individual BCTs 
mentioned in at least one percent of interventions (to ensure sufficient variance, see Figure 
4) were included in a forward conditional model. This showed that the presence of BCT 5 
(“Reduce negative emotions”) was associated with worse (higher) cost-utility values for 
lower (β=0.475, t=6.45, p<0.001) and higher estimates (β=0.349, t=4.16, p<0.001). In 
addition, BCT 57 (“Non-specific reward”) was associated with worse CUA outcomes for lower 
(β=0.401, t=5.43, p<0.001) and BCT12 (“Monitoring of behaviour by others without 
feedback”) for higher (β=0.284, t=3.39, p=0.001) estimates when controlling for other 
confounders. 
5.2.1.2 Health behaviour 
The same approach as above was used to determine the association of relevant factors, if 
any, with cost-effectiveness but analysed separately for each health-related behaviour 
targeted. Owing to the small number of eligible papers neither physical activity nor alcohol 
interventions were analysed. Only independent associations from multiple linear regression 
analyses are reported. 
Smoking cessation interventions: There were no associations with the higher CUA estimate. 
However, based on the lower estimate, a greater number of BCTs (β=0.409, t=7.31, 
p<0.001), BCT 15 (“Prompts/cues”), BCT 66 (“Goal setting (behaviour)”) and BCT 85 
(“Salience of consequences”; β=0.850, t=15.29, p<0.001) were all associated with worse 
(higher) cost-utility estimates. By contrast, BCTs 14 (“Biofeedback”; β=-377, t=5.54, p<0.001) 
and 35 (“Body changes”; β=-0.130, t=2.45, p=0.044) predicted better (lower) CUA values. 
Diet interventions: Compared with all other intervention categories, medication only 
interventions were associated with worse CUA values for lower (β=0.798, t=5.94, p<0.001) 
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and upper (β=1.02, t=15.93, p<0.001) estimates, respectively. In addition, based on lower 
estimates, BCT 36 (“Instruction on how to perform a behaviour”) predicted better (lower) 
CUA values (β=-0.295, t=2.46, p=0.026). Based on upper estimates, brief interventions 
(β=0.255, t=2.35, p=0.037), BCT 13 (“Monitoring outcome(s) of behaviour by others without 
feedback”; β=0.495, t=7.72, p<0.001) and BCT 60 (“Material incentive (behaviour)”; β=0.274, 
t=3.25, p=0.007) were associated with worse and BCT 88 (“Demonstration of the behaviour”; 
β=-0.335, t=4.41, p<0.001) with better cost-utility, controlling for other variables. 
Sexual health intervention: BCT 5 (“Reduce negative emotions”)was associated with worse 
CUA values for lower (β=0.951, t=10.24, p<0.001) and upper (β=0.916, t=7.55, p<0.001) 
estimates, respectively. No other factors were associated with cost-utility. 
Multiple health-related behaviour intervention: As was the case when looking at all health-
related behaviours together, BCT 57 (“Non-specific reward”) was associated with worse CUA 
outcomes for lower (β=0.481, t=2.74, p=0.011) and BCT12 (“Monitoring of behaviour by 
others without feedback”; β=0.469, t=2.65, p=0.014) for higher estimates. No other factors 
were associated with cost-utility. 
5.2.2 Cost-utility analyses (categorical outcome) 
5.2.2.1 All interventions 
In this analysis interventions were not classified along a cost-effectiveness continuum but in 
two mutually exclusive categories: as being cost-effective or cost-ineffective. As before, 
given the large number of predictor variables and for the sake of simplicity, only those 
variables that were associated with cost-(in)effectiveness in univariate analysis (detailed 
below) were included in the multiple regression analysis. Cost-effectiveness was based on 
upper CUA estimates falling below the £20,000/QALY threshold as this is the most 
conservative measure and also produced maximal variance (see Table 8) 
- Intervention characteristics (see Table 4): As for the analysis using a continuous CUA 
value, interventions targeting the general population were significantly more cost-
effective than those targeting vulnerable populations (Fisher exact test, p=0.047). 
- Intervention functions (see Table 5): There were no significant associations. 
- BCTs / BCT clusters (see Table 6): Given that there was no association between the 
number of BCTs recorded and whether an intervention was appraised to be cost-
effective and because there were large differences in the prevalence of individual 
BCTs, only BCT clusters were included in univariate analysis. However, as can be 
seen in Figure 13, the prevalence of cost-effective interventions was relatively 
equally spread for all clusters and there were no significant differences. 
- Choice Architecture (see Table 3): Whether interventions were considered cost-
effective was not related to the presence of BCTs relevant to ‘choice. 
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FIGURE 13: PERCENT OF INTERVENTIONS IDENTIFIED AS COST-EFFECTIVE AS A 
FUNCTION OF PRESENCE AND ABSENCE OF BCT CLUSTERS# 
#No intervention featured BCT clusters ‘Scheduled consequences’ (BCT44-53) or ‘Covert learning’ (BCT91-93); Bars are 
95% confidence intervals 
Multivariate logistic regression was conducted to establish the independent association of 
significant variables from univariate analysis. However, given that only the target population 
was associated with cost-effectiveness and as no BCT cluster was associated with cost-
effectiveness, a second logistic two-step regression was carried out to establish whether any 
important associations may have been missed. In the first step the target population was 
entered and in the second step individual BCTs mentioned in at least one percent of 
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interventions (to ensure sufficient variance, see Figure 4) were included in a forward 
conditional model. This revealed that interventions targeting the general population were 
significantly more likely to be cost-effective (OR 12.0, 95%CI 1.5-96.4) whereas interventions 
containing BCT 13 (“Monitoring outcome(s) of behaviour by others without feedback”) were 
significantly less likely to be cost-effective (OR 0.01 , 95%CI 0.0-0.3). 
5.2.2.2 Health behaviour 
Again the association of relevant factors, if any, with cost-effectiveness using a dichotomous 
outcome was analysed separately for each health-related behaviour targeted, except 
physical activity and alcohol interventions. Only independent associations from multiple 
linear regression analyses are reported. 
Smoking cessation interventions: The only variable associated with cost-effectiveness was 
the target population, interventions for the general population were more likely to be cost-
effective than those for vulnerable populations (Fisher’s exact test, p=0.005). 
Diet interventions: The only variable associated with cost-effectiveness was the BCT cluster 
“Comparison of outcomes” – those interventions with BCTs from this cluster were less likely 
to be cost-effective (OR 0.30 , 95%CI 0.0-0.7). 
Sexual health intervention: No factors were associated with cost-effectiveness. 
Multiple health-related behaviour intervention: The only variable associated with cost-
effectiveness was the use of supporting material: interventions that used electronic 
supporting material appeared to be less likely to be cost-effective than those using other or 
no supporting material (OR 0.02; 95%CI 0.0-0.7). 
5.3 Comparison of cost-effective interventions identified in Stage 1 
with cost-effective interventions identified in Stage 3 
Altogether 79 cost-effective interventions were identified in Stage 1 [1] compared with 87 
cost-effective interventions in this report according to the criteria described above (highest 
CUA estimate lies below £20,000/QALY threshold). However, it should be noted that due to 
the different approach taken in identifying eligible interventions, many of the interventions 
included in Stage 1 would not have represented individual interventions but rather a set of 
interventions that were appraised and grouped together in terms of their cost-effectiveness 
due to their similarity. By contrast, the current report mostly concentrated on individual 
interventions appraised for their cost-effectiveness separately since interventions were not 
identified through NICE reports but in published papers of interventions. Thus the number of 
individual interventions that contributed to Stage 1 may have been larger. Notwithstanding 
this, the following attempts to compare interventions appraised as cost-effective in Stage 1 
and Stage 3 of the behaviour change update in terms of their general characteristics, main 
functions, behaviour change technique used as well as choice architecture. 
5.3.1 General characteristics of interventions 
Perhaps unsurprisingly, there are a number of differences between cost-effective 
interventions included in both reports. As shown in Figure 14a, while a greater proportion of 
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interventions in Stage 1 focused on alcohol, more interventions in this report focused on 
multiple behavioural targets (χ2(5)=21.6, p=0.001). 
FIGURE 14: INTERVENTION CHARACTERISTICS BY STAGE 
Bars are 95% confidence intervals; *p<0.05; **p<0.01; PA – Physical Activity; SH – Sexual Health 
Stage 3 interventions also were more often set in primary care while a much smaller 
proportion was set in the workplace (χ2(4)=20.9, p<0.001, Figure 14b). Cost-effective 
interventions in Stage 1 were more likely to be population-level interventions compared with 
those included in Stage 3, but more interventions in Stage 3 had a mixed intervention target 
(χ2(3)=16.9, p=0.001, Figure 14c), possibly due to the fact that more interventions in this 
report had multiple behavioural targets. However, a higher proportion of interventions in 
Stage 3 had no supporting material at all and in particular less self-help material (χ2(3)=12.2, 
p=0.007, Figure 14d). In addition, a higher proportion of interventions identified in Stage 1 
targeted the general population (Fisher’s exact test, p=0.027) and involved the use of 
incentives (Fisher’s exact test, p=0.001). In terms of cost-effectiveness estimates of 
interventions, while there was a significant difference for the lower estimate (cost-effective 
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interventions identified in Stage 1 on average cost £2,046/QALY saved compared with 
£4,209 in Stage 3; t(157)=3.1, p=0.002), the upper estimates were much more similar and did 
not differ significantly (Stage 1: £5,792/adjusted LY saved; Stage 3: £4,883). 
5.3.2 Main functions of interventions 
Stage 1 interventions fulfilled more functions than those in Stage 3 (see Figure 15). While the 
prevalence of interventions focusing on training was greater in Stage 3 than 1, the opposite 
was observed for enablement, persuasion, environmental restructuring and modeling. The 
only functions which did not differ were education (highly prevalent in both stages) and 
restriction, incentivisation and coercion (least prevalent across both stages, see Figure 15). 
FIGURE 15: INTERVENTION FUNCTION BY STAGE 
Bars are 95% confidence intervals; **p<0.01; ***p<0.001 
5.3.3 BCT clusters in interventions 
The average number and range of clusters was significantly higher and wider for 
interventions included in Stage 1 (6.8; 1-15) than in Stage 3 (4.0; 1-9; t(164)=6.5, p<0.001). 
Perhaps unsurprising then, the prevalence of most clusters was much higher in cost-effective 
interventions in Stage 1 than Stage 3 (see Figure 16). 
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FIGURE 16: BCT CLUSTERS BY STAGE 
Bars are 95% confidence intervals; *p<0.05; **p<0.01; ***p<0.001 
Whilst there was no difference in the clusters most prevalent (“Regulation’; “Shaping 
knowledge”; “Antecendents”; “Outcome comparison”) and least prevalent (“Scheduled 
consequences”; “Covert Learning”) across both stages, all other BCT clusters were 
significantly more common in cost-effective interventions covered by Stage 1 than those in 
Stage 3 (see Figure 16). This is consistent with the finding that interventions in Stage 1 were 
judged to be fulfilling more functions than interventions covered in the current report. 
5.3.4 Prevalence of individual BCTs 
In keeping with the findings described above, the average cost-effective intervention in 
Stage 1 included a larger number and wider range of individual BCTs (9.7, 2-39) than those in 
Stage 3 (5.1, 1-16; t(164)=5.2, p<0.001). Notwithstanding this, there was a fair amount of 
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overlap for the most prevalent BCTs reported. Some eight BCTs (3, 4, 35, 36, 40, 66, 74, 82) 
were mentioned in at least a fifth of interventions in both Stage 1 and 3 and a further six 
BCTs (8, 14, 65, 67, 83, 84) in at least a tenth of interventions (see Figure 17). 
FIGURE 17: MOST COMMON BCTS ACROSS STAGE 1 AND 3# 
#Includes interventions which on average across Stage 1 and 3 have been coded in at least ten percent of interventions; 
Differences by stage: *p<0.05; **p<0.01; ***p<0.001  
There were differences in the prevalence of the most commonly reported BCTs across both 
reports (see Figure 17). Whilst BCTs 3, 5, 8, 10, 15, 34, 40, 65, 67, 68, 82 and 88 were more 
prevalent in interventions from Stage 1 than 3, the opposite was true for BCTs 1, 2 and 35. 
TABLE 9: LEAST COMMON BCTS ACROSS STAGE 1 AND 3 
No.  Label  No.  Label  No.  Label  
17.  Cue signalling reward  18.  Remove access to the 
reward  
19.  Remove aversive stimulus  
20.  Satiation  21.  Exposure  22.  Associative learning  
27.  Overcorrection  31.  Restructuring the social 
environment  
33.  Distraction  
  
 
 
 
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
40 
No.  Label  No.  Label  No.  Label  
37.  Information about 
antecedents  
39.  Behavioural experiments  41.  Mental rehearsal of 
successful performance  
42.  Focus on past success  43.  Self-talk  45.  Behaviour cost  
46.  Remove reward  47.  Reward approximation  48.  Rewarding completion  
49.  Situation-specific 
reward  
50.  Reward incompatible 
behaviour  
51.  Reward alternative 
behaviour  
52.  Reduce reward 
frequency  
53.  Remove punishment  64.  Self-incentive  
70.  Review outcome 
goal(s)  
73.  Discrepancy between 
current behaviour and goal  
76.  Comparative imagining of 
future outcomes  
77.  Identification of self 
as role model  
78.  Valued self-identity  87.  Anticipated regret  
91.  Imaginary 
punishment  
92.  Imaginary reward  93.  Vicarious consequences  
A full list of BCTs and definitions is provided in Appendix 11 
By contrast, among the most prevalent behaviour change techniques, BCTs 4, 14, 23, 36, 66, 
74, 83 and 84 were equally common. Interestingly, 33 BCTs were not mentioned once, either 
in Stage 1 or Stage 3 (see Table 9). 
5.3.5 Prevalence of ‘choice architecture’ in interventions 
Given the overall differences in BCTs coded for in cost-effective interventions in Stage 1 and 
Stage 3 and the fact that choice architecture in this report has been operationalized in 
relation to BCTs, there was consequent difference in the prevalence of ‘choice architecture’ 
(CA). CA was significantly more prevalent in interventions included in Stage 1 than in 
interventions included in Stage 3 (Stage 1: 70.9%; 95%CI 60.0-79.8 vs. Stage 3: 5.8%, 95%CI 
2.2-13.2; p<0.001). However, as can be seen in Figure 18, this difference was not significant 
for physical activity interventions and most pronounced for smoking cessation and diet 
interventions and interventions targeting multiple health-related behaviours. 
FIGURE 18: PREVALENCE OF CA BY INTERVENTION TARGET AND STAGE 
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Bars are 95% confidence intervals;**p<0.01, ***p<0.001; PA – Physical Activity; SH – Sexual Health  
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6. Summary 
Over 250 cost-effective as well as cost-ineffective interventions across six different 
behaviour targets (smoking cessation, diet, physical activity, alcohol, sexual health and 
multiple behaviour targets) were identified from a total of 84 papers and reviews. The large 
majority of interventions (over four fifth) were considered cost-effective based on estimates 
from cost-utility analysis and other types of cost-effectiveness analyses. However, few 
studies were tested rigorously against adequate (matched) control conditions.  
With regards to interventions characteristics, similar to the Stage 1 report, the majority of 
cost-effective interventions based on NICE criteria focused on smoking cessation. However, 
by comparison with Stage 1, fewer interventions in this report focused on alcohol and more 
on targeting multiple health-related behaviours. Whilst most interventions in this and in the 
previous report were set in primary care, this proportion was much higher in Stage 3 than in 
Stage 1 interventions. However, as in the previous report, the majority of interventions were 
delivered by health professionals to individuals, even if, relatively speaking, fewer 
interventions in the current report were delivered to the population at large, e.g. by means 
of mass media and use of legislation. Moreover, compared with interventions in Stage 1, 
more interventions in this report targeted vulnerable populations while the use of 
supporting material and incentives in interventions was lower. Nonetheless, cost-utility 
estimates for cost-effective interventions in Stage 1 and Stage 3 were reasonably similar. 
When it comes to differences between different health-related behaviours, as in Stage 1, 
compared with other interventions, smoking cessation interventions were most likely to 
involve pharmacological support, but few other differences in intervention characteristics as 
a function of the health-related behaviour targeted were consistent with the Stage 1 report. 
This is most likely due to a different composition of interventions in this report, namely the 
inclusion of cost-ineffective interventions.12 Compared with other interventions, fewer 
interventions targeting multiple health-related behaviours were judged to be cost-effective; 
more specifically, multiple health-related behaviour interventions provided worse (higher) 
CUA estimates than smoking cessation interventions. This finding may reflect the fact 
interventions targeting multiple behaviours result in diluted effectiveness and thus cost-
effectiveness and, given the high intensity of such interventions, that there is no linear 
positive relationship between cost-effectiveness and intervention intensity. The latter 
suggestion is also confirmed by the positive association of the numbers of BCTs included in 
interventions with higher (i.e. worse) CUA values. As in Stage 1, sexual health and smoking 
cessation interventions were mainly set in primary care but, unlike Stage 1, so were alcohol 
interventions. Smoking cessation and alcohol interventions were also most rigorously tested 
in terms of their control condition and while multiple health-related behaviour interventions 
were most comprehensive (and thus intensive), physical activity and alcohol interventions 
                                                             
12 Please note that the analysis of differences between interventions targeting different health-related behaviours 
reported in section 5.1 includes both cost-effective and cost-ineffective interventions while the direct comparison of 
Stage 1 and Stage 3 interventions reported in 5.3 only includes cost-effective interventions (as no cost-ineffective 
interventions were included in the Stage 1 report). 
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were mostly brief interventions and smoking cessation interventions judged to be least 
intensive. 
As in the Stage 1 report, most interventions in this report focused on imparting knowledge, 
as indicated by a similar proportion having “Education” as its main function, including the 
BCT cluster “Shaping knowledge” and, more specifically, focusing on BCT 36 (“Providing 
instructions on how to perform a behaviour”). There was also some consistency in terms of 
main functions, BCT clusters and individual BCTs that were uncommon in cost-effective 
interventions. A similarly low proportion of cost-effective interventions in Stage 1 and 3 had 
as its main functions “Restriction”, “Incentivisation” or “Coercion”, focused on BCT clusters 
“Scheduled consequences”, “Covert learning” or included related BCTs such as BCT 18 
(“Remove access to reward”); BCT 64 (“Self-incentive) or BCT 91 (“Imaginary punishment”). 
Lastly, among the more commonly coded individual BCTs, interventions in both this and the 
previous report commonly featured BCTs relating to verbal persuasion (BCT 74), to providing 
pharmacological support (BCT 4) or information about emotional (BCT 83), social and 
environmental consequences (BCT 84) as well as biofeedback (BCT 14) and behavioural 
practice and rehearsal (BCT 23). Whilst more interventions in this than in the previous report 
focused on training and included BCTs pertaining to practical and emotional (but not 
unspecified) social support (BCTs 1, 2) as well as to body changes (BCT 35), this was the 
exception not the rule. Compared with Stage 1 interventions, cost-effective interventions in 
this report generally focused on fewer functions, covered fewer BCT clusters (and some not 
at all) and consequently fewer BCTs were coded. However, it should be noted that a third of 
available BCTs (N=33) did not feature in any cost-effective interventions either in this or the 
previous report. 
In terms of differences between interventions targeting different health-related behaviours 
with regards to intervention function, BCT clusters and individual BCTs, there were not many 
similarities to those reported in Stage 1 for the reasons outlined above. Compared with 
other interventions, diet interventions were most likely to focus on training, those for 
multiple health-related behaviours on education, smoking cessation interventions on 
enablement and alcohol interventions on persuasion. Given their comprehensive nature and 
greater intensity, interventions targeting multiple health-related behaviours on average 
covered the greatest number of BCT clusters followed by smoking cessation interventions (in 
Stage 1, smoking cessation and multiple health-related behaviour interventions also covered 
most BCT clusters). As was the case for in Stage 1, among the most common clusters, 
“Shaping knowledge” was least prevalent in alcohol and “Comparison of outcomes” least 
prevalent in diet interventions, “Regulation” most prevalent in smoking cessation 
interventions while “Social support” was equally prevalent across interventions. However, 
unlike Stage 1, “Feedback and monitoring”, Goals and planning” and “Natural consequences” 
were least prevalent, and “Antecedents” most prevalent, in smoking cessation interventions 
and “Self-beliefs” most prevalent in physical activity interventions.  
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When considering individual BCTs and in contrast to Stage 1, interventions with multiple 
behavioural targets, being more comprehensive and intensive, featured the largest number 
of BCTs on average (around seven) - significantly more than smoking cessation, diet and 
physical activity interventions - but differences between health-related behaviours were 
generally small. As in Stage 1 interventions, instructions on how to perform a behaviour (BCT 
36) and pharmacological support (BCT 4) were prevalent in smoking cessation interventions, 
BCT 36 and body changes (BCT 35) prevalent in diet interventions, BCT 36 and non-specific 
support (BCT 3) prevalent in physical activity interventions, and the latter also prevalent in 
alcohol interventions, and BCT 36 prevalent in sexual health interventions as well as 
interventions targeting multiple behaviours. Notable differences to Stage 1 include that BCT 
35 was more in common and information about health consequence (BCT 82) less common 
in smoking cessation interventions in this report. Similarly, adding objects to the 
environment (BCT 34) was much less common and BCT 4 more common in diet 
interventions, practical and emotional support (BCT 1 and 2) more prevalent and BCT 82 less 
prevalent in physical activity interventions, restructuring the physical environment (BCT 30) 
and inclusion of a persuasive source (BCT 74) much less common and BCTs 1 and 2 much 
more common in alcohol interventions. Lastly, the use of problem solving techniques (BCT 
65) was less prevalent and BCTs 4 and 82 more prevalent in sexual health interventions and 
providing feedback on behaviour (BCT 8) was less common and BCTs 1 and 2 more common 
in multiple health-related behaviour interventions. 
Though not a focus of this report, perhaps the biggest differences between interventions 
included in Stage 1 and Stage 3 relates to the occurrence of BCTs related to ‘Choice 
architecture’ (CA). CA was much more prevalent in interventions included in Stage 1 than in 
Stage 3. Less than one in twenty of cost-effective interventions featured BCTs that reflect CA 
compared with over two thirds of interventions in Stage 1. These differences between Stage 
1 and 3 interventions were particularly pronounced for smoking cessation and diet 
interventions while physical activity were roughly comparable in their use of ‘choice 
architecture’ to Stage 1 interventions. Although the prevalence of CA was highest in physical 
activity interventions (around one in three included BCTs related to CA) and not a single 
alcohol intervention showed evidence of CA using our definition, there was no overall 
significant difference in CA as a function of the health-related behaviour targeted in the 251 
interventions included in this report. 
In contrast to the Stage 1 report, this report included both cost-effective as well as cost-
ineffective interventions which allowed for a comparison between these types of 
interventions based on cost-utility analyses only and using an accepted NICE threshold. The 
first analysis used cost-utility estimates as a continuous outcome to evaluate associations of 
various intervention characteristics with better (that is lower) cost-utility estimates 
expressed in £/QALY gained. These results suggest that smoking cessation interventions 
tended to produce lower (better) CUA values on average than interventions targeting 
multiple behaviours related to health. Everything else being equal only two factors were 
independently associated with both lower and higher CUA estimates: interventions targeting 
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vulnerable populations and those which included BCT 5 to “reduce negative emotions” were 
associated with worse (higher) CUA values. In addition, when looking at interventions 
targeting different health-related behaviours separately, the only consistent finding was that 
diet interventions which provided medication only had worse CUA outcomes than other 
types of diet interventions, showing an association with both the lower and higher CUA 
estimate.  
The second analysis dichotomised all interventions into cost-effective and cost-ineffective 
interventions based on the NICE threshold using reported CUA. As for the previous analysis, 
smoking cessation interventions tend to be more cost-effective than interventions for 
multiple health-related behaviours when using the lower CUA estimate to determine cost-
effectiveness (see Table 8) or when including studies reporting economic analyses other than 
cost-utility analyses (Table 4). Controlling for all other factors, the results confirm that 
interventions which target vulnerable populations tend to be less cost-effective than those 
targeting the general population. In addition, interventions which included BCT 13 
(“Monitoring outcome(s) of behaviour by others without feedback”) were significantly less 
likely to be cost-effective. When looking at interventions for different health-related 
behaviours separately, the inclusion of BCTs related to “Comparison of outcomes” was 
associated with being cost-ineffective diet interventions and the use of electronic material 
with cost-ineffective interventions targeting multiple behaviours related to health. 
6.1 Caveats 
In addition to the problem of comparing interventions included in Stage 1 and in Stage 3 (see 
page 35 and Footnote 12), there are some other caveats and limitations that need to be 
acknowledged when interpreting the findings of this report. First, BCTs were coded from 
published/available information rather than from intervention protocols. As most papers 
provide only limited information on intervention content, this is likely to have resulted in 
some discrepancy between actual intervention content and coded content. This is further 
confounded by the fact that due to the large number of interventions included from reviews, 
resource limitations required coding of intervention content second-hand from descriptions 
obtained in reviews. For this reason only reviews with sufficiently detailed description were 
included so as to reduce this bias. 
Second, the BCT taxonomy approach is conservative: one of the principles of coding for BCTs 
using the taxonomy is to only code the presence of a technique where there is unequivocal 
evidence from written material that that technique has been used. Thus, one of the 
advantages of the taxonomy, its specificity and precision in identifying BCTs, also makes it 
difficult to extract BCTs, because many intervention reports are poorly specified. So, it may 
be that other techniques have been used in many of these interventions but were not 
adequately reported, so we could not detect them. This is a frequent observation among 
those who use the BCT taxonomy to code intervention reports. Reports need to be better 
specified to allow for BCT coding. 
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Third, this report is limited by the quality and time-frame of the papers which provided the 
evidence-based for interventions included in this BCT analysis. As indicated in Sections 4.1 
and 4.2, economic modelling itself is open to a number of limitations, such as uncertainty 
about temporal discounting, adjustment for quality of life and the use of disparate 
methodologies (e.g. assumptions) across reports. Whilst care was taken to account for 
different control conditions and econometric approaches employed, it is still likely that 
considerable heterogeneity remains as exemplified by the fact that the same intervention is 
appraised as cost-effective in some but not other analyses (e.g. see Shepherd et al [ 18]). 
Fourth, given the relative vague definition of ‘choice architecture’ in the literature, it is 
possible that the analyses in this report either over- or underestimate its prevalence in cost-
effective interventions, depending on whether the operationalization of ‘choice architecture’ 
in this report is too inclusive or too restrictive. A fact which is underlined by the rather 
disparate results obtained in this report when using differing ways of estimating the 
presence of ‘choice architecture’. In addition, the same limitations that apply to the 
association of BCTs with cost-effectiveness (outlined below) apply to ‘choice architecture’, 
given that this construct was operationalized based on BCTs. Moreover, as the Bazian 
searches did not include search terms for choice architecture, it is possible that papers that 
should have been identified may have been missed. 
Fifth, whilst different forms of economic analyses and different thresholds were used to 
define cost-effectiveness, there remains considerable variability in the methodologies used 
to derive cost-utility and other types of economic estimates which are likely to have 
introduced some noise into the analysis of factors associated with cost-effectiveness. 
Sixth, and most importantly, it is not possible to infer that, because certain BCTs have been 
used frequently in (cost-)effective interventions, that these BCTs will always result in 
behaviour change. Whilst we attempted to address this issue in part by evaluating the 
association of BCTs with cost-utility estimates and by comparing cost-effective with cost-
ineffective interventions, these findings need to be interpreted with caution as they assume 
independence between study outcome and reporting of intervention content. As indicated 
above, the accuracy of BCT analysis crucially depends on the quality of the study and 
intervention description. Without an explicit quality assessment, the possibility cannot be 
excluded that, for instance, some BCTs are negatively (or positively) associated with cost-
effectiveness simply because these findings derive from ‘better’ studies which also provide a 
more detailed account of intervention content. Put differently, if study quality is reflected 
both in outcome and ability to identify BCTs accurately this could result in artefactual or 
spurious associations. Furthermore, it is not possible to reliably isolate the contribution of 
each BCT/intervention characteristic to effectiveness because many BCTs are used in 
conjunction with others, and meta-analysis/meta-regression would be more suitable to 
discern these effects but this is outside of remit of the current project. Lastly, any 
conclusions of this report rely on the assumption that the description of BCTs reflects actual 
implementation of BCTs in interventions. However, since fidelity of intervention delivery was 
not assessed, this is by no means guaranteed. 
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Appendix 1: Detailed overview of reviewed interventions13 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Medication Bupropion No intervention £25098 ICER in QALY 
when benefits last 1 year, 
dominant when it lasts 10 
years 
Yes Coleman 2010 
[Review] 
Bupropion NRT $702 per QALY gained for 
men and $521 for women 
Yes Ruger 2012 [Review] 
Bupropion Placebo Cost per non-smoking 
employee $270-151 
Yes* Ruger 2012 [Review] 
Bupropion Standard care $3852 per life year saved Yes Ruger 2012 [Review] 
Bupropion Usual care VND $172582000 / DALY No Higashi 2012 
Free nicotine patch 
incentive 
Preinitiative 
program 
$2688 per quit, $86 more 
per life year saved 
Yes Ruger 2012 [Review] 
Full coverage nicotine 
gum 
No coverage of 
gum 
Cost per qutter $716 Yes* Reda 2012 [Review] 
  
                                                             
13 aClassification by consensus of authors of report; bData come directly from reports; cIn order to determine cost-effectiveness (ICER) compared with control condition CUA/CEA data were transferred 
into £ per QALY/DALY/LY, where necessary, representing costs for average user at time of analysis (see 4.2 Review of economic analyses for more details); in cases where CEA was not expressed in 
terms of (adjusted) life years saved and another economic analysis was used, authors conclusions (indicated by asterisk*) was used to indicate cost-effectiveness; dIndicates whether intervention was 
found in individual paper or review; full references provided in Appendix 9; Interventions in bold are cost-effective based on the threshold used in this report for section 5.2.2 and 5.3 (higher CUA 
estimate below £20,000/QALY saved, see Table 8) 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Medication Full coverage nicotine 
gum 
Partial coverage Cost per quitter $260 Yes* Reda 2012 [Review] 
Gum Usual care VND $376261000 per 
DALY 
No Higashi 2012 
NRT No intervention £49731 ICER in QALY 
when benefits last 1 year, 
dominant when it lasts 10 
years 
Yes Coleman 2010 
[Review] 
NRT Standard care $1867 per life year saved Yes Ruger 2012 [Review] 
Patch Usual care VND $287684000 per 
DALY 
No Higashi 2012 
Placebo Placebo Cost per non-smoking 
employee $82 
Yes* Ruger 2012 [Review] 
Varenicline Brief counselling Euro 240/QALY Yes Annemans 2009 
Varenicline Brief counselling £172-1192 per QALY Yes Ruger 2012 [Review] 
Varenicline Bupropion Varenicline dominant Yes Annemans 2009 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Medication Varenicline Compared with 
nortriptyline 
$1472 per QALY Yes Ruger 2012 [Review] 
Varenicline No intervention £322 ICER in QALY when 
benefits last 10 years; 
£91189 ICER when 
benefits last one year 
Yes Coleman 2010 
[Review] 
Varenicline NRT Varenicline dominant Yes Annemans 2009 
Varenicline NRT Cost effectiveness ratio 
$3936 per QALY gained 
Yes Ruger 2012 [Review] 
Varenicline NRT $919 more compared to 
NRT per additional quitter 
Yes* Ruger 2012 [Review] 
Varenicline Placebo QALY $420 for men and 
$7464 for women 
Yes Ruger 2012 [Review] 
Varenicline Placebo Cost per non-smoking 
employee $541 
Yes* Ruger 2012 [Review] 
Varenicline Unaided cessation Euro 1656/QALY Yes Annemans 2009 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Medication Varenicline Unaided cessation $285 per QALY Yes Ruger 2012 [Review] 
Varenicline Usual care VND $108412000 per 
DALY - varenicline 
dominated bupropion and 
NRT 
Yes Higashi 2012 
Varenicline plus 
additional 12 months 
Unaided cessation Incremental cost of $972, 
dominated control 
Yes Ruger 2012 [Review] 
Brief 
intervention 
Brief bed side 
counselling 
Usual care Incremental cost per 
incremental discounted 
life year saved $1691-
7444 
Yes Ruger 2012 [Review] 
Brief counselling Usual care More costly and less 
effective 
No* Ruger 2012 [Review] 
Computerised program Standard care Incremental cost-
effectiveness ratio was 
$1174 per life year aved 
($869 per QALY) 
Yes Smith 2007 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Brief 
intervention 
Manual No treatment $691 incremental cost per 
quit from society 
perspective $264 from 
provider 
Yes* Ruger 2012 [Review] 
Minimal or brief 
counselling 
Usual care Euro per QALY 16900 Yes Hoogendoorn 2010 
[Review] 
Moderate no NRT Brief counselling Incremental cost per quit 
$1912 
Yes* Hollis 2007 
NOT teen smoking 
cessation 
Brief intervention Incremental cost 
effectiveness ratio per 
discounted life year saved 
$443 
Yes Ruger 2012 [Review] 
Physician brief advice Usual care VND $1742000 per DALY Yes Higashi 2012 
Recruitment postcard Standard contact Total cost £3389.00; only 
1.3% enrolled versus 0% 
control condition 
No* Holtrop 2005 
Recruitment telephone 
call 
Standard contact Total cost £4766.00; total 
cost per quit $1191; 
20.6% enrolled compared 
to 0% control condition 
Yes* Holtrop 2005 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Brief 
intervention 
Self-help No treatment $1131 incremental cost 
per quit from society 
perspective $973 from 
provider 
Yes* Ruger 2012 [Review] 
Structured community 
pharmacist 
Usual care Cost savings to health 
system of $500 and $614 
and 0.18 life years gained 
and 0.24 life years gained 
men and women, 
respectively 
Yes* Ruger 2012 [Review] 
Brief 
intervention 
and medication 
Advice and motivation 
from pharmacist 
Usual advice from 
pharmacist 
Cost per life year saved 
$337-603 for men and 
$310-1332 for women 
Yes Ruger 2012 [Review] 
Basic advice and 
medication 
No intervention The 30 year cost/QALY is 
$3000 less than the base-
case assumpions and less 
than $10000 under 
pessimistic assumptions 
Yes Eddy 2009 
Brief advice and NRT Brief GP advice 
without NRT 
$965-1585 average cost 
per life year saved for me, 
$1634-2360 for women 
Yes Ruger 2012 [Review] 
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55 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Brief 
intervention 
and medication 
Brief advice and NRT Physician advice 
and counselling 
Cost per life year saved 
$4113-6465 for men and 
$6880-9473 for women 
Yes Ruger 2012 [Review] 
Brief NRT Brief counselling Incremental cost per quit 
$2467 
Yes* Hollis 2007 
Brief telephone 
counselling with NRT 
Brief counselling 
and no NRT 
$2467 for each additional 
quit 
Yes* Ruger 2012 [Review] 
Bupropion and NRT and 
proactive telephone 
counselling 
Pharmacotherapy 
(bupropion and 
NRT) 
$731 per additional 
quitter 
Yes* Reda 2012 [Review] 
Full coverage Partial coverage Incremental cost 
effectiveness ratio: 
financial gain $5316 
Yes* Reda 2012[Review] 
GP advice and NRT GP advice only $4390-10943 per QALY 
men, $4955-6983 women 
Yes Ruger 2012 [Review] 
GP brief counselling 
with NRT 
Same intervention 
with placebo NRT 
$568 per life years saved Yes Ruger 2012 [Review] 
GP training and NRT Usual care $107 per additional 
quitter 
Yes* Ruger 2012 [Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Brief 
intervention 
and medication 
GP training, NRT and 
remuneration 
Usual care $97 per additional quitter Yes* Ruger 2012 [Review] 
Minimal advice and 
NRT 
Minimal advice 
without NRT 
Cost per QALY aved 
ranged from $1108 to 
4542 with more intensive 
interventions being more 
cost effective 
Yes Ruger 2012 [Review] 
Minimal counselling 
from GP with NRT 
Current practice Cost per QALY gained in 
Euros if 1-year 
implementation 1700, 10 
year implementation 
1500 and permanent 
implementation 1400 
Yes Feenstra 2005 
Moderate NRT Brief counselling Incremental cost per quit 
$2109 
Yes* Hollis 2007 
Patches and uninsured 
quitline for 8 weeks 
Patches and 
uninsured quitline 
for 2 weeks 
Average cost per quit 
$1405 compared to $1156 
for 2 weeks 
Yes* McAfee 2008 
Pharmacist directed 
smoking cessation with 
bupropion 
Self-directed quit 
attempt 
$1150 incremental cost 
per quit 
Yes* Ruger 2012 [Review] 
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57 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Brief 
intervention 
and medication 
Pharmacist directed 
smoking cessation with 
gum 
Self-directed quit 
attempt 
$1232 incremental cost 
per quit 
Yes* Ruger 2012 [Review] 
Pharmacist directed 
smoking cessation with 
patch 
Self-directed quit 
attempt 
$936 incremental cost per 
quit 
Yes* Ruger 2012 [Review] 
Pharmacy Self-quit cessation £4400 per QALY Yes Boyd 2009 
Pharmacy Self-quit scenario £2600 per QALY Yes Bauld 2010 
Reimbursement for 
counselling and 
pharmacotherapy 
Usual care $2342/QALY Yes Reda 2012 [Review] 
Reimbursement for 
Smoking Cessation 
Support 
No 
reimbursement 
Intervention costs per 
QALY gained compared to 
the reference scenario 
were approximately Euro 
1200 extrapolating the 
trial effects directly and 
4200 when combining the 
trials use of SCS with the 
cessation rates from the 
literature 
Yes Vemer 2010 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Brief 
intervention 
and medication 
Two telephone call 
backs to initial call 
4 telephone call 
backs to initial call 
Cost per quit was the 
same for the two groups. 
Two call backs $442 and 4 
call backs $445, no 
difference in effectiveness 
either 
No* Carlin-Menter 2011 
Comprehensive 
intervention 
Assisted self-help Manual only Incremental cost per quit 
$922-$1758 
Yes* Akers 2007 
Intensive counselling Usual care Euro per QALY 8200 Yes Hoogendoorn 2010 
[Review] 
Intensive no NRT Brief counselling Incremental cost per quit 
$2640 
Yes* Hollis 2007 
Motivational 
interviewing 
Usual care $628 QALY for relapse 
prevention but 
dominated by usual care 
for smoking cessation. 
Yes Ruger 2008 
Motivational telephone 
counselling 
No telephone call Effectiveness to cost ratio 
of 1:$84 
Yes* Parker 2004 
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59 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Comprehensive 
intervention 
Smoking cessation or 
reduction in pregnancy 
treatment 
No treatment Cost benefit ratio of 
$1:$12, cost-saving 
Yes* Windsor 2003 
[Review] 
Telephone assistance 
for smoking cessation 
Self-help booklets Smoking cessation 
attributable to counselling 
availability is 
approximately $1300 
Yes* McAlister 2004 
Telephone based 
intervention 
Usual care $11408 cost per quitter Yes* Smith 2011 
Telephone counselling Current practice Cost per QALY gained in 
Euros if 1-year 
implementation 1500, 10 
year implementation 
1200 and permanent 
implementation 1100 
Yes Feenstra 2005 
Usual care plus 
population based direct 
to smoker outreach 
Usual care Estimated incremental 
cost per quit $464 
Yes* Rigotti 2011 
Comprehensive 
intervention 
and medication 
Counselling and 
Bupropion 
Advice or 
counselling alone 
Incremental cost per life 
year saved $920-2150 
Yes Ruger 2012 [Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Comprehensive 
intervention 
and medication 
Counselling and NRT Advice or 
counselling alone 
Incremental cost per life 
year saved $1441-3445 
Yes Ruger 2012 [Review] 
Counselling and NRT 
and Bupropion 
Advice or 
counselling alone 
Incremental cost per life 
year saved $1282-2836 
Yes Ruger 2012 [Review] 
Genetic testing within 
the course of usual 
smoking cessation 
intervention with NRT 
and counselling 
Usual smoking 
cessation 
intervention with 
NRT and 
counselling 
The discounted 
incremental cost per 
QALY was AU$34687 over 
35 years. 
Yes Gordon 2010 
Group intensive and 
NRT 
Minimal advice 
without NRT 
Cost per QALY saved 
ranged from $1108 to 
4542 with more intensive 
interventions being more 
cost effective 
Yes Ruger 2012 [Review] 
Group support Self-quit cessation £5400 per QALY Yes Boyd 2009 
Group support Self-quit scenario £4800 per QALY Yes Bauld 2010 
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61 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Comprehensive 
intervention 
and medication 
Individual intensive 
and NRT 
Minimal advice 
without NRT 
Cost per QALY aved 
ranged from $1108 to 
4542 with more intensive 
interventions being more 
cost effective 
Yes Ruger 2012 [Review] 
Intensive counselling 
with NRT 
Minimal 
counselling 
without NRT 
QALY gained $4939 Yes Ruger 2012 [Review] 
Intensive counselling 
with bupropion 
Current practice Cost per QALY gained in 
Euros if 1-year 
implementation 3600, 10 
year implementation 
3400 and permanent 
implementation 3400 
Yes Feenstra 2005 
Intensive counselling 
with NRT 
Current practice Cost per QALY gained in 
Euros if 1-year 
implementation 5200, 10 
year implementation 
4900 and permanent 
implementation 4900 
Yes Feenstra 2005 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Smoking Comprehensive 
intervention 
and medication 
Intensive counselling 
with pharmacotherapy 
Usual care Euro per QALY 2400 Yes Hoogendoorn 2010 
[Review] 
Intensive NRT Brief counselling Incremental cost per quit 
$2112 
Yes* Hollis 2007 
Intensive telephone 
counselling with NRT 
Brief counselling 
and no NRT 
$2467 for each additional 
quit 
Yes* Ruger 2012 [Review] 
Mobile smoking 
cessation service 
Other 
comprehensive 
programs 
Per self reported quitter 
$594 
Yes* Abdullah 2008 
Moderate telephone 
counselling with NRT 
Brief counselling 
and no NRT 
$2467 for each additional 
quit 
Yes* Ruger 2012 [Review] 
Peer delivered smoking 
cessation counselling 
Self help Cost per participant $300. 
The incremental cost 
effectiveness of the 
intervention was$5371 
per additional quit 
Yes* Emmons 2005 
Stepped care No treatment $5170 per life-year Yes Barnett 2008 
Stepped care and 
mental health services 
No treatment $9580 per life-year Yes Barnett 2008 
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63 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Diet Medication Acarbose No treatment CER AD $37000/DALY Yes Bertram 2010 
Metformin No treatment CER AD $22000/DALY Yes Bertram 2010 
Metformin Placebo 
intervention 
$34974-$123964/QALY 
from societal perspective 
No Diabetes research 
group 2003 
Orlistat No treatment CER AD $100000/DALY No Bertram 2010 
Orlistat AHT Diet £4633 per life years Yes Avenell 2004 [Review] 
Orlistat 
hypercholesterolemia 
Diet £4645 per life years Yes Avenell 2004 [Review] 
Orlistat 
hypercholesterolemia 
and AHT 
Diet £2171 per life years Yes Avenell 2004 [Review] 
Orlistat no 
complications 
Diet £12522 per life-years Yes Avenell 2004 [Review] 
Brief 
intervention 
Adjustable gastric 
banding 
No treatment £8527 per QALY Yes Avenell 2004 
[Review] 
Diet intervention No treatment ICER per QALY Euro 8996 Yes Hertzman 2005 
Educational video Usual care £14066 per QALY Yes Avenell 2004 
[Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Diet Brief 
intervention 
Gastric bypass surgery - 
10% IGT, 90% NGT 
No intervention £5527 per life years Yes Avenell 2004 [Review] 
Gastric bypass surgery - 
IGT 
No intervention £2067 per life years Yes Avenell 2004 [Review] 
New York State 
Expanded Food and 
Nutrition Education 
Program 
No intervention $20863 QALY (sensitivity 
$42935 QALY) 
Yes Dollahite 2008 
Roux-en-Y gastric 
bypass 
No treatment £6289 per QALY Yes Avenell 2004 
[Review] 
Sibutramine Placebo £7860 per QALY gained Yes Avenell 2004 
[Review] 
Sibutramine Placebo £10500 per QALY gained Yes Avenell 2004 
[Review] 
Vertical banded 
gastroplasty 
No treatment £10237 per QALY Yes Avenell 2004 
[Review] 
Vertical banded 
gastroplasty 
No treatment $5865 direct costs of 
surgery and productivity 
gained $2765 per year, 
dominated control 
Yes Avenell 2004 
[Review] 
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65 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Diet Brief 
intervention 
VLCD and individual 
therapy - IGT and NGT 
No intervention £1168 per life years Yes Avenell 2004 [Review] 
Brief 
intervention 
and medication 
Orlistat and diet 
intervention 
Diet intervention 
for 12 months and 
no treatment 
The ICER per QALY gained 
versus diet only was 
estimated to be Euro 
13125 for the average 
patient. When compared 
with no intervention, the 
cost effectiveness was 
improved. Comparing 
diet only with no diet 
gave a slightly higher 
ICER, indicating that 
Orlistat had extended 
dominance over the diet 
only intervention. 
Yes Hertzman 2005 
Comprehensive 
intervention 
Diet No treatment CER AD $38000/DALY Yes Bertram 2010 
Diet Routine care Dominated by the 
exercise, diet and 
behaviour modification 
program 
No* Loveman 2011 
[Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Diet Comprehensive 
intervention 
Food stamp nutrition 
education program and 
video 
Expanded food 
and nutrition 
education 
program 
$4820 compared to 
$13463 for control 
Yes* Cox 2003 
Gutbusters workplace No control group dominates to £7900, 
average £7900 
Yes Dalziel 2007 [Review] 
Intensive life style 
change to prevent 
diabetes 
General dietary 
advice at trial start 
AU$9500  per percentage 
point increase in the 
incremental cost 
effectiveness ratio 
Yes Dalziel 2007 [Review] 
Lighten up Current practice Cost-effectiveness ratio 
$130000/DALY 
No Cobiac 2010 
Mediterranean diet Prudent Western 
diet 
dominates to £1400, 
average £410 
Yes Dalziel 2007 [Review] 
Nutritional counselling 
in GP 
Feedback of initial 
measurements 
£2600-26000, average 
£4200 
Yes Dalziel 2007 [Review] 
Oxcheck nurse checks 
in GP 
Delayed treatment 
group 
£2700-26000, average 
£5100 
Yes Dalziel 2007 [Review] 
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67 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Diet Comprehensive 
intervention 
Reduced fat diet for 
IGT 
General dietary 
advice at trial 
start 
dominates to £4000, 
average £4000 
Yes Dalziel 2007 [Review] 
Screening followed by 
lifestyle intervention 
for subjects diagnosed 
with either impaired 
glucose tolerance or 
impaired fasting 
glucose 
No screening Cost-effectiveness ratio 
of $9511 per QALY 
Yes Hoerger 2007 
Screening overweight 
subjects and giving 
them the lifestyle 
intervention included 
in the diabetes 
prevention program if 
diagnosed with 
impaired glucose 
tolerance and impaired 
fasting glucose 
No screening Cost-effectiveness ratio 
of $8181 per QALY 
Yes Hoerger 2007 
Web based intervention 
MENU tailored 
Non-tailored 
intervention 
Cost per average change 
in fruit and veg $27 
Yes* Sukhanova 2009 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Diet Comprehensive 
intervention 
Web based intervention 
MENU tailored and 
HOBI counselling 
Non-tailored 
intervention 
Cost per average change 
in fruit and veg $61 
Yes* Sukhanova 2009 
Weight watchers Current practice Cost-effectiveness ratio 
$140000/DALY 
No Cobiac 2010 
Comprehensive 
intervention 
and medication 
Diet and pharmacology Routine care Dominated by the 
exercise, diet and 
behaviour modification 
program 
No* Loveman 2011 
[Review] 
Mass media FFFF media campaign No control group £4 to dominated, average 
£2300 
Yes Dalziel 2007 [Review] 
Multi media 2 fruit 5 
veg 
No control group £10 to dominated, 
average £18 
Yes Dalziel 2007 [Review] 
Physical activity Brief 
intervention 
Community campaign No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 0.009 
Yes* Wu 2007 [Review] 
Creation or enhanced 
access to places for 
physical activity 
No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 0.40 
Yes* Wu 2007 [Review] 
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69 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Physical activity Brief 
intervention 
GP prescription Current practice $11000 AD/DALY Yes Cobiac 2009 
GP referral to exercise 
physiologist 
Current practice $75000 (37500-150000) 
AD/DALY 
Yes Cobiac 2009 
Internet Current practice $2000 AD/DALY Yes Cobiac 2009 
Pedometers Current practice Dominant Yes Cobiac 2009 
Phone intervention Mailings unrelated 
to physical activity 
$1290-$3967 per 
participant moved out of 
sedentary status 
Yes* Sevick 2007 
Point of decision 
prompts 
No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 0.07 
Yes* Wu 2007[Review] 
Print intervention Mailings unrelated 
to physical activity 
$756-$955 per participant 
moved out of sedentary 
status 
Yes*  Sevick 2007 
TravelSmart Current practice $18000 AD/DALY Yes Cobiac 2009 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Physical activity Comprehensive 
intervention 
Disease register 
screening 
Opportunistic 
patient 
recruitment 
£53 per patient in 
controls and £191 in 
disease sites. The 
incremental cost of 
converting one sedentary 
adult to an active state of 
150 minutes of moderate 
intensity physical activity 
per week amounts to 
£886.50 in disease 
register practices 
compared to control. 
Yes* Boehler 2011 
Exercise No treatment CER AD $30000/DALY Yes Bertram 2010 
Green prescription 
program 
Usual care NZ $2053 per QALY Yes Dalziel 2006 
High intensity 
individually adapted 
behaviour 
No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 0.084 
Yes* Wu 2007 [Review] 
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71 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Physical activity Comprehensive 
intervention 
High intensity social 
support 
No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 1.16 
No* Wu 2007 [Review] 
Intervention group Intervention 
offered once 
Incremental cost 
effectiveness ratio over 
the first 6 months Euro 
142 per score point on 
the McMaster Toronto 
Arthritis Patient 
Preference Disability 
Questionnaire 
Yes* Bulthuis 2008 
LIFE-P exercise 
intervention 
Aging 
intervention: 
educational 
meetings 
Cost/disability avoided 
$28206 
Yes* Groessl 2009 
Low intensity 
individually adapted 
behaviour 
No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 0.10 
Yes* Wu 2007 [Review] 
Low intenstiy social 
support 
No intervention Cost effectiveness ratio as 
$ per MET-hour 
gained/person 0.47 
Yes* Wu 2007 [Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Physical activity Mass media Mass media-based 
campaign 
Current practice Dominant Yes Cobiac 2009 
Alcohol Brief 
intervention 
Brief intervention No treatment Net cost savings per 
participant $89. Potential 
net savings of $1.82 
billion annually. 
Yes* Gentilello 2005 
Brief relationship 
therapy 
Individual based 
treatment 
Higher cost effectiveness 
ratio than control 
Yes* Fals-Stewart 2005 
Brief relationship 
therapy 
Psychosocial 
educational 
attention control 
treatment 
Higher cost effectiveness 
ratio than control 
Yes* Fals-Stewart 2005 
Brief relationship 
therapy 
Standard 
behavioural 
couples therapy 
Higher cost effectiveness 
ratio than control 
Yes* Fals-Stewart 2005 
Screening and brief 
intervention 
Normal care Cost-effectiveness ratio 
of Euro 5,400 per QALY 
gained. 
Yes Tariq 2009 
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73 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Alcohol Brief 
intervention 
Screening and referral 
to alcohol health 
worker 
Information only 
control 
65% probability that more 
cost effective then the 
information only control 
Yes* Barrett 2005 
Comprehensive 
intervention 
Motivational 
interviewing 
Standard care per QALY $8795 Yes Neighbors 2010 
Stepped care 
intervention 
Minimal 
intervention 
Cost-saving of £9000 per 
participant, 98% 
confidence that stepped 
care more cost-effective 
than control 
Yes* Drummond 2009 
Sexual health Medication STI treatment No intervention $739 to $767/DALY 
averted 
Yes Aldridge 2009 
Brief 
intervention 
Condoms No intervention $500 to $503/DALY 
averted 
Yes Aldridge 2009 
Incentive Standard 
treatment 
Incremental cost 
effectiveness ratio $1,104 
per treated infection 
Yes* Gift 2005 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Brief 
intervention 
Peer education for sex 
workers 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $4 and 
Sear-D $3 
Yes Hogan 2013 [Review] 
Reminder Standard 
treatment 
Incremental cost 
effectiveness ratio $345 
per treated infection 
Yes* Gift 2005 
Tailored print 
communication 
No intervention ICER QALY EURO 2867 Yes van Keulen 2010 
Usual care and 
behavioural internet 
treatment 
Usual care $25.92 per kilogram of 
weight loss and $28.96 
per centimeter of waist-
circumference loss; cost 
per each additional point 
gained on the efficacy 
lifestyle questionnaire 
$37.88 
Yes* Rasu 2010 
Voluntary counselling 
and testing 
No intervention $116 to $118/DALY 
averted 
Yes Aldridge 2009 
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75 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Brief 
intervention 
and medication 
Antiretroviral - 
intensive monitoring, 
first and second line 
drugs 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $1977 
and Sear-D $1280 
Yes Hogan 2013 [Review] 
Antiretroviral - 
intensive monitoring, 
first line drugs only 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $596 
and Sear-D $570 
Yes Hogan 2013 [Review] 
Antiretroviral - no 
intensive monitoring, 
first and second line 
drugs 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $2010 
and Sear-D $1319 
Yes Hogan 2013 [Review] 
Antiretroviral - no 
intensive monitoring, 
first line drugs only 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $556 
and Sear-D $542 
Yes Hogan 2013 [Review] 
HAART basic No intervention $2403/DALY averted Yes Aldridge 2009 
HAART comprehensive No intervention $1995/DALY averted Yes Aldridge 2009 
HAART intermediate No intervention $2297/DALY averted Yes Aldridge 2009 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Brief 
intervention 
and medication 
Treatment of sexually 
transmitted infections 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $32 
and Sear-D $20 
Yes Hogan 2013 [Review] 
Comprehensive 
intervention 
Community - peer 
opinion leaders (1) 
Two comparison 
cities 
Cost per QALY saved $0 Yes Herbst 2007 [Review] 
Community - peer 
opinion leaders 
Two comparison 
cities 
Cost per QALY saved $0 Yes Herbst 2007 [Review] 
Group intervention - 
safe sex training 
60-90 minute 
safer sex lecture 
$9757 per discounted 
QALY saved 
Yes Herbst 2007 [Review] 
Group intervention - 
small group 
Wait-list group $0 per discounted QALY 
saved 
Yes Herbst 2007 [Review] 
HIV harm reduction 
intervention 
No intervention $359 per HIV infection 
averted 
Yes* Kumaranayake 2003 
HIV prevention No intervention Cost-effectiveness ratio of 
US$530 per DALY averted 
Yes Shepard 2010 
[Review] 
HIV prevention 
intervention 
No intervention $6180 per QALY saved Yes Shepard 2010 
[Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Comprehensive 
intervention 
Intervention group - 
annually 
Intervention 
offered only once 
$1075 per QALY Yes Burgos 2010 
Intervention group - 
once 
No intervention $183 per QALY Yes Burgos 2010 
Motivation counselling 
and reminder 
Standard 
treatment 
Dominated by control No* Gift 2005 
Motivational 
counselling 
Standard 
treatment 
Dominated by control No* Gift 2005 
Mpowerment project Santa Barbara Pre-steady to steady state 
$41993-49580 per HIV 
infection prevented (year 
1, societal perspective), 
$7373-10578 (year 20 
societal perspective); 
Yes* Herbst 2007 [Review] 
Obesity management Standard dietetic 
therapy 
Cost per KG weight loss 
$AU31 - $100 per patient 
per year 
Yes* Osland 2006 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Comprehensive 
intervention 
One-day CB HIV risk 
reduction 
No intervention $57000 per QALY saved 
when training costs 
included and $41000 per 
QALY saved when they 
were excluded 
No Shepard 2010 
[Review] 
Safer choices 
intervention 
No intervention $2.65 saved for every 
dollar spent on the 
programme 
Yes* Shepard 2010 
[Review] 
School based education No intervention Cost per person $305 and 
cost per HIV case averted 
$39M 
No* Shepard 2010 
[Review] 
Self-help cardiac 
rehabilitation 
Usual care control $40463/QALY Yes Lee 2007 [Review] 
SHARE project No intervention £11,622/QALY gained Yes Shepard 2010 
[Review] 
Time matched session Small group CB 
skills 
$136,295 per QALY when 
restricted to women not 
cost effective for men 
No Johnson-Masotti 2003 
[Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Comprehensive 
intervention 
Voluntary counselling 
and testing 
No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $82 
and Sear-D $40 
Yes Hogan 2013 [Review] 
Comprehensive 
intervention 
and medication 
Intervention group plus 
HAART 
Intervention 
offered annually 
Cost per QALY of $2436 Yes Burgos 2010 
Intervention group plus 
HAART 
Intervention 
offered once 
Cost per QALY of $14136 Yes Burgos 2010 
Peer counselling and 
treatment of STIs for 
female sex workers 
No intervention $55/DALY averted Yes Aldridge 2009 
Peer counselling and 
treatment of STIs for 
men who have sex with 
men 
No intervention $1317 to $1336/DALY 
averted 
Yes Aldridge 2009 
Peer education and 
treatment of sexually 
transmitted infections 
for sex workers 
No treatment Average ICER per DALY 
averted Afr-E $4 and Sear-
D $3 
Yes Hogan 2013 [Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Sexual health Comprehensive 
intervention 
and medication 
Prevention of mother 
and child transmission 
No intervention $5928/DALY averted Yes Aldridge 2009 
Prevention of mother 
to child transmission 
No treatment Average ICER per DALY 
averted Afr-E $34 and 
Sear-D $310 
Yes Hogan 2013 [Review] 
Mass media Mass media campaign No intervention $246/DALY averted Yes Aldridge 2009 
Mass media campaign No treatment Average cost 
effectiveness ratio per 
DALY averted Afr-E $3 and 
Sear-D $18 
Yes Hogan 2013 [Review] 
Multiple 
behaviours 
Medication Metformin 
intervention 
Placebo 
metformin 
Cost per QALY $31300 Yes Herman 2005 
Brief 
intervention 
Behavioural 
intervention 
Non-behavioural 
intervention 
Ranged from $42457/LY 
saved for normal weight 
women to $87300 for 
men. 
No Datta 2010 
Community 
intervention 
Usual care €3100-3900 per QALY Yes Jacobs-van-der-
Bruggen 2007 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Brief 
intervention 
Internet intervention Usual care £39248 per QALY No McConnon 2007 
Mail Invited for 
measurements 
Cost per participant per 
month £38.22 
Yes* Dzator 2004 
Screening No screening £14150/QALY 
(discounted 3.5% a year)  
Yes Gillies 2008 
Telephone Real control $29375 QALY Yes Graves 2009 
Usual care Real control $12153 QALY Yes Graves 2009 
Video plus self-help Routine care AU$11 million No* Avenell 2004 [Review] 
Weight-wise Wait-listed control The incremental cost per 
life year gained 
(discounted) from a 
decrease in obesity was 
$1862 
Yes Gustafson 2009 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Brief 
intervention 
and medication 
Nurse led clinics to 
promote of secondary 
prevention 
Usual care per QALY £1097 Yes Raftery 2004 
Screening and 
pharmacological 
intervention 
No screening QALY (discounted 3.5% a 
year for both costs and 
benefits) £7023 
Yes Gillies 2008 
Comprehensive 
intervention  
Cardiac rehabilitation Usual care $9200 per QALY Yes Lee 2007 [Review] 
Cardiac rehabilitation Traditional 
protocol 
No difference in clinical 
measures, cost $738 less 
than control treatment. 
No* Lee 2007 [Review] 
Cardiac rehabilitation Traditional 
protocol 
No difference in clinical 
measures, cost $738 less 
than control treatment. 
No* Lee 2007 [Review] 
Chronic care diabetes Usual care ICER £94511 per QALY No Carr 2011 [Review] 
Chronic care diabetes Usual care Was dominated No* Carr 2011 [Review] 
Chronic care diabetes Usual care ICER £13565 per QALY Yes Carr 2011 [Review] 
Counterweight 
program 
No treatment £473 per QALY Yes Loveman 2011 
[Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Comprehensive 
intervention 
Diet and exercise Routine care Dominated by the 
exercise, diet and 
behaviour modification 
program 
No* Loveman 2011 
[Review] 
Diet and exercise 
therapy 
Control education 
about diabetes 
$10870 per well life year Yes Avenell 2004 
[Review] 
Diet, exercise and 
behaviour modification 
Routine care $12640 per QALY Yes Loveman 2011 
[Review] 
Dietary intervention  Combination Dominated by Dietary 
intervention+Exercise 
No Barton 2009 
Strengthening exercise Leaflet Subject to extended 
dominance  
No Barton 2009 
Dietary intervention 
plus strengthening 
exercise 
Leaflet provision Incremental cost per 
QALY £10469.44 
Yes Barton 2009 
Exercise and diet 
intervention 
Usual care ICER of £67184 per QALY No Irvine 2011 
Finnish Diabetes 
Prevention study 
Usual care Cost-effectiveness ratio 
was Euro 2363 per QALY 
Yes Lindgren 2007 
  
  
 
 
84 
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Comprehensive 
intervention 
Group phone based 
obesity treatment for 
rural women 
Individual phone 
based obesity 
treatment for rural 
women 
$714 for group 
counselling and $1029 for 
individual counselling per 
participant 
Yes* Befort 2010 
Health care 
intervention 
Usual care €3100-3900 per QALY Yes Jacobs-van-der-
Bruggen 2007 
Improving control with 
activity and nutrition 
Usual care $3586 lower than control Yes* Wolf 2007 
In person group 
behaviour weight loss 
intervention 
Internet group 
behavioural 
weight loss 
intervention 
Incremental cost-
effectiveness ratio was 
$7177 per (discounted) 
LYG 
Yes Krukowski 2011 
Internet group 
behaviour weight loss 
intervention 
No intervention Incremental cost-
effectiveness ratio was 
$2160 per (discounted) 
LYG 
Yes Krukowski 2011 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Comprehensive 
intervention 
LHT intervention Diet intervention 
control 
ICER was £14480 per 
QALY, yet there was a 
61% chance of making 
the wrong decision at a 
£20000/QALY threshold 
Yes Barton 2012 
Life-style intervention Placebo 
metformin 
Cost per QALY $1100. Life 
style intervention 
dominanted the 
metformin intervention 
Yes Herman 2005 
Lifestyle intervention Placebo 
intervention 
$28053-$54613/QALY 
from societal perspective 
Yes Diabetes research 
group 2003 
Lifestyle intervention 
with standard care 
Standard care 
alone 
$1668-4813 per QALY Yes Eriksson 2010 
Mail and interactive 
group sessions 
Invited for 
measurements 
Cost per participant per 
month £38.37 
Yes* Dzator 2004 
PREVENT intervention Usual care $379 per risk factor 
dropped. $228 cost 
effectiveness estimate per 
unit change in multiple 
risk factor score 
Yes* Emmons 2005 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Comprehensive 
intervention 
Screening and lifestyle 
intervention 
No screening QALY (discounted 3.5% a 
year for both costs and 
benefits) £6242 
Yes Gillies 2008 
Cardiac rehabilitation Usual care SEK 43000 for the control 
group and SEK 36030 for 
intervention group. 52% 
of treatment group 
participants were 
employed compared to 
27% of controls. Saves 
70610 on sick leave. Total 
benefit-cost ratio of 51.1 
Yes* Lee 2007 [Review] 
Home based cardiac 
rehabilitation 
No cardiac 
rehabilitation 
Improved work capacity. 
Cost per patient $1898 
No* Lee 2007 [Review] 
Hospital based cardiac 
rehabilitation 
No cardiac 
rehabilitation 
Improved work capacity. 
Cost per patient $10170 
No* Lee 2007 [Review] 
Video cardiac 
rehabilitation 
Usual care control $40463/QALY Yes Lee 2007 [Review] 
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Health-related 
Behaviour 
Intervention 
typea 
Intervention name Control condition Economic analysis datab Cost-
effectivec 
Sourced 
Multiple 
behaviours 
Comprehensive 
intervention 
Cardiac rehabilitation Usual care $2688 per patient 
treated. Program entrants 
were less likely to be 
rehospitalised and pre-
admission charges when 
hospitalised significantly 
less. 
Yes* Lee 2007 [Review] 
Comprehensive 
intervention 
and medication 
Diet plus exercise No treatment CER AD $23000/DALY Yes Bertram 2010 
Israeli Blood Pressure 
Control Program 
No treatment $931000 for 1000 QALYs Yes Yosefy 2003 
Metformin+diet plus 
exercise 
No treatment CER AD $81000/DALY No Bertram 2010 
Wisewomen 
intervention 
No treatment $4400 per discounted life-
year gained 
Yes Finkelstein 2006 
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Appendix 2: Behaviour change techniques classified in interventions for Smoking Cessation14 
SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Social support 
  
    
1 Social  support 
(practical) 
 
X
36
 X
40,53,59
 X
64,67-69,72,73
 X
88,90,92
  
2 Social support 
(emotional) 
 X
36
 X
40,53,59
 X
64,67-69,72,73
 X
88,90,92
  
3 Social support 
(unspecified) 
 X
29,30,31-33,36
 X
40,41,43,45,46,47,48,53,55,56,59,60
 X
64,65,67-69,72,73
 X
75,77-79,81-88,90,92
  
Regulation       
4 Pharmacological 
support 
X
1-27 
 X
40-63
 X
65, 67,69,70,72,73
 X
74-92
  
5 Reduce negative  X
36
 X
51,53,54,57-59
 X
73
 X
88,89,91
  
                                                             
14 See Appendix 8 for details of references indicated by numbers in Table 
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
emotions  
6 Conserving 
mental 
resources 
  
 
   
7 Paradoxical 
instructions 
      
Feedback and 
monitoring 
      
8 Feedback on 
behaviour 
   X
68,69
 X
76,80,88,92
  
9 Feedback on 
outcome(s) of 
behaviour 
      
10 Self-monitoring       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
of behaviour 
11 Self-monitoring 
of outcome(s) of 
behaviour 
      
12 Monitoring of 
behaviour by 
others without 
feedback 
    X
92
  
13 Monitoring 
outcome(s) of 
behaviour by 
others without 
feedback 
      
14 Biofeedback    X
66
 X
74,82
  
Associations       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
15 Prompts/cues  X
30
 X
40,59
 X
67-69,73
 X
90
  
16 Reduce 
prompts/cues 
      
17 Cue signalling 
reward 
      
18 Remove access 
to the reward 
      
19 Remove 
aversive 
stimulus 
      
20 Satiation       
21 Exposure       
22 Associative       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
learning 
Repetition and 
substitution  
      
23 Behavioural 
practice/rehears
al 
      
24 Habit formation       
25 Behaviour 
substitution 
      
26 Habit reversal       
27 Overcorrection       
28 Generalisation 
of a target 
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
behaviour 
29 Graded tasks       
Antecedents       
30 Restructuring 
the physical 
environment 
  X
53
   
 
31 Restructuring 
the social 
environment 
      
32 Avoidance/redu
cing exposure to 
cues for the 
behaviour 
      
33 Distraction       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
34 Adding objects 
to the 
environment 
      
35 Body changes X
1-27
 X
29,37
 X
40-63
 X
73
 X
74-92
  
Shaping knowledge       
36 Instruction on 
how to perform 
a behaviour 
X
1-27 
 
X
28,29,34,35,36-39
 X
40-63
 X
64,66-73
 X
74-92
  
37 Information 
about 
antecedents 
      
38 Re-attribution       
39 Behavioural 
experiments 
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Self-beliefs        
40 Verbal 
persuasion 
about capability 
 X
28-31,36,37
 X
40,42,44,45, 49-51,53,59
 X
64,66,68-73
 X
88,92
  
41 Mental 
rehearsal of 
successful 
performance 
      
42 Focus on past 
success 
      
43 Self-talk       
Scheduled 
consequences 
      
44 Punishment       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
45 Behaviour cost       
46 Remove reward       
47 Reward 
approximation 
      
48 Rewarding 
completion 
      
49 Situation-
specific reward 
      
50 Reward 
incompatible 
behaviour 
      
51 Reward 
alternative 
behaviour 
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
52 Reduce reward 
frequency 
      
53 Remove 
punishment 
      
Reward and threat       
54 Material reward 
(behaviour) 
      
55 Material reward 
(outcome) 
      
56 Social reward       
57 Non-specific 
reward 
      
58 Self-reward   X
60
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
59 Future 
punishment 
  X
46
    
60 Material 
incentive 
(behaviour) 
X
23,24 
 
 X
56
    
61 Material 
incentive 
(outcome) 
  X
58
    
62 Social incentive       
63 Non-specific 
incentive 
      
64 Self-incentive       
Goals and planning       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
65 Problem solving   X
53,59
 X
68,70,71
 X
82,88,92
  
66 Goal setting 
(behaviour) 
  X
42,44,53
 X
66,68-70
 X
75,88,92
  
67 Goal setting 
(outcome) 
  X
40
 X
68-70
 X
77,88,92
  
68 Action planning   X
53
 X
68-70
 X
88
  
69 Review 
behaviour 
goal(s) 
  X
53
    
70 Review 
outcome goal(s) 
      
71 Behavioural 
contract 
   X
70
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
72 Commitment       
73 Discrepancy 
between 
current 
behaviour and 
goal 
      
74 Persuasive 
source 
X
1-4,7,13,19,20
 X
30,32
 X
41-45,47-52,54-58,61-63
 X
65,66,70
 X
74-78,80,81,89,91
  
75 Pros and cons       
76 Comparative 
imaging of 
future 
outcomes 
      
Identity       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
77 Identification of 
self as role 
model 
      
78 Valued self-
identity  
      
79 Framing/reframi
ng 
      
80 Incompatible 
beliefs 
    X
74
  
81 Identity 
associated with 
changed 
behaviour 
      
Natural consequences       
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
82 Information 
about health 
consequences 
   X
64,66, 67,69,70
 X
74,82,92
  
83 Information 
about 
emotional 
consequences 
   X
64,67,69,70
 X
82,92
  
84 Information 
about social and 
environmental 
consequences 
   X
64,67,69,70
 X
82,92
  
85 Salience of 
consequences 
   X
70
 X
82,92
  
86 Monitoring of 
emotional 
consequences 
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
87 Anticipated 
regret 
      
Comparison of 
behaviour 
      
88 Demonstration 
of behaviour 
      
89 Social 
comparison 
    X
74
  
90 Information 
about others’ 
approval 
      
Covert learning       
91 Imaginary 
punishment 
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SMOKING 
CESSSATION 
Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
92 Imaginary 
reward 
      
93 Vicarious 
consequences 
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Appendix 3: Behaviour change techniques classified in interventions for diet15 
DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Social support 
       
1 Social  support 
(practical) 
   X116,117,120-125,128 X129  
2 Social support 
(emotional) 
   X116,117,120-125,128 X129  
3 Social support 
(unspecified) 
 X111  X116,117-125,128 X129  
Regulation       
4 Pharmacological 
support 
X93-100 X103,106,108 X113  X129  
5 Reduce negative 
emotions  
   X115   
                                                             
15 See Appendix 8 for details of references indicated by numbers in Table 
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
6 Conserving 
mental 
resources 
      
7 Paradoxical 
instructions 
      
Feedback and 
monitoring 
      
8 Feedback on 
behaviour 
   X118,120,123,125   
9 Feedback on 
outcome(s) of 
behaviour 
      
10 Self-monitoring 
of behaviour 
   X123-164  X130 
11 Self-monitoring 
of outcome(s) 
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
of behaviour 
12 Monitoring of 
behaviour by 
others without 
feedback 
   X122   
13 Monitoring 
outcome(s) of 
behaviour by 
others without 
feedback 
   X119-121   
14 Biofeedback X93,95,97   X117   
Associations       
15 Prompts/cues    X126,128  X131 
16 Reduce       
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
prompts/cues 
17 Cue signalling 
reward 
      
18 Remove access 
to the reward 
      
19 Remove 
aversive 
stimulus 
      
20 Satiation       
21 Exposure       
22 Associative 
learning 
      
Repetition and       
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
substitution  
23 Behavioural 
practice/rehear
sal 
   X120,126   
24 Habit formation       
25 Behaviour 
substitution 
   X123   
26 Habit reversal       
27 Overcorrection       
28 Generalisation 
of a target 
behaviour 
      
29 Graded tasks       
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Antecedents       
30 Restructuring 
the physical 
environment 
      
31 Restructuring 
the social 
environment 
      
32 Avoidance/redu
cing exposure to 
cues for the 
behaviour 
      
33 Distraction       
34 Adding objects 
to the 
environment 
 X101,103-112     
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
35 Body changes X93-100 X102-112 X113 X118 X129  
Shaping knowledge       
36 Instruction on 
how to perform 
a behaviour 
X93-100  X113 X114-116,120-128 X129 X130,131 
37 Information 
about 
antecedents 
      
38 Re-attribution       
39 Behavioural 
experiments 
      
Self-beliefs       
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
40 Verbal 
persuasion 
about capability 
     X131 
41 Mental 
rehearsal of 
successful 
performance 
      
42 Focus on past 
success 
      
43 Self-talk       
Scheduled 
consequences 
      
44 Punishment       
45 Behaviour cost       
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
46 Remove reward       
47 Reward 
approximation 
      
48 Rewarding 
completion 
      
49 Situation-
specific reward 
      
50 Reward 
incompatible 
behaviour 
      
51 Reward 
alternative 
behaviour 
      
52 Reduce reward 
frequency 
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
53 Remove 
punishment 
      
Reward and threat       
54 Material reward 
(behaviour) 
      
55 Material reward 
(outcome) 
      
56 Social reward       
57 Non-specific 
reward 
      
58 Self-reward       
59 Future 
punishment 
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
60 Material 
incentive 
(behaviour) 
     X130 
61 Material 
incentive 
(outcome) 
      
62 Social incentive       
63 Non-specific 
incentive 
      
64 Self-incentive       
Goals and planning       
65 Problem solving    X115   
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
66 Goal setting 
(behaviour) 
   X114,115,120,121,124,128  X130 
67 Goal setting 
(outcome) 
   X118,120,121,124,128  X130 
68 Action planning    X120,128   
69 Review 
behaviour 
goal(s) 
      
70 Review 
outcome goal(s) 
      
71 Behavioural 
contract 
      
72 Commitment       
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
73 Discrepancy 
between 
current 
behaviour and 
goal 
      
74 Persuasive 
source 
X93-95,97   X115,117,121,124   
75 Pros and cons X94      
76 Comparative 
imaging of 
future 
outcomes 
      
Identity       
77 Identification of 
self as role 
model 
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
78 Valued self-
identity  
      
79 Framing/reframi
ng 
      
80 Incompatible 
beliefs 
      
81 Identity 
associated with 
changed 
behaviour 
      
Natural consequences       
82 Information 
about health 
consequences 
X94 X101,102  X120,123,124,127,128 X130  
83 Information 
about 
 X101,102  X123,124,126-128   
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
emotional 
consequences 
84 Information 
about social and 
environmental 
consequences 
 X101,102  X123,124,126-128   
85 Salience of 
consequences 
   X126-128   
86 Monitoring of 
emotional 
consequences 
      
87 Anticipated 
regret 
      
Comparison of 
behaviour 
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DIET Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
88 Demonstration 
of behaviour 
   X123,126  X130 
89 Social 
comparison 
      
90 Information 
about others’ 
approval 
      
Covert learning       
91 Imaginary 
punishment 
      
92 Imaginary 
reward 
      
93 Vicarious 
consequences 
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Appendix 4: Behaviour change techniques classified in interventions for physical activity16 
PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Social support       
1 Social  support 
(practical) 
 X132,135  X142,144,148,153   
2 Social support 
(emotional) 
 X132,135  X142,144,148,153   
3 Social support 
(unspecified) 
 X132,135,137  X142,144,146,148,149,152,153   
Regulation       
4 Pharmacological 
support 
      
5 Reduce negative 
emotions  
      
                                                             
16 See Appendix 8 for details of references indicated by numbers in Table 
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
6 Conserving 
mental 
resources 
      
7 Paradoxical 
instructions 
      
Feedback and 
monitoring 
      
8 Feedback on 
behaviour 
 X139,141     
9 Feedback on 
outcome(s) of 
behaviour 
      
10 Self-monitoring 
of behaviour 
 X139,141     
11 Self-monitoring 
of outcome(s) 
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
of behaviour 
12 Monitoring of 
behaviour by 
others without 
feedback 
      
13 Monitoring 
outcome(s) of 
behaviour by 
others without 
feedback 
   X148   
14 Biofeedback    X144   
Associations       
15 Prompts/cues  X140  X148,151   
16 Reduce       
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
prompts/cues 
17 Cue signalling 
reward 
      
18 Remove access 
to the reward 
      
19 Remove 
aversive 
stimulus 
      
20 Satiation       
21 Exposure       
22 Associative 
learning 
      
Repetition and       
  
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
125 
PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
substitution  
23 Behavioural 
practice/rehears
al 
   X150,151   
24 Habit formation       
25 Behaviour 
substitution 
      
26 Habit reversal       
27 Overcorrection       
28 Generalisation 
of a target 
behaviour 
   X151   
29 Graded tasks    X151   
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Antecedents       
30 Restructuring 
the physical 
environment 
 X138     
31 Restructuring 
the social 
environment 
      
32 Avoidance/redu
cing exposure to 
cues for the 
behaviour 
      
33 Distraction       
34 Adding objects 
to the 
environment 
 X133,136  X151   
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
35 Body changes  X139-141  X150   
Shaping knowledge       
36 Instruction on 
how to perform 
a behaviour 
 X133,134,137  X142,146,148,149,150-153   
37 Information 
about 
antecedents 
      
38 Re-attribution       
39 Behavioural 
experiments 
      
Self-beliefs        
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
40 Verbal 
persuasion 
about capability 
 X139,141  X142,148,149,152,153  X154 
41 Mental 
rehearsal of 
successful 
performance 
      
42 Focus on past 
success 
      
43 Self-talk       
Scheduled 
consequences 
      
44 Punishment       
45 Behaviour cost       
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
46 Remove reward       
47 Reward 
approximation 
      
48 Rewarding 
completion 
      
49 Situation-
specific reward 
      
50 Reward 
incompatible 
behaviour 
      
51 Reward 
alternative 
behaviour 
      
52 Reduce reward 
frequency 
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
53 Remove 
punishment 
      
Reward and threat       
54 Material reward 
(behaviour) 
 X133 
 
    
55 Material reward 
(outcome) 
 X133 
 
    
56 Social reward       
57 Non-specific 
reward 
      
58 Self-reward       
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
59 Future 
punishment 
      
60 Material 
incentive 
(behaviour) 
 X139,141 
 
 X151   
61 Material 
incentive 
(outcome) 
      
62 Social incentive       
63 Non-specific 
incentive 
      
64 Self-incentive       
Goals and planning       
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
65 Problem solving       
66 Goal setting 
(behaviour) 
 X135,139-141 
 
 X148,150,151   
67 Goal setting 
(outcome) 
 X135,139-141 
 
 X148   
68 Action planning    X148,149   
69 Review 
behaviour 
goal(s) 
   X148,151   
70 Review 
outcome goal(s) 
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
71 Behavioural 
contract 
      
72 Commitment       
73 Discrepancy 
between 
current 
behaviour and 
goal 
      
74 Persuasive 
source 
 X132,135  X144,150,151   
75 Pros and cons       
76 Comparative 
imaging of 
future 
outcomes 
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Identity       
77 Identification of 
self as role 
model 
      
78 Valued self-
identity  
      
79 Framing/reframi
ng 
      
80 Incompatible 
beliefs 
      
81 Identity 
associated with 
changed 
behaviour 
      
Natural consequences       
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
82 Information 
about health 
consequences 
 X134  X148  X154 
83 Information 
about 
emotional 
consequences 
 X134  X148  X154 
84 Information 
about social and 
environmental 
consequences 
 X134  X148  X154 
85 Salience of 
consequences 
      
86 Monitoring of 
emotional 
consequences 
      
87 Anticipated       
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
regret 
Comparison of 
behaviour 
      
88 Demonstration 
of behaviour 
      
89 Social 
comparison 
      
90 Information 
about others’ 
approval 
      
Covert learning       
91 Imaginary 
punishment 
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PHYSICAL ACTIVITY Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
92 Imaginary 
reward 
      
93 Vicarious 
consequences 
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Appendix 5: Behaviour change techniques classified in interventions for alcohol17 
ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Social support 
 
     
1 Social  support 
(practical) 
 X157-160  X161,162   
2 Social support 
(emotional) 
 X157-160  X161,162   
3 Social support 
(unspecified) 
 X155, 157-160  X161,162   
Regulation       
4 Pharmacological 
support 
      
5 Reduce negative 
emotions  
      
                                                             
17 See Appendix 8 for details of references indicated by numbers in Table 
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
6 Conserving 
mental 
resources 
      
7 Paradoxical 
instructions 
      
Feedback and 
monitoring 
      
8 Feedback on 
behaviour 
 X155,160     
9 Feedback on 
outcome(s) of 
behaviour 
      
10 Self-monitoring 
of behaviour 
      
11 Self-monitoring 
of outcome(s) of 
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
behaviour 
12 Monitoring of 
behaviour by 
others without 
feedback 
      
13 Monitoring 
outcome(s) of 
behaviour by 
others without 
feedback 
      
14 Biofeedback  X155-160     
Associations       
15 Prompts/cues       
16 Reduce       
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
prompts/cues 
17 Cue signalling 
reward 
      
18 Remove access 
to the reward 
      
19 Remove 
aversive 
stimulus 
      
20 Satiation       
21 Exposure       
22 Associative 
learning 
      
Repetition and       
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
substitution  
23 Behavioural 
practice/rehears
al 
      
24 Habit formation       
25 Behaviour 
substitution 
      
26 Habit reversal       
27 Overcorrection       
28 Generalisation 
of a target 
behaviour 
      
29 Graded tasks       
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Antecedents       
30 Restructuring 
the physical 
environment 
      
31 Restructuring 
the social 
environment 
      
32 Avoidance/redu
cing exposure to 
cues for the 
behaviour 
      
33 Distraction       
34 Adding objects 
to the 
environment 
      
  
 
 
144 
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
35 Body changes       
Shaping knowledge       
36 Instruction on 
how to perform 
a behaviour 
 X156-159     
37 Information 
about 
antecedents 
      
38 Re-attribution       
39 Behavioural 
experiments 
      
Self-beliefs        
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
40 Verbal 
persuasion 
about capability 
 X156  X161,162   
41 Mental 
rehearsal of 
successful 
performance 
      
42 Focus on past 
success 
      
43 Self-talk       
Scheduled 
consequences 
      
44 Punishment       
45 Behaviour cost       
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
46 Remove reward       
47 Reward 
approximation 
      
48 Rewarding 
completion 
      
49 Situation-
specific reward 
      
50 Reward 
incompatible 
behaviour 
      
51 Reward 
alternative 
behaviour 
      
52 Reduce reward 
frequency 
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
53 Remove 
punishment 
      
Reward and threat       
54 Material reward 
(behaviour) 
      
55 Material reward 
(outcome) 
      
56 Social reward       
57 Non-specific 
reward 
      
58 Self-reward       
59 Future 
punishment 
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
60 Material 
incentive 
(behaviour) 
      
61 Material 
incentive 
(outcome) 
      
62 Social incentive       
63 Non-specific 
incentive 
      
64 Self-incentive       
Goals and planning       
65 Problem solving  X157-159  X162   
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
66 Goal setting 
(behaviour) 
      
67 Goal setting 
(outcome) 
      
68 Action planning       
69 Review 
behaviour 
goal(s) 
      
70 Review 
outcome goal(s) 
      
71 Behavioural 
contract 
 X157-159     
72 Commitment       
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
73 Discrepancy 
between 
current 
behaviour and 
goal 
      
74 Persuasive 
source 
 X155  X161   
75 Pros and cons       
76 Comparative 
imaging of 
future 
outcomes 
      
Identity       
77 Identification of 
self as role 
model 
      
  
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
151 
ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
78 Valued self-
identity  
      
79 Framing/reframi
ng 
      
80 Incompatible 
beliefs 
      
81 Identity 
associated with 
changed 
behaviour 
      
Natural consequences       
82 Information 
about health 
consequences 
   X161,162   
83 Information 
about 
   X161,162   
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
emotional 
consequences 
84 Information 
about social and 
environmental 
consequences 
   X161,162   
85 Salience of 
consequences 
      
86 Monitoring of 
emotional 
consequences 
      
87 Anticipated 
regret 
      
Comparison of 
behaviour 
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ALCOHOL Intervention type 
BCT category code 
and BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
88 Demonstration 
of behaviour 
      
89 Social 
comparison 
      
90 Information 
about others’ 
approval 
      
Covert learning       
91 Imaginary 
punishment 
      
92 Imaginary 
reward 
      
93 Vicarious 
consequences 
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Appendix 6: Behaviour change techniques classified in interventions for sexual health18 
SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Social support 
 
     
1 Social  support 
(practical) 
   X179, 195,196,200,201 X205,206,209  
2 Social support 
(emotional) 
   X179,195,196,200,201 X205,206,209  
3 Social support 
(unspecified) 
  X178 X179,185,186,188, 
190,194,196,199-201 
X205-209  
Regulation       
4 Pharmacological 
support 
X163 X165 X171-178 X189,195-197,200 X203-209  
5 Reduce negative    X179   
                                                             
18 See Appendix 8 for details of references indicated by numbers in Table 
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
emotions  
6 Conserving mental 
resources 
      
7 Paradoxical 
instructions 
      
Feedback and monitoring       
8 Feedback on 
behaviour 
 X164-166,170  X201   
9 Feedback on 
outcome(s) of 
behaviour 
      
10 Self-monitoring of 
behaviour 
 X170  X189,197   
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
11 Self-monitoring of 
outcome(s) of 
behaviour 
      
12 Monitoring of 
behaviour by others 
without feedback 
  X171-173    
13 Monitoring 
outcome(s) of 
behaviour by others 
without feedback 
      
14 Biofeedback  X165,166,170 X171-173 X189,194,197   
Associations       
15 Prompts/cues  X169,170  X185,189   
16 Reduce       
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
prompts/cues 
17 Cue signalling 
reward 
      
18 Remove access to 
the reward 
      
19 Remove aversive 
stimulus 
      
20 Satiation       
21 Exposure       
22 Associative learning       
Repetition and 
substitution  
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
23 Behavioural 
practice/rehearsal 
   X189,197   
24 Habit formation       
25 Behaviour 
substitution 
      
26 Habit reversal       
27 Overcorrection       
28 Generalisation of a 
target behaviour 
      
29 Graded tasks       
Antecedents       
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
30 Restructuring the 
physical 
environment 
      
31 Restructuring the 
social environment 
      
32 Avoidance/reducing 
exposure to cues 
for the behaviour 
      
33 Distraction       
34 Adding objects to 
the environment 
 X165,167 X178 X199 X206,208,209  
35 Body changes X163 X165 X171-178 X179,180,185,186,187-193,195-
197,199-202 
X203-209  
Shaping knowledge       
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
36 Instruction on how 
to perform a 
behaviour 
X163 X164,165,167-170 X171-178  X203-209 X210,211 
37 Information about 
antecedents 
      
38 Re-attribution    X189,197   
39 Behavioural 
experiments 
   X185,186,191,193,201   
Self-beliefs        
40 Verbal persuasion 
about capability 
 X168-170   X203,204 X210,211 
41 Mental rehearsal of 
successful 
performance 
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
42 Focus on past 
success 
      
43 Self-talk       
Scheduled consequences       
44 Punishment       
45 Behaviour cost       
46 Remove reward       
47 Reward 
approximation 
      
48 Rewarding 
completion 
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
49 Situation-specific 
reward 
      
50 Reward 
incompatible 
behaviour 
      
51 Reward alternative 
behaviour 
      
52 Reduce reward 
frequency 
      
53 Remove 
punishment 
      
Reward and threat       
54 Material reward 
(behaviour) 
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
55 Material reward 
(outcome) 
      
56 Social reward       
57 Non-specific reward       
58 Self-reward       
59 Future punishment       
60 Material incentive 
(behaviour) 
 X168     
61 Material incentive 
(outcome) 
      
62 Social incentive       
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
63 Non-specific 
incentive 
      
64 Self-incentive       
Goals and planning       
65 Problem solving    X188,189,197,201   
66 Goal setting 
(behaviour) 
 X170  X189,191,193,197,201 X203,204  
67 Goal setting 
(outcome) 
 X170  X189,197,201   
68 Action planning  X170  X189,197,201   
69 Review behaviour 
goal(s) 
   X201   
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
70 Review outcome 
goal(s) 
      
71 Behavioural 
contract 
      
72 Commitment       
73 Discrepancy 
between current 
behaviour and goal 
      
74 Persuasive source X163 X164-166   X205,206,209  
75 Pros and cons       
76 Comparative 
imaging of future 
outcomes 
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Identity       
77 Identification of self 
as role model 
      
78 Valued self-identity        
79 Framing/reframing       
80 Incompatible 
beliefs 
      
81 Identity associated 
with changed 
behaviour 
      
Natural consequences       
82 Information about 
health 
 X167 X178 X179,180,187,188-190,192,194- X207,208 X210 
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
consequences 197,199-202 
83 Information about 
emotional 
consequences 
   X179,180,187,188-190,195-
197,199-202 
X207  
84 Information about 
social and 
environmental 
consequences 
   X179,180,187,188-190,195-
197,199-202 
X207  
85 Salience of 
consequences 
   X201   
86 Monitoring of 
emotional 
consequences 
      
87 Anticipated regret       
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SEXUAL HEALTH Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Comparison of behaviour       
88 Demonstration of 
behaviour 
   X189,197,201   
89 Social comparison    X189,195-197,200   
90 Information about 
others’ approval 
      
Covert learning       
91 Imaginary 
punishment 
      
92 Imaginary reward       
93 Vicarious 
consequences 
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Appendix 7: Behaviour change techniques classified in interventions for multiple behaviours 19 
MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
Social support 
 
     
1 Social  support 
(practical) 
 X215,220  X143,145,181-184,224,225,227, 
228, 231,233,236,237,239 ,242, 
245,247 
X248,249  
2 Social support 
(emotional) 
   X143,145,181-184,224,225,227, 
228,231,233,236,237,239 ,242, 
245,247 
X248,249  
3 Social support 
(unspecified) 
X212  X222,223 X143,145,181-184,224,225,227, 
228,231,233,234,236,237,239,24
0, 242,245,247 
X248-251  
Regulation       
                                                             
19 See Appendix 8 for details of references indicated by numbers in Table 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
4 Pharmacological 
support 
   X224,227,231 X248,250,251  
5 Reduce negative 
emotions  
   X198   
6 Conserving 
mental 
resources 
   X198   
7 Paradoxical 
instructions 
      
Feedback and 
monitoring 
      
8 Feedback on 
behaviour 
 X213,218  X184,224,227,231,245,247 X250  
9 Feedback on 
outcome(s) of 
 X213 X223    
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
behaviour 
10 Self-monitoring 
of behaviour 
 X216,220  X230,236,239, 244,247   
11 Self-monitoring 
of outcome(s) of 
behaviour 
   X236,239   
12 Monitoring of 
behaviour by 
others without 
feedback 
   X224,227,231   
13 Monitoring 
outcome(s) of 
behaviour by 
others without 
feedback 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
14 Biofeedback  X215,217 X222 X183,235,345 X248,249  
Associations       
15 Prompts/cues  X215,216,221  X245,246   
16 Reduce 
prompts/cues 
      
17 Cue signalling 
reward 
      
18 Remove access 
to the reward 
      
19 Remove 
aversive 
stimulus 
      
  
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
173 
MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
20 Satiation       
21 Exposure       
22 Associative 
learning 
      
Repetition and 
substitution  
      
23 Behavioural 
practice/rehears
al 
 X217  X143,145,147,183,184,198,226, 
232,235,238, 240,243 
  
24 Habit formation  X221  X236,239,246,247   
25 Behaviour 
substitution 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
26 Habit reversal       
27 Overcorrection       
28 Generalisation 
of a target 
behaviour 
   X147,183,198   
29 Graded tasks    X234   
Antecedents       
30 Restructuring 
the physical 
environment 
      
31 Restructuring 
the social 
environment 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
32 Avoidance/redu
cing exposure to 
cues for the 
behaviour 
      
33 Distraction       
34 Adding objects 
to the 
environment 
   X184,232   
35 Body changes X212 X216 X222,223 X181-184,198,224,226,227, 
231,232,234,243 
X248,250,251  
Shaping knowledge       
36 Instruction on 
how to perform 
a behaviour 
X212 X213,214,215,218-220,221 X222,223 X143,145,147,181-184,189,224-
229,231-234,237,238,240-244, 
245,246 
X248,250,251  
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
37 Information 
about 
antecedents 
      
38 Re-attribution       
39 Behavioural 
experiments 
      
Self-beliefs        
40 Verbal 
persuasion 
about capability 
 X213,220  X230,238,244,247   
41 Mental 
rehearsal of 
successful 
performance 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
42 Focus on past 
success 
      
43 Self-talk       
Scheduled 
consequences 
      
44 Punishment       
45 Behaviour cost       
46 Remove reward       
47 Reward 
approximation 
      
48 Rewarding       
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
completion 
49 Situation-
specific reward 
      
50 Reward 
incompatible 
behaviour 
      
51 Reward 
alternative 
behaviour 
      
52 Reduce reward 
frequency 
      
53 Remove 
punishment 
      
Reward and threat       
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
54 Material reward 
(behaviour) 
 X220     
55 Material reward 
(outcome) 
 X220     
56 Social reward       
57 Non-specific 
reward 
   X224,227,231   
58 Self-reward       
59 Future 
punishment 
      
60 Material 
incentive 
(behaviour) 
 X220     
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
61 Material 
incentive 
(outcome) 
 X220     
62 Social incentive       
63 Non-specific 
incentive 
      
64 Self-incentive       
Goals and planning       
65 Problem solving  X220,221  X145,230,240,244,245-247 X251  
66 Goal setting 
(behaviour) 
 X213,220  X183,184,198,224,226,227,229-
232,236,239,240,242-247 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
67 Goal setting 
(outcome) 
 X213,220  X147,184,229,236,239,240,242, 
244,245-247 
  
68 Action planning  X213,220  X147,184,226,229,232,236,239, 
240,242,243 
  
69 Review 
behaviour 
goal(s) 
   X245,246   
70 Review 
outcome goal(s) 
      
71 Behavioural 
contract 
      
72 Commitment       
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
73 Discrepancy 
between 
current 
behaviour and 
goal 
      
74 Persuasive 
source 
X212 X215,216,218,220,221 X223 X143,145,147, 183,184,198,224, 
225,227,229,231,237,239,241,24
6 
X248,250,251  
75 Pros and cons    X230,240   
76 Comparative 
imaging of 
future 
outcomes 
      
Identity       
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
77 Identification of 
self as role 
model 
      
78 Valued self-
identity  
      
79 Framing/reframi
ng 
      
80 Incompatible 
beliefs 
      
81 Identity 
associated with 
changed 
behaviour 
   X198   
Natural consequences       
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
82 Information 
about health 
consequences 
 X213,213,219,221 X223 X143, 183,184,224,227,230,231, 
237,241,246 
  
83 Information 
about emotional 
consequences 
 X213,215,219,221  X145,224,227,231,237,241,246   
84 Information 
about social and 
environmental 
consequences 
 X213,215,219,221  X145,224,227,231,237,241,246   
85 Salience of 
consequences 
 X213 X223    
86 Monitoring of 
emotional 
consequences 
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
87 Anticipated 
regret 
      
Comparison of 
behaviour 
      
88 Demonstration 
of behaviour 
 X212,213,219,221  X143,145,147, 183,184,198, 
226,232,234,238, 240,243,246 
  
89 Social 
comparison 
      
90 Information 
about others’ 
approval 
      
Covert learning       
91 Imaginary       
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MULTIPLE 
BEHAVIOURS 
Intervention type 
BCT category code and 
BCT 
Medication Brief Intervention 
Brief intervention and 
medication 
Comprehensive 
intervention 
Comprehensive 
intervention and 
medication 
Mass media 
punishment 
92 Imaginary 
reward 
      
93 Vicarious 
consequences 
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Appendix 8: Legend for Appendices 2-7 
 
Study 
number 
Primary Study Year Secondary study(ies) Intervention 
1 Higashi 2012  Gum 
2 Higashi 2012  Patch 
3 Higashi 2012  Bupropion 
4 Higashi 2012  Varenicline 
5 Ruger [Review] 2012 Bolin Varenicline 
6 Ruger [Review] 2012 Antonanzas Bupropion 
7 Annemans 2009  Varenicline 
8 Ruger [Review] 2012 Antonanzas NRT 
9 Ruger [Review] 2012 Hoogendoorn Varenicline 
10 Ruger [Review] 2012 Bolin Bupropion 
11 Coleman 
[Review] 
2010 Gonzales, Jorenby, Nakamura, Oncken, 
Williams 
Varenicline 
12 Ruger [Review] 2012 Bolin Varenicline 
13 Annemans 2009  Varenicline 
14 Ruger [Review] 2012 Hoogendoorn Varenicline 
15 Ruger [Review] 2012 Annemans Varenicline 
16 Ruger [Review] 2012 Fellows Free nicotine patch incentive 
17 Coleman 
[Review] 
2010 Blondal, Hurt, Jarvis, Jorenby, Schneider, 
Shiffman, Piper 
NRT 
18 Coleman 
[Review] 
2010 Gonzales, Hurt, Jorenby, Piper Bupropion 
19 Annemans 2009  Varenicline 
20 Annemans 2009  Varenicline 
21 Ruger [Review] 2012 Knight Varenicline plus additional 12 months 
22 Ruger [Review] 2012 Jackson Bupropion 
23 Reda [Review] 2012 Hughes Full coverage nicotine gum 
24 Reda [Review] 2012 Hughes Full coverage nicotine gum 
25 Ruger [Review] 2012 Jackson Placebo 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
26 Ruger [Review] 2012 Hoogendoorn Varenicline 
27 Ruger [Review] 2012 Jackson Varenicline 
28 Ruger [Review] 2012 Ruger Brief couselling 
29 Holtrop 2005  Recruitment postcard 
30 Hoogendoorn 
[Review] 
2010 Kotz, Wilson, Hiberink Minimal or brief counselling 
31 Ruger [Review] 2012 Meenan Brief bed side counselling 
32 Smith 2007  Computerised program 
33 Higashi 2012  Physician brief advice 
34 Ruger [Review] 2012 Dino NOT teen smoking cessation 
35 Ruger [Review] 2012 Akers Manual 
36 Hollis 2007  Moderate no NRT 
37 Holtrop 2005  Recruitment telephone call 
38 Ruger [Review] 2012 Akers Self-help 
39 Ruger [Review] 2012 Thavorn Structured community pharmacist 
40 Carlin-Menter 2011  Two telephone call backs to initial call 
41 Boyd 2009  Pharmacy 
42 Ruger [Review] 2012 Fiscella GP advice and NRT 
43 Bauld 2010  Pharmacy 
44 Ruger [Review] 2012 Oster Brief advice and NRT 
45 Eddy 2009  Basic advice and medication 
46 Reda [Review] 2012 Kaper Reinbursement for counselling and pharmacotherpy 
47 Feenstra 2005  Minimal couselling from GP with NRT 
48 Vemer 2010  Reinbursement for Smking Cessation Support 
49 Ruger [Review] 2012 Cromwell Minimal advice and NRT 
50 Ruger [Review] 2012 Wasley Brief advice and NRT 
51 Ruger [Review] 2012 Stapleton GP brief couselling with NRT 
52 Ruger [Review] 2012 Crealey Advice and motivation from pharmacist 
53 Hollis 2007  Brief NRT 
54 Ruger [Review] 2012 Hollis Brief telephone couselling with NRT 
55 Reda [Review] 2012 Halpin Bupropion and NRT and proactive telephone couselling 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
56 Reda [Review] 2012 Curry Full coverage 
57 Ruger [Review] 2012 Salize GP training and NRT 
58 Ruger [Review] 2012 Salize GP training, NRT and remuneration 
59 Hollis 2007  Moderate NRT 
60 McAfee 2008  Patches and uninsured quitline for 8 weeks 
61 Ruger [Review] 2012 Tran Pharmacist directed smoking cessation with bupropion 
62 Ruger [Review] 2012 Tran Pharmacist directed smoking cessation with gum 
63 Ruger [Review] 2012 Tran Pharmacist directed smoking cessation with patch 
64 Hoogendoorn 
[Review] 
2010 Wilson,  Christenhusz, Tonnesen, Wagena, 
Tashkin, Brandt 
Intensive couselling 
65 Feenstra 2005  Telephone couselling 
66 Ruger 2008  Motivational interviewing 
67 Akers 2007  Assisted self-help 
68 Hollis 2007  Intenstive no NRT 
69 Parker 2004  Motivational telephone counselling 
70 Windsor 
[Review] 
2003 n/a Smoking cessation or reduction in pregnancy treatment 
71 McAlister 2004  Telephone assistance for smoking cessation 
72 Smith 2011  Telephone based intervention 
73 Rigotti 2011  Usual care plus population based direct to smoker outreach 
74 Gordon 2010  Genetic testing within the course of usual smoking cessation intervention with NRT and 
counselling 
75 Boyd 2009  Group support 
76 Barnett 2008  Stepped care and mental health services 
77 Bauld 2010  Group support 
78 Feenstra 2005  Intensive couselling with NRT 
79 Ruger [Review] 2012 Feenstra Intensive counselling with NRT 
80 Barnett 2008  Stepped care 
81 Feenstra 2005  Intensive couselling with bupropion 
82 Hoogendoorn 
[Review] 
2010 Kotz, Wilson, Christenhusz, Tonnesen, 
Wagena, Tashkin, Anthonisen 
Intensive couselling with pharmacotherapy 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
83 Ruger [Review] 2012 Song Counselling and NRT 
84 Ruger [Review] 2012 Song Couselling and NRT and Bupropion 
85 Ruger [Review] 2012 Cromwell Group intensive and NRT 
86 Ruger [Review] 2012 Cromwell Individual intensive and NRT 
87 Ruger [Review] 2012 Song Counselling and Bupropion 
88 Hollis 2007  Intensive NRT 
89 Ruger [Review] 2012 Hollis Intensive telephone couselling with NRT 
90 Abdullah 2008  Mobile smoking cessation service 
91 Ruger [Review] 2012 Hollis Moderate telephone couselling with NRT 
92 Emmons 2005  Peer delivered smoking cessation couselling 
93 Bertram 2010  Orlistat 
94 Diabetes 
research group 
2003  Metformin 
95 Bertram 2010  Acarbose 
96 Avenell [Review] 2004 Lamotte Orlistat no complications 
97 Bertram 2010  Metformin 
98 Avenell [Review] 2004 Lamotte Orlistat hypercholesterolemia 
99 Avenell [Review] 2004 Lamotte Orlistat AHT 
100 Avenell [Review] 2004 Lamotte Orlistat hypercholesterolemia and AHT 
101 Avenell [Review] 2004 Salkeld Educational video 
102 Dollahite 2008  New York State Expanded Food and Nutrition Education Program 
103 Avenell [Review] 2004 O'Meara Sibutramine 
104 Avenell [Review] 2004 Clegg Vertical banded gastroplasty 
105 Avenell [Review] 2004 Clegg Adjustable gastric banding 
106 Avenell [Review] 2004 BASF Sibutramine 
107 Avenell [Review] 2004 Clegg Roux-en-Y gastric bypass 
108 Hertzman 2005  Diet intervention 
109 Avenell [Review] 2004 Segal Gastric bypass surgery - 10% IGT, 90% NGT 
110 Avenell [Review] 2004 Segal Gastric bypass surgery - IGT 
111 Avenell [Review] 2004 Segal VLCD and individual therapy - IGT and NGT 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
112 Avenell [Review] 2004 van Gemert Vertical banded gastroplasty 
113 Hertzman 2005  Orlistat and diet intervention 
114 Cobiac 2010  Weight watchers 
115 Cobiac 2010  Lighten up 
116 Loveman 
[Review] 
2011 Roux Diet 
117 Bertram 2010  Diet 
118 Hoerger 2007  Screening followed by lifestyle intervention for subjects diagnosed with either impaired glucose 
tolerance or impaired fasting glucose 
119 Hoerger 2007  Screening overweight subjects and giving them the lifestyle intervention included in the 
diabetes prevention program if diagnosed with impaired glucose tolerane and impaired fasting 
glucose 
120 Dalziel [Review] 2007 Eriksson Intensive life style change to prevent diabetes 
121 Dalziel [Review] 2007 ICRF Oxcheck nurse checks in GP 
122 Dalziel [Review] 2007 Pritchard Nutritional counselling in GP 
123 Dalziel [Review] 2007 Egger Gutbusters workplace 
124 Dalziel [Review] 2007 Swinburn Reduced fat diet for IGT 
125 Dalziel [Review] 2007 Lorgeril Mediteranen diet 
126 Cox 2003  Food stamp nutrition education program and video 
127 Sukhanova 2009  Web based intervention MENU tailored 
128 Sukhanova 2009  Web based intervention MENU tailored and HOBI counselling 
129 Loveman 
[Review] 
2011 Roux Diet and pharmacology 
130 Dalziel [Review] 2007 Wardle FFFF media campaign 
131 Dalziel [Review] 2007 Dixon Multi media 2 fruit 5 veg 
132 Cobiac 2009  GP referral to exercuse physiologist 
133 Cobiac 2009  TravelSmart 
134 Cobiac 2009  Internet 
135 Cobiac 2009  GP prescription 
136 Cobiac 2009  Pedmeters 
137 Wu [Review] 2007 Community campaign Community campaign 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
138 Wu [Review] 2007 Creation or enhanced access to places for 
physical activity 
Creation or enhanced access to places for physical activity 
139 Sevick 2007  Phone intervention 
140 Wu [Review] 2007 Point of decision prompts Point of decision prompts 
141 Sevick 2007  Print intervention 
142 Wu [Review] 2007 High intensity social support High intensity social support 
143 Lee [Review] 2007 Marchionni Hospital based cardiac rehabilitation 
144 Bertram 2010  Exercise 
145 Lee [Review] 2007 Oldridge Cardiac rehabilitation 
146 Dalziel 2006  Green prescription program 
147 Lee [Review] 2007 Levin Cardiac rehabilitation 
148 Boehler 2011  Disease register screening 
149 Wu [Review] 2007 High intensity individually adapted behaviour High intensity individually adapted behaviour 
150 Bulthuis 2008  Intervention group 
151 Groessl 2009  LIFE-P exercise intervention 
152 Wu [Review] 2007 Low intensity individually adapted behaviour Low intensity individually adapted behaviour 
153 Wu [Review] 2007 Low intenstiy social support Low intenstiy social support 
154 Cobiac 2009  Mass media-based campaign 
155 Tariq 2009  Screening and brief intervention 
156 Gentilello 2005  Brief intervention 
157 Fals-Stewart 2005  Brief relationship therapy 
158 Fals-Stewart 2005  Brief relationship therapy 
159 Fals-Stewart 2005  Brief relationship therapy 
160 Barrett 2005  Screening and referral to alcohol health worker 
161 Neighbors 2010  Motivational interviewing 
162 Drummond 2009  Stepped care intervention 
163 Aldridge 2009  STI treatment 
164 van Keulen 2010  Tailored print communication 
165 Aldridge 2009  Condoms 
166 Aldridge 2009  Voluntary couselling and testing 
167 Hogan [Review] 2013 n/a Peer education for sex workers 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
168 Gift 2005  Incentive 
169 Gift 2005  Reminder 
170 Rasu 2010  Usual care and behavioural internet treatment 
171 Aldridge 2009  HAART basic 
172 Aldridge 2009  HAART intermediate 
173 Aldridge 2009  HAART comprehensive 
174 Hogan [Review] 2013 n/a Antiretrovial - no intensive monitoring, first and second line drugs 
175 Hogan [Review] 2013 n/a Antiretrovial - intensive monitoring, first and second line drugs 
176 Hogan [Review] 2013 n/a Antiretrovial - intensive monitoring, first line drugs only 
177 Hogan [Review] 2013 n/a Antiretrovial - no intensive monitoring, first line drugs only 
178 Hogan [Review] 2013 n/a Treatment of sexually transmitted infections 
179 Johnson-Masotti 
[Review] 
2003 Pinkerton/Otto-Salaj Time matched session 
180 Shepard 
[Review] 
2010 Pinkerton One-day CB HIV risk reduction 
181 Lee [Review] 2007 Salkeld Self-help cardiac rehabilitation 
182 Lee [Review] 2007 Salkeld Video cardiac rehabiliation 
183 Lee [Review] 2007 Carlson Cardiac rehabilitation 
184 Lee [Review] 2007 Marchionni Home based cardiac rehabilitation 
185 Gift 2005  Motivation counselling and reminder 
186 Gift 2005  Motivational counselling 
187 Shepard 
[Review] 
2010 Cohen School based education 
188 Shepard 
[Review] 
2010 Wright SHARE project 
189 Herbst [Review] 2007 Pinkerton Group level intervention - safe sex training 
190 Shepard 
[Review] 
2010 Tao HIV prevention intervention 
191 Burgos 2010  Intervention group - annually 
192 Shepard 
[Review] 
2010 Hogan HIV prevention 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
193 Burgos 2010  Intervention group - once 
194 Hogan [Review] 2013 n/a Voluntary counselling and testing 
195 Herbst [Review] 2007 Kahn Community - peer opinion leaders 
196 Herbst [Review] 2007 Pinkerton Community - peer opinion leaders 
197 Herbst [Review] 2007 Holtgrave Group level intervention - small group 
198 Lee [Review] 2007 Ades Cardiac rehabilitation 
199 Kumaranayake 2003  HIV harm reduction intervention 
200 Herbst [Review] 2007 Kahn Mpowerment project 
201 Osland 2006  Obesity management 
202 Shepard 
[Review] 
2010 Wang Safer choices intervention 
203 Burgos 2010  Intervention group plus HAART 
204 Burgos 2010  Intervention group plus HAART 
205 Aldridge 2009  Prevention of mother and child transmission 
206 Aldridge 2009  Peer couselling and treatment of STIs for men who have sex with men 
207 Hogan [Review] 2013 n/a Prevention of mother to child transmission 
208 Hogan [Review] 2013 n/a Peer education and treatment of sexually transmitted infections for sex workers 
209 Aldridge 2009  Peer couselling and treatment of STIs for female sex workers 
210 Aldridge 2009  Mass media 
211 Hogan [Review] 2013 n/a Mass media 
212 Herman 2005  Metformin intervention 
213 McConnon 2007  Internet intervention 
214 Avenell [Review] 2004 Salkeld Video plus self-help 
215 Datta 2010  Behavioural intervention 
216 Graves 2009  Telephone 
217 Gillies 2008  Screening 
218 Graves 2009  Usual care 
219 Jacobs-van-der-
Bruggen 
2007  Community intervention 
220 Gustafson 2009  weight-wise 
221 Dzator 2004  Mail 
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Study 
number 
Primary Study Year Secondary study(ies) Intervention 
222 Gillies 2008  Screening and pharmacological intervention 
223 Raftery 2004  Nurse led clinics to promote medical and lifestycomponents of secondary prevention 
224 Carr [Review] 2011 Lujan Chronic care diabetes 
225 Irvine 2011  Exercise and diet intervention 
226 Barton 2009  Dietary intervention plus strengthening exercise 
227 Carr [Review] 2011 Gary Chronic care diabetes 
228 Loveman 
[Review] 
2011 Roux Diet and exercise 
229 Diabetes 
research group 
2003  Lifestyle intervention 
230 Barton 2012  LHT intervention 
231 Carr [Review] 2011 Young Chronic care diabetes 
232 Barton 2009  Dietary intervention plus strengthening exercise 
233 Loveman 
[Review] 
2011 Roux Diet, exercise and behaviour modification 
234 Avenell [Review] 2004 Kaplan Diet and exercise therapy 
235 Gillies 2008  Screening and lifestyle intervention 
236 Krukowski 2011  In person group behaviour weight loss intervention 
237 Jacobs-van-der-
Bruggen 
2007  Health care intervention 
238 Lindgren 2007  Finnish Diabetes Prevention study 
239 Krukowski 2011  Internet group behaviour weight loss intervention 
240 Eriksson 2010  Lifestyle intervention with standard care 
241 Herman 2005  Life-style intervention 
242 Loveman 
[Review] 
2011 Counterweight program Counterweight program 
243 Barton 2009  Dietary intervention plus strengthening exercise 
244 Befort 2010  Group phone based obesity treatment for rural women 
245 Wolf 2007  Improving control with activity and nutrition 
246 Dzator 2004  Mail and interactive group sessions 
247 Emmons 2005  PREVENT intervention 
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248 Bertram 2010  Metformin+diet plus exercise 
249 Bertram 2010  Diet plus exercise 
250 Finkelstein 2006  Wisewomen intervention 
251 Yosefy 2003  Israeli Blood Pressure Control Program 
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Appendix 9: Studies/Reviews included in BCT analysis 
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Appendix 11: BCT codes, clusters and definitions 
No.  Label  Definition  Examples  
Social support  
1.  Social 
support 
(practical)  
Advise on, arrange, or provide practical help 
(beyond adding objects to the environment) for 
performance of the behaviour  
Note: if emotional, code 2, Social support 
(emotional); if general or unspecified, code 3, 
Social support (unspecified) If only restructuring 
the physical environment or adding objects to the 
environment, code 30, Restructuring the physical 
environment or 34, Adding objects to the 
environment  
Ask the partner of the 
patient to put their 
tablet on the breakfast 
tray so that the patient 
remembers to take it  
2.  Social 
support 
(emotional)  
Advise on, arrange, or provide emotional social 
support for performance of the behaviour  
Note: if practical, code 1, Social support 
(practical); if unspecified, code 3, Social support 
(unspecified)  
Ask the patient to take 
a partner or friend with 
them to their 
colonoscopy 
appointment  
3.  
 
Social 
support 
(unspecified)  
Advise on, arrange or provide social support (e.g. 
friends, relatives, colleagues,’ buddies’ or staff) or 
non-contingent praise or reward for performance 
of the behaviour. It includes encouragement and 
counselling, but only when it is directed at the 
behaviour  
Note: attending a group class does not necessarily 
apply this BCT, support must be explicitly 
mentioned; if practical, code 1, Social support 
(practical); if emotional, code 2, Social support 
(emotional)  
Advise the person to 
call a ‘buddy’ when 
they experience an 
urge to smoke  
Arrange for a 
housemate to 
encourage continuation 
with the behaviour 
change programme  
Give information about 
a self-help group that 
offers support for the 
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No.  Label  Definition  Examples  
behaviour  
Regulation  
4.  Pharmacolog
ical support  
Provide, or encourage the use of or adherence to, 
drugs to facilitate behaviour change  
Suggest the patient 
asks the family 
physician for nicotine 
replacement therapy to 
facilitate smoking 
cessation  
5.  Reduce 
negative 
emotions  
Advise on ways of reducing negative emotions to 
facilitate performance of the behaviour (includes 
‘Stress Management’)  
Advise on the use of 
stress management 
skills, e.g. to reduce 
anxiety about joining 
Alcoholics Anonymous  
6.  Conserving 
mental 
resources  
Advise on ways of minimising demands on mental 
resources to facilitate behaviour change  
Advise smokers on how 
to minimise work-
related stress during 
the first weeks of 
quitting  
7.  Paradoxical 
instructions  
Advise to engage in some form of the unwanted 
behaviour with the aim of reducing motivation to 
engage in that behaviour  
Advise a smoker to 
smoke twice as many 
cigarettes a day as they 
usually do  
Tell the person to stay 
awake as long as 
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
 
219 
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
No.  Label  Definition  Examples  
possible in order to 
reduce insomnia  
Feedback and monitoring  
8.  Feedback on 
behaviour  
Monitor and provide feedback on performance of 
the behaviour (e.g. form, frequency, duration, 
intensity)  
Note: if Biofeedback, code only 14, Biofeedback 
and not 8, Feedback on behaviour; if feedback is 
on outcome(s) of behaviour, code 9, Feedback on 
outcome(s) of behaviour; if there is no clear 
evidence that feedback was given, code 12, 
Monitoring of behaviour by others without 
feedback  
Inform the person of 
how many steps they 
walked each day (as 
recorded on a 
pedometer) or how 
many calories they ate 
each day (based on a 
food consumption 
questionnaire)  
9.  Feedback on 
outcome(s) of 
behaviour  
Monitor and provide feedback on the outcome of 
performance of the behaviour  
Note: if Biofeedback, code only 14, Biofeedback 
and not 9, Feedback on outcome(s) of behaviour; 
if feedback is on behaviour code 8, Feedback on 
behaviour; if there is no clear evidence that 
feedback was given code 13, Monitoring 
outcome(s) of behaviour by others without 
feedback  
Inform the person of 
how much weight they 
have lost following the 
implementation of a 
new exercise regime  
10.  Self-
monitoring of 
behaviour  
Establish a method for the person to monitor and 
record their behaviour(s) as part of a behaviour 
change strategy Note: if monitoring is part of a 
data collection procedure rather than a strategy 
aimed at changing behaviour, do not code; if 
monitoring of outcome of behaviour, code 11, 
Self-monitoring of outcome(s) of behaviour; if 
Ask the person to 
record daily, in a diary, 
whether they have 
brushed their teeth for 
at least two minutes 
before going to bed  
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No.  Label  Definition  Examples  
monitoring is by someone else (without 
feedback), code 12, Monitoring of behaviour by 
others without feedback  
Give patient a 
pedometer and a form 
for recording daily total 
number of steps  
11.  Self-
monitoring of 
outcome(s) of 
behaviour  
Establish a method for the person to monitor and 
record the outcome(s) of their behaviour as part 
of a behaviour change strategy  
Note: Only code if monitoring is aimed at 
changing behaviour rather than part of data ; if 
monitoring behaviour, code 10, Self-monitoring of 
behaviour; if monitoring is by someone else 
(without feedback), code 13, Monitoring 
outcome(s) of behaviour by others without 
feedback  
Ask the person to weigh 
themselves at the end 
of each day, over a two 
week period, and 
record their daily 
weight on a graph to 
increase exercise 
behaviours  
12.  Monitoring 
of behaviour 
by others 
without 
feedback  
Observe or record behaviour with the person’s 
knowledge as part of a behaviour change strategy  
Note: if monitoring is part of a data collection 
procedure rather than a strategy aimed at 
changing behaviour, do not code; if feedback 
given, code only 8, Feedback on behaviour, and 
not 12, Monitoring of behaviour by others 
without feedback; if monitoring outcome(s) code 
13, Monitoring outcome(s) of behaviour by others 
without feedback; if self-monitoring behaviour, 
code 10, Self-monitoring of behaviour  
Watch hand washing 
behaviours among 
health care staff and 
make notes on context, 
frequency and 
technique used  
13. Monitoring 
outcome(s) of 
behaviour by 
others 
without 
Observe or record outcomes of behaviour with 
the person’s knowledge as part of a behaviour 
change strategy  
Note: if monitoring is part of a data collection 
procedure rather than a strategy aimed at 
Record blood pressure, 
blood glucose, weight 
loss, or physical fitness  
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No.  Label  Definition  Examples  
feedback  changing behaviour, do not code; if feedback 
given, code only 9, Feedback on outcome(s) of 
behaviour; if monitoring behaviour code 12, 
Monitoring of behaviour by others without 
feedback; if self-monitoring outcome(s), code 11, 
Self-monitoring of outcome(s) of behaviour  
14.  Biofeedback  Provide feedback about the body (e.g. 
physiological or biochemical state) using an 
external monitoring device as part of a behaviour 
change strategy  
Note: if Biofeedback, code only 14, Biofeedback 
and not 8, Feedback on behaviour or 9, Feedback 
on outcome(s) of behaviour  
Inform the person of 
their blood pressure 
reading to improve 
adoption of health 
behaviours  
Associations  
15.  Prompts/cue
s  
Introduce or define environmental or social 
stimulus with the purpose of prompting or cueing 
the behaviour. The prompt or cue would normally 
occur at the time or place of performance  
Note: when a stimulus is linked to a specific action 
in an if-then plan, code also 64, Action planning,  
Put a sticker on the 
bathroom mirror to 
remind people to brush 
their teeth  
16.  Reduce 
prompts/cue
s  
Withdraw gradually prompts to perform the 
behaviour (includes ‘Fading’)  
Reduce gradually the 
number of reminders 
used to take 
medication  
17.  Cue 
signalling 
reward  
Identify an environmental stimulus that reliably 
predicts that reward will follow the behaviour 
(includes ‘Discriminative cue’)  
Advise that a fee will be 
paid to dentists for a 
particular dental 
treatment of 6-8 year 
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No.  Label  Definition  Examples  
old children to 
encourage delivery of 
that treatment (the 6-8 
year old children are 
the environmental 
stimulus)  
18.  Remove 
access to the 
reward  
Advise or arrange for the person to be separated 
from situations in which unwanted behaviour can 
be rewarded in order to reduce the behaviour 
(includes ‘Time out’)  
Arrange for cupboard 
containing high calorie 
snacks to be locked for 
a specified period to 
reduce the 
consumption of sugary 
foods in between meals  
19.  Remove 
aversive 
stimulus  
Advise or arrange for the removal of an aversive 
stimulus to facilitate behaviour change (includes 
‘Escape learning’)  
Arrange for a gym-
buddy to stop nagging 
the person to do more 
exercise in order to 
increase the desired 
exercise behaviour  
20.  Satiation  Advise or arrange repeated exposure to a stimulus 
that reduces or extinguishes a drive for the 
unwanted behaviour  
Arrange for the person 
to eat large quantities 
of chocolate, in order 
to reduce the person’s 
appetite for sweet 
foods  
21.  Exposure  Provide systematic confrontation with a feared 
stimulus to reduce the response to a later 
encounter  
Agree a schedule by 
which the person will 
e.g. make a telephone 
call to their boss, spend 
an evening without 
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No.  Label  Definition  Examples  
snacking  
22.  Associative 
learning  
Present a neutral stimulus jointly with a stimulus 
that already elicits the behaviour repeatedly until 
the neutral stimulus elicits that behaviour 
(includes ‘Classical/Pavlovian Conditioning’)  
Note: when a BCT involves reward or punishment, 
do not code 22, Associative learning  
Present repeatedly 
fatty foods with a 
disliked flavoured 
sauce to discourage the 
consumption of fatty 
foods  
Repetition and substitution  
23.  Behavioural 
practice/ 
rehearsal  
Prompt practice or rehearsal of the performance 
of the behaviour one or more times in a context 
or at a time when the performance may not be 
necessary, in order to increase habit and skill  
Note: if aiming to associate performance with the 
context, also code 24, Habit formation  
Prompt asthma 
patients to measure 
their peak flow 
regularly  
24.  Habit 
formation  
Prompt rehearsal and repetition of the behaviour 
in the same context repeatedly so that the 
context elicits the behaviour  
Note: also code 23, Behavioural 
practice/rehearsal  
Prompt patients to 
always take their statin 
tablet before brushing 
their teeth in the 
evening  
25.  Behaviour 
substitution  
Prompt substitution of the unwanted behaviour 
with a wanted or neutral behaviour  
Note: if this occurs regularly, also code 26, Habit 
reversal  
Suggest that the person 
carries a piece of fruit 
to eat instead of 
biscuits or cake if they 
are offered them  
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No.  Label  Definition  Examples  
26.  Habit 
reversal  
Prompt rehearsal and repetition of an alternative 
behaviour to replace an unwanted habitual 
behaviour  
Note: also code 25, Behaviour substitution  
Ask the person to walk 
up stairs every time 
they consider taking a 
lift or escalator  
27.  Overcorrectio
n  
Ask to repeat the wanted behaviour in an 
exaggerated way following an unwanted 
behaviour  
Ask to eat only fruit and 
vegetables the day 
after a poor diet  
28.  Generalisatio
n of a target 
behaviour  
Advise to perform the wanted behaviour already 
performed in a particular situation, in another 
situation  
Advise to repeat toning 
exercises learned in the 
gym when at home  
29.  Graded tasks  Set easy-to-perform tasks, making them 
increasingly difficult, but achievable, until 
behaviour is performed  
Ask the person to walk 
for 100 yards a day for 
the first week, then half 
a mile a day after they 
have successfully 
achieved 100 yards, 
then two miles a day 
after they have 
successfully achieved 
one mile  
Antecedents  
30.  Restructuring 
the physical 
environment  
Change, or advise to change the environment in 
order to facilitate performance of the wanted 
behaviour or create barriers to the unwanted 
behaviour (other than prompts/cues, rewards and 
punishments)  
Note: this may also involve 32, 
Avoidance/reducing exposure to cues for the 
Advise to keep biscuits 
and snacks in a 
cupboard that is 
inconvenient to get to  
Arrange to move 
vending machine out of 
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No.  Label  Definition  Examples  
behaviour; if restructuring of the social 
environment code 31, Restructuring the social 
environment  
if only adding objects to the environment, code 
34, Adding objects to the environment  
the school  
31.  Restructuring 
the social 
environment  
Change, or advise to change the social 
environment in order to facilitate performance of 
the wanted behaviour or create barriers to the 
unwanted behaviour (other than prompts/cues, 
rewards and punishments)  
Note: this may also involve 32, 
Avoidance/reducing exposure to cues for the 
behaviour; if restructuring of the physical 
environment code 30, Restructuring the physical 
environment  
Advise to minimise time 
spent with friends who 
drink heavily to reduce 
alcohol consumption  
32.  Avoidance/re
ducing 
exposure to 
cues for the 
behaviour  
Advise on how to avoid exposure to specific social 
and contextual/physical cues for the behaviour, 
including changing daily or weekly routines  
Note: this may also involve 30, Restructuring the 
physical environment and/or 31, Restructuring 
the social environment; if the BCT includes 
analysing the behavioural problem, only code 61, 
Problem solving  
Suggest to a person 
who wants to quit 
smoking that their 
social life focus on 
activities other than 
pubs and bars which 
have been associated 
with smoking  
33.  Distraction  Advise or arrange to use an alternative focus for 
attention to avoid triggers for unwanted 
behaviour  
Suggest to a person 
who is trying to avoid 
between-meal snacking 
to focus on a topic they 
enjoy (e.g. holiday 
plans) instead of 
focusing on food when 
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No.  Label  Definition  Examples  
they are feeling hungry  
34.  Adding 
objects to the 
environment  
Add objects to the environment in order to 
facilitate performance of the behaviour  
Note: if this is accompanied by social support, also 
code 1, Social support (practical); if the 
environment is changed beyond the addition of 
objects, also code 30, Restructuring the physical 
environment  
Provide free condoms 
to facilitate safe sex  
Provide attractive 
toothbrush to improve 
tooth brushing 
technique  
35.  Body changes  Alter body structure, functioning or support 
directly to facilitate behaviour change  
Prompt strength 
training, relaxation 
training or provide 
assistive aids  
Shaping knowledge  
36.  Instruction 
on how to 
perform a 
behaviour  
Advise or agree on how to perform the behaviour 
(includes ‘Skills training’)  
Note: when the person attends classes such as 
exercise or cookery, code 36, Instruction on how 
to perform the behaviour, 23, Behavioural 
practice/rehearsal and 84, Demonstration of the 
behaviour  
Advise the person how 
to put a condom on a 
model of a penis 
correctly  
37.  Information 
about 
antecedents  
Provide information about antecedents  
(e.g. social and environmental situations and 
events, emotions, cognitions) that reliably predict 
performance of the behaviour  
Advise to keep a record 
of snacking and of 
situations or events 
occurring prior to 
snacking  
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No.  Label  Definition  Examples  
38.  Re-
attribution  
Elicit perceived causes of behaviour and suggest 
alternative explanations (e.g. external or internal 
and stable or unstable)  
If the person attributes 
their over-eating to the 
frequent presence of 
delicious food, suggest 
that the ‘real’ cause 
may be the person’s 
inattention to bodily 
signals of hunger and 
satiety  
39.  Behavioural 
experiments  
Advise on how to identify and test hypotheses 
about the behaviour, its causes and 
consequences, by collecting and interpreting data  
Ask a family physician 
to give evidence-based 
advice rather than 
prescribe antibiotics 
and to note whether 
the patient is grateful 
or annoyed  
Self-belief  
40.  Verbal 
persuasion 
about 
capability  
Tell the person that they can successfully perform 
the wanted behaviour, arguing against self-doubts 
and asserting that they can and will succeed  
Note: distinction between 89, Vicarious 
consequences, and 40, Verbal persuasion about 
capability, i.e. 40 is not about the consequences of 
performing the behaviour  
Tell the person that 
they can successfully 
increase their 
frequency of physical 
activity, arguing against 
self-doubts and 
asserting that they can 
and will succeed  
41.  Mental 
rehearsal of 
successful 
performance  
Advise to practise imagining performing the 
behaviour successfully in relevant contexts  
Advise to imagine 
eating a salad in a work 
canteen  
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No.  Label  Definition  Examples  
42.  Focus on past 
success  
Advise to think about or list previous successes in 
performing the behaviour (or parts of it)  
Advise to describe or 
list the occasions on 
which a doctor advised 
a patient with acute 
low back pain to stay 
active to manage this 
condition  
43.  Self-talk  Prompt positive self-talk (aloud or silently) before 
and during the behaviour  
Prompt the person to 
tell themselves that a 
walk will be energising  
Scheduled consequences  
44.  Punishment  Identify and provide aversive consequence 
contingent on the performance of the unwanted 
behaviour  
Arrange for the person 
to wear unattractive 
clothes following 
consumption of fatty 
foods  
45.  Behaviour 
cost  
Withdraw something valued (not a contingent 
reward) if and only if an unwanted behaviour is 
performed (includes ‘Response cost’)  
Subtract money from a 
prepaid refundable 
deposit when a 
cigarette is smoked  
46.  Remove 
reward  
Discontinue contingent reward for performing the 
unwanted behaviour (includes ‘Extinction’)  
Arrange for the other 
people in the 
household to ignore 
the person every time 
they eat chocolate 
(rather than attending 
to them by criticising or 
persuading)  
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No.  Label  Definition  Examples  
47.  Reward 
approximatio
n  
Reward any approximation to the target 
behaviour, gradually rewarding only performance 
closer to the wanted behaviour (includes 
‘Shaping’)  
Note: also code one of 54-57  
Arrange for or reward 
the person for any 
reduction in daily 
calories, gradually 
requiring the daily 
calorie count to 
become closer to the 
planned calorie intake  
48.  Rewarding 
completion  
Build up behaviour by rewarding final component 
of the behaviour; gradually add the components 
of the behaviour that occur earlier in the 
behavioural sequence (includes ‘Backward 
chaining’)  
Note: also code one of 54-57  
Reward eating a 
supplied low calorie 
meal; then make 
reward contingent on 
cooking and eating the 
meal; then make 
reward contingent on 
purchasing, cooking 
and eating the meal  
49.  Situation-
specific 
reward  
Reward the behaviour in one situation but not in 
another. Note: also code one of 54-57 (includes 
‘Discrimination training’)  
Arrange for or reward 
eating sweet foods at 
mealtimes but not 
between meals  
50.  Reward 
incompatible 
behaviour  
Reward for responding to a stimulus in a manner 
that is incompatible with a previous response to 
that stimulus (includes ‘Counter-conditioning’)  
Note: also code one of 54-57  
Arrange for or reward 
the person for ordering 
a soft drink at the bar 
rather than an alcoholic 
beverage  
51.  Reward 
alternative 
behaviour  
Arrange reward for performance of an alternative 
to the unwanted behaviour (includes ‘Differential 
reinforcement’)  
Note: also code one of 54-57; consider also coding 
Reward for 
consumption of low fat 
foods but not 
consumption of high fat 
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61, Problem solving  foods  
52.  Reduce 
reward 
frequency  
Arrange for rewards to be made contingent on 
increasing duration or frequency of the behaviour 
(includes ‘Thinning’)  
Note: also code one of 54-57  
Arrange for or reward 
for each day without 
smoking, then each 
week, then each 
month, then every 2 
months and so on  
53.  Remove 
punishment  
Arrange for removal of an unpleasant 
consequence contingent on performance of the 
wanted behaviour (includes ‘Negative 
reinforcement’)  
Arrange for someone 
else to do 
housecleaning only if 
the person has adhered 
to the medication 
regimen for a week  
Reward and threat  
54.  Material 
reward 
(behaviour)  
Arrange for the delivery of money, vouchers or 
other valued objects if and only if there has been 
effort and/or progress made towards performing 
the behaviour (includes ‘Positive reinforcement’)  
Note: if reward is social, code 56, Social reward, if 
unspecified code 57, Non-specific reward, and not 
54, Material reward (behaviour); if reward is for 
outcome, code 55, Material reward (outcome)  
Arrange for the person 
to receive money that 
would have been spent 
on cigarettes if and only 
if the smoker has not 
smoked for one month  
55.  Material 
reward 
(outcome)  
Arrange for the delivery of a reward if and only if 
there has been effort and/or progress made 
towards achieving the behavioural outcome 
(includes ‘Positive reinforcement’)  
Note: this includes social, material, self- and non-
Arrange for the person 
to receive money if and 
only if a certain amount 
of weight is lost  
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No.  Label  Definition  Examples  
specific rewards for outcome; if reward is for the 
behaviour code 56,Social reward, 54 Material 
reward (behaviour), 57 Non-specific reward or 
58, Self-reward and not 55, Material reward 
(outcome)  
56.  Social reward  Arrange verbal or non-verbal reward if and only if 
there has been effort and/or progress made 
towards performing the behaviour (includes 
‘Positive reinforcement’)  
Note: if reward is material, code 54, Material 
reward (behaviour), if unspecified code 57, Non-
specific reward, and not 56, Social reward; if 
reward is for outcome code 55, Material reward 
(outcome)  
Congratulate the 
person for each day 
they eat a reduced fat 
diet  
57.  Non-specific 
reward  
Arrange delivery of a reward if and only if there 
has been effort and/or progress made towards 
performing the behaviour (includes ‘Positive 
reinforcement’)  
Note: if reward is material, code 54, Material 
reward (behaviour), if social, code 56, Social 
reward, and not 57, Non-specific reward; if 
reward is for outcome code 55, Material reward 
(outcome)  
Identify something (e.g. 
an activity such as a 
visit to the cinema) that 
the person values and 
arrange for this to be 
delivered if and only if 
they attend for health 
screening  
58.  Self-reward  Prompt self-praise or self-reward if and only if 
there has been effort and/or progress made 
towards the behaviour  
Note: if self-reward is material, also code 54, 
Material reward (behaviour), if social, also code 
56, Social reward, if unspecified, also code 57, 
Non-specific reward; if reward is for outcome 
Encourage to reward 
self with material (e.g., 
new clothes) or other 
valued objects if and 
only if they have 
adhered to a healthy 
diet  
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No.  Label  Definition  Examples  
code 55, Material reward (outcome)  
59.  Future 
punishment  
Inform that future punishment or removal of 
reward will be a consequence of performance of 
an unwanted behaviour (may include fear 
arousal) (includes ‘Threat’)  
Inform that continuing 
to consume 30 units of 
alcohol per day is likely 
to result in liver disease 
and early death  
60.  Material 
incentive 
(behaviour)  
Inform that money, vouchers or other valued 
objects will be delivered if and only if there has 
been effort and/or progress made towards 
performing the behaviour (includes ‘Positive 
reinforcement’)  
Note: if incentive is social, code 62, Social 
incentive if unspecified code 63, Non-specific 
incentive, and not 60, Material incentive 
(behaviour); if incentive is for outcome, code 61, 
Material incentive (outcome)  
Inform that a financial 
payment will be made 
each month in 
pregnancy that the 
woman has not smoked  
61.  Material 
incentive 
(outcome)  
Inform that a reward will be delivered if and only 
if there has been effort and/or progress made 
towards achieving the behavioural outcome 
(includes ‘Positive reinforcement’)  
Note: this includes social, material, self- and non-
specific incentives for outcome; if incentive is for 
the behaviour code 62,Social incentive, 60 
Material incentive (behaviour), 63 Non-specific 
incentive or 64, Self-incentive and not 61, 
Material incentive (outcome)  
Inform the person that 
they will receive money 
if and only if a certain 
amount of weight is lost  
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No.  Label  Definition  Examples  
62.  Social 
incentive  
Inform that a verbal or non-verbal reward will be 
delivered if and only if there has been effort 
and/or progress made towards performing the 
behaviour (includes ‘Positive reinforcement’)  
Note: if incentive is material, code 60, Material 
incentive (behaviour), if unspecified code 63, 
Non-specific incentive, and not 62, Social 
incentive; if incentive is for outcome code 61, 
Material incentive (outcome)  
Inform that they will be 
congratulated for each 
day they eat a reduced 
fat diet  
63.  Non-specific 
incentive  
Inform that a reward will be delivered if and only 
if there has been effort and/or progress made 
towards performing the behaviour (includes 
‘Positive reinforcement’)  
Note: if reward is material, code 54, Material 
reward (behaviour), if social, code 56, Social 
reward, and not 57, Non-specific reward; if 
reward is for outcome code 55, Material reward 
(outcome)  
Identify something (e.g. 
an activity such as a 
visit to the cinema) that 
the person values and 
inform them that this 
will be delivered if and 
only if they attend for 
health screening  
64.  Self-incentive  Prompt self-incentive if and only if there has been 
effort and/or progress made towards the 
behaviour  
Note: if self-reward is material, also code 60, 
Material incentive (behaviour), if social, also code 
62, Social incentive, if unspecified, also code 63, 
Non-specific incentive; if incentive is for outcome 
code 61, Material incentive (outcome)  
Encourage to provide 
self with material (e.g., 
new clothes) or other 
valued objects if and 
only if they have 
adhered to a healthy 
diet  
Goals and planning  
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65.  Problem 
solving  
Analyse factors influencing the behaviour and 
generate or select strategies that include 
overcoming barriers and/or increasing facilitators 
(includes ‘Relapse Prevention’ and ‘Coping 
Planning’)  
Note: barrier identification without solutions is not 
sufficient. If the BCT does not include analysing the 
behavioural problem, consider 32, 
Avoidance/changing exposure to cues for the 
behaviour, 30, Restructuring the physical 
environment, 31, Restructuring the social 
environment, or 5, Reduce negative emotions  
Identify specific triggers 
(e.g. being in a pub, 
feeling anxious) that 
generate the 
urge/want/need to 
drink and develop 
strategies for avoiding 
environmental triggers 
or for managing 
negative emotions, 
such as anxiety, that 
motivate drinking  
66.  Goal setting 
(behaviour)  
Set or agree a goal defined in terms of the 
behaviour to be achieved  
Note: only code goal-setting if there is sufficient 
evidence that goal set as part of intervention; if 
goal unspecified or a behavioural outcome, code 
63, Goal setting (outcome); if the goal defines a 
specific context, frequency, duration or intensity 
for the behaviour, also code 64, Action planning  
Invite the person to 
propose a daily walking 
goal (e.g. to walk for at 
least 30 minutes every 
day) and reach 
agreement about the 
goal  
Set the goal of eating 5 
pieces of fruit per day 
as specified in public 
health guidelines  
67.  Goal setting 
(outcome)  
Set or agree a goal defined in terms of a positive 
outcome of wanted behaviour  
Note: only code guidelines if set as a goal in an 
intervention context; if goal is a behaviour, code 
62, Goal setting (behaviour); if goal unspecified 
code 63, Goal setting (outcome)  
Invite the person to set 
a weight loss goal (e.g. 
0.5 kilogram over one 
week) as an outcome of 
changed eating 
patterns  
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68.  Action 
planning  
Prompt detailed planning of performance of the 
behaviour (must include at least one of context, 
frequency, duration and intensity). Context may 
be environmental (physical or social) or internal 
(physical, emotional or cognitive) (includes 
‘Implementation Intentions’)  
Note: evidence of action planning does not 
necessarily imply goal setting, only code latter if 
sufficient evidence  
Encourage a plan to 
carry condoms when 
going out socially at 
weekends  
Prompt planning the 
performance of a 
particular physical 
activity (e.g. running) at 
a particular time (e.g. 
before work) on certain 
days of the week  
69.  Review 
behaviour 
goal(s)  
Review behaviour goal(s) jointly with the person 
and consider modifying goal(s) or behaviour 
change strategy in light of achievement. This may 
lead to re-setting the same goal, a small change in 
that goal or setting a new goal instead of, or in 
addition to, the first Note: if goal specified in 
terms of behaviour, code 65, Review behaviour 
goal(s), if goal unspecified, code 66, Review 
outcome goal(s); if discrepancy created consider 
also 69, Discrepancy between current behaviour 
and goal  
Examine how well a 
person’s performance 
corresponds to agreed 
goals e.g. whether they 
consumed less than 
one unit of alcohol per 
day, and consider 
modifying future 
behavioural goals 
accordingly e.g. by 
increasing or 
decreasing alcohol 
target or changing type 
of alcohol consumed  
70.  Review 
outcome 
goal(s)  
Review outcome goal(s) jointly with the person 
and modify goal(s) or behaviour change strategy 
in light of achievement. This may lead to re-
setting the same goal, a small change in that goal 
or setting a new goal instead of, or in addition to 
the first  
Note: if goal specified in terms of behaviour, code 
Examine how much 
weight has been lost 
and consider modifying 
outcome goal(s) 
accordingly e.g., by 
increasing or 
decreasing subsequent 
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65, Review behaviour goal(s), if goal unspecified, 
code 66, Review outcome goal(s); if discrepancy 
created consider also 69, Discrepancy between 
current behaviour and goal  
weight loss targets  
71.  Behavioural 
contract  
Create a written specification of the behaviour to 
be performed, agreed by the person, and 
witnessed by another  
Note: also code 62, Goal setting (behaviour)  
Sign a contract with the 
person e.g. specifying 
that they will not drink 
alcohol for one week  
72.  Commitment  Ask the person to make statements indicating 
strong commitment to change the behaviour  
Note: if defined in terms of the behaviour to be 
achieved also code 62, Goal setting (behaviour)  
Ask the person to use 
an “I will” statement to 
affirm or reaffirm a 
strong commitment 
(i.e. using the words 
‘strongly’, ‘committed’ 
or ‘high priority’) to 
start, continue or 
restart the attempt to 
reduce alcohol use  
73.  Discrepancy 
between 
current 
behaviour 
and goal  
Draw attention to discrepancies between a 
person’s current behaviour (in terms of the form, 
frequency, duration, or intensity of that 
behaviour) and the person’s previously set 
outcome goals, behavioural goals or action plans 
(goes beyond self-monitoring of behaviour)  
Note: if discomfort is created only code 76, 
Incompatible beliefs and not 69, Discrepancy 
between current behaviour and goal; if goals are 
Point out that the 
recorded exercise fell 
short of the goal set  
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modified, also code 65, Review behaviour goal(s) 
and/or 66, Review outcome goal(s); if feedback is 
provided, also code 8, Feedback on behaviour  
Comparison of outcomes  
74.  Persuasive 
source  
Present verbal or visual communication from a 
credible source in favour of or against the 
behaviour  
Note: code this BCT if source generally agreed on 
as credible e.g., health professionals, celebrities or 
words used to indicate expertise or leader in field; 
if information about health consequences, also 
code 78, Information about health consequences, 
if about emotional consequences, also code 79, 
Information about emotional consequences; if 
about social, environmental or unspecified 
consequences also code 80, Information about 
social and environmental consequences  
Present a speech given 
by a high status 
professional to 
emphasise the 
importance of not 
exposing patients to 
unnecessary radiation 
by ordering x-rays for 
back pain  
75.  Pros and cons  Advise the person to identify and compare 
reasons for wanting (pros) and not wanting to 
(cons) change the behaviour (includes ‘Decisional 
balance’)  
Note: if information about health consequences, 
also code 78, Information about health 
consequences; if about emotional consequences, 
also code 79, Information about emotional 
consequences; if about social, environmental or 
unspecified consequences also code 80, 
Advise the person to 
list and compare the 
advantages and 
disadvantages of 
prescribing antibiotics 
for upper respiratory 
tract infections  
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Information about social and environmental 
consequences  
76.  Comparative 
imagining of 
future 
outcomes  
Prompt or advise the imagining and comparing of 
future outcomes of changed versus unchanged 
behaviour  
Prompt the person to 
imagine and compare 
likely or possible 
outcomes following 
attending versus not 
attending a screening 
appointment  
Identity  
77.  Identification 
of self as role 
model  
Inform that one's own behaviour may be an 
example to others  
Inform the person that 
healthy eating may be a 
good example for their 
children  
78.  Valued self-
identity  
Advise the person to write or complete rating 
scales about a cherished value or personal 
strength as a means of affirming the person’s 
identity as part of a behaviour change strategy 
(includes ‘Self-affirmation’)  
Advise the person to 
write about their 
personal strengths 
before they receive a 
message advocating 
the behaviour change  
79.  Framing/refr
aming  
Suggest the deliberate adoption of a perspective 
or new perspective on behaviour (e.g. its purpose) 
in order to change cognitions or emotions about 
performing the behaviour (includes ‘Cognitive 
Suggest that the person 
might think of the tasks 
as reducing sedentary 
behaviour (rather than 
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structuring’)  increasing activity)  
80.  Incompatible 
beliefs  
Draw attention to discrepancies between current 
or past behaviour and self-image, in order to 
create discomfort (includes ‘Cognitive 
dissonance’)  
Draw attention to a 
critical care 
consultant’s liberal use 
of blood transfusion 
and their self-
identification as a 
proponent of evidence-
based medical practice  
81.  Identity 
associated 
with changed 
behaviour  
Advise the person to construct a new self-identity 
as someone who ‘used to engage with the 
unwanted behaviour’  
Ask the person to 
articulate their new 
identity as an ‘ex-
smoker’  
Natural consequences  
82.  Information 
about health 
consequences  
Provide information about health consequences 
of performing the behaviour  
Note: consequences can be for any target, not just 
the recipient(s) of the intervention; if information 
about emotional consequences, code 79, 
Information about emotional consequences; if 
about social, environmental or unspecified 
consequences code 80, Information about social 
and environmental consequences  
Explain that not 
finishing a course of 
antibiotics can increase 
susceptibility to future 
infection  
Present the likelihood 
of contracting a sexually 
transmitted infection 
following unprotected 
sexual behaviour  
  
 
 
B
eh
av
io
u
r 
C
h
an
ge
 U
p
d
at
e:
 S
ta
ge
 3
 
 
240 
No.  Label  Definition  Examples  
83.  Information 
about 
emotional 
consequences  
Provide information about emotional 
consequences of performing the behaviour  
Note: not including 83, Anticipated regret; 
consequences can be for any target, not just the 
recipient(s) of the intervention; if information 
about health consequences code 78, Information 
about health consequences; if about social, 
environmental or unspecified code 80, 
Information about social and environmental 
consequences  
Explain that quitting 
smoking increases 
happiness and life 
satisfaction  
84.  Information 
about social 
and 
environment
al 
consequences  
Provide information about social and 
environmental consequences of performing the 
behaviour  
Note: consequences can be for any target, not 
just the recipient(s) of the intervention; if 
information about health or consequences, code 
78, Information about health consequences; if 
about emotional consequences, code 79, 
Information about emotional consequences; if 
unspecified, code 80, Information about social 
and environmental consequences  
Tell family physician 
about financial 
remuneration for 
conducting health 
screening  
85.  Salience of 
consequences  
Use methods to emphasise (make more 
memorable) the consequences of changing the 
behaviour (goes beyond informing about 
consequences)  
Produce cigarette 
packets showing 
pictures of health 
consequences e.g. 
diseased lungs  
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86.  Monitoring 
of emotional 
consequences  
Prompt assessment of feelings after attempts at 
performing the behaviour  
Agree that the person 
will record how they 
feel after e.g., taking 
their daily walk  
87.  Anticipated 
regret  
Induce expectations of future regret about 
performance of the unwanted behaviour  
Note: not including 79, Information about 
emotional consequences  
Ask the person to assess 
the degree of regret 
they will feel if they do 
not quit smoking (e.g. 
on a 5 point scale)  
Comparison of behaviour  
88.  Demonstra-
tion of the 
behaviour  
Provide an example of the behaviour being 
performed for the person to aspire to or imitate 
(includes ‘Modelling’)  
Demonstrate to nurses 
how to raise the issue 
of excessive drinking 
with patients via a role-
play exercise  
89.  Social 
comparison  
Draw attention to others’ performance to 
explicitly elicit comparisons Note: being in a group 
setting does not necessarily mean that social 
comparison is actually taking place  
Show the general 
practitioner the 
proportion of patients 
who were prescribed 
antibiotics for a 
common cold by 
themselves and by 
their colleagues  
90.  Information 
about others’ 
approval  
Provide information about what other people 
think about the behaviour. The information 
clarifies whether others will like, approve or 
disapprove of what the person is doing or will do  
Tell the staff at the 
hospital ward that staff 
at all other wards 
approve of washing 
their hands according 
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to the guidelines  
 
Covert learning  
91.  Imaginary 
punishment  
Advise to imagine performing the unwanted 
behaviour in a real-life situation followed by 
imagining an unpleasant consequence (includes 
‘Covert sensitisation’)  
Advise to imagine 
overeating and then 
vomiting  
92.  Imaginary 
reward  
Advise to imagine performing the wanted 
behaviour in a real-life situation followed by 
imagining a pleasant consequence (includes 
‘Covert conditioning’)  
Advise the health 
professional to imagine 
giving dietary advice 
followed by the patient 
losing weight and no 
longer being diabetic  
93.  Vicarious 
consequences  
Prompt observation of the consequences 
(including rewards and punishments) for others 
when they perform the behaviour  
Note: if observation of health consequences, also 
code 78, Information about health consequences; 
if of emotional consequences, also code 79, 
Information about emotional consequences, if of 
social, environmental or unspecified 
consequences, also code 80, Information about 
social and environmental consequences  
Draw attention to the 
positive comments 
other staff get when 
they disinfect their 
hands regularly  
 
